0001558370-23-009840.txt : 20230515 0001558370-23-009840.hdr.sgml : 20230515 20230515160549 ACCESSION NUMBER: 0001558370-23-009840 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ClearSign Technologies Corp CENTRAL INDEX KEY: 0001434524 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 000000000 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35521 FILM NUMBER: 23922041 BUSINESS ADDRESS: STREET 1: 8023 E. 63RD PLACE, SUITE 101 CITY: TULSA STATE: OK ZIP: 74133 BUSINESS PHONE: (918) 236-6461 MAIL ADDRESS: STREET 1: 8023 E. 63RD PLACE, SUITE 101 CITY: TULSA STATE: OK ZIP: 74133 FORMER COMPANY: FORMER CONFORMED NAME: CLEARSIGN COMBUSTION CORP DATE OF NAME CHANGE: 20080507 10-Q 1 clir-20230331x10q.htm 10-Q
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet0001434524--12-312023Q1false003854555638023701P6MP3YP3Y0001434524us-gaap:RetainedEarningsMember2023-03-310001434524us-gaap:AdditionalPaidInCapitalMember2023-03-310001434524us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001434524us-gaap:RetainedEarningsMember2022-12-310001434524us-gaap:AdditionalPaidInCapitalMember2022-12-310001434524us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001434524us-gaap:RetainedEarningsMember2022-03-310001434524us-gaap:ParentMember2022-03-310001434524us-gaap:AdditionalPaidInCapitalMember2022-03-310001434524us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001434524us-gaap:RetainedEarningsMember2021-12-310001434524us-gaap:ParentMember2021-12-310001434524us-gaap:AdditionalPaidInCapitalMember2021-12-310001434524us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001434524us-gaap:CommonStockMember2023-03-310001434524us-gaap:CommonStockMember2022-12-310001434524us-gaap:CommonStockMember2022-03-310001434524us-gaap:CommonStockMember2021-12-310001434524clir:ConsultantPlanMember2023-03-310001434524clir:ConsultantPlanMember2022-12-310001434524clir:EquityIncentivePlanMember2023-01-012023-03-310001434524us-gaap:RestrictedStockUnitsRSUMember2023-03-310001434524us-gaap:RestrictedStockUnitsRSUMember2022-12-310001434524us-gaap:WarrantMember2023-01-012023-03-310001434524clir:ConsultantPlanMember2023-01-012023-03-310001434524srt:MinimumMemberclir:PropertyPlantAndEquipmentOtherThanLeaseholdImprovementsMember2023-01-012023-03-310001434524srt:MaximumMemberclir:PropertyPlantAndEquipmentOtherThanLeaseholdImprovementsMember2023-01-012023-03-310001434524us-gaap:RetainedEarningsMember2023-01-012023-03-310001434524us-gaap:RetainedEarningsMember2022-01-012022-03-310001434524us-gaap:MachineryAndEquipmentMember2023-03-310001434524us-gaap:MachineryAndEquipmentMember2022-12-310001434524country:CN2022-06-300001434524srt:MinimumMemberclir:SeattleAndTulsaMember2023-03-310001434524srt:MaximumMemberclir:SeattleAndTulsaMember2023-03-310001434524us-gaap:LeaseholdsAndLeaseholdImprovementsMember2023-03-310001434524us-gaap:LeaseholdsAndLeaseholdImprovementsMember2022-12-3100014345242023-03-012023-03-310001434524clir:OklahomaQualityJobsActMember2021-01-012021-12-310001434524clir:ResearchGrantFromDepartmentOfEnergyMember2023-01-012023-03-310001434524clir:OklahomaQualityJobsActMember2023-01-012023-03-310001434524clir:ResearchGrantFromDepartmentOfEnergyMember2022-01-012022-03-310001434524clir:OklahomaQualityJobsActMember2022-01-012022-03-310001434524us-gaap:FurnitureAndFixturesMember2023-03-310001434524us-gaap:FurnitureAndFixturesMember2022-12-310001434524clir:TrademarksPendingMember2023-03-310001434524clir:RegisteredTrademarksMember2023-03-310001434524clir:TrademarksPendingMember2022-12-310001434524clir:RegisteredTrademarksMember2022-12-310001434524clir:PatentsPendingMember2023-03-310001434524clir:IssuedPatentsMember2023-03-310001434524clir:PatentsPendingMember2022-12-310001434524clir:IssuedPatentsMember2022-12-310001434524us-gaap:TrademarksMember2023-01-012023-03-310001434524srt:MinimumMember2023-01-012023-03-310001434524srt:MaximumMember2023-01-012023-03-310001434524srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMember2023-03-310001434524srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMember2022-03-3100014345242022-03-3100014345242021-12-310001434524country:CN2022-12-3100014345242022-01-012022-12-3100014345242023-05-100001434524us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001434524us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001434524srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001434524clir:ParticipationRightMember2018-07-310001434524us-gaap:ShareBasedPaymentArrangementEmployeeMember2023-01-012023-03-310001434524us-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-03-310001434524us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001434524us-gaap:CommonStockMember2023-01-012023-03-310001434524us-gaap:CommonStockMember2022-01-012022-03-310001434524us-gaap:ParentMember2022-01-012022-03-310001434524us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001434524clir:TwoThousandAndTwentyOnePlanMember2023-01-012023-03-310001434524clir:SeattleAndTulsaMember2023-01-012023-03-310001434524clir:SeattleAndTulsaMember2022-01-012022-12-310001434524clir:ResearchGrantFromDepartmentOfEnergyMember2022-01-012022-12-3100014345242022-12-310001434524srt:MinimumMemberclir:SeattleAndTulsaMember2023-01-012023-03-310001434524clir:EquityIncentivePlanMember2023-03-310001434524clir:EquityIncentivePlanMember2022-12-310001434524clir:SeattleAndTulsaMember2023-03-012023-03-310001434524country:CN2022-06-012022-06-300001434524clir:AtMarketOfferingMember2023-03-310001434524us-gaap:CommonStockMemberclir:AtMarketOfferingMember2023-03-3100014345242023-03-3100014345242022-01-012022-03-3100014345242023-01-012023-03-310001434524country:CN2023-03-310001434524clir:AtMarketOfferingMember2023-01-012023-03-31iso4217:USDiso4217:USDxbrli:sharesxbrli:sharesxbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to _______________

Commission File Number 001-35521

CLEARSIGN TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in its charter)

Washington
(State or other jurisdiction of
incorporation or organization)

    

26-2056298
(I.R.S. Employer
Identification No.)

8023 E. 63rd Place, Suite 101

Tulsa, Oklahoma 74133

(Address of principal executive offices)

(Zip Code)

(918) 236-6461

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

 

 

 

 

 

Common Stock

CLIR

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period than the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

    

Accelerated filer 

 

 

 

Non-accelerated filer 

 

Smaller reporting company

 

 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No 

As of May 10, 2023, the issuer has 38,545,556 shares of common stock, par value $0.0001, issued and outstanding.

TABLE OF CONTENTS

PART I

FINANCIAL INFORMATION

Item 1.

Unaudited Condensed Consolidated Financial Statements

Unaudited Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022

1

Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022

2

Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2023 and 2022

3

Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022

4

Notes to Unaudited Condensed Consolidated Financial Statements

5

Item 2.

Management’s Discussion and Analysis of Financial Conditions and Results of Operations

19

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

24

Item 4.

Controls and Procedures

24

PART II

OTHER INFORMATION

25

Item 1.

Legal Proceedings

25

Item 1A.

Risk Factors

25

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

26

Item 3.

Defaults Upon Senior Securities

26

Item 4.

Mine Safety Disclosures

26

Item 5.

Other Information

26

Item 6.

Exhibits

27

SIGNATURES

28

PART I-FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ClearSign Technologies Corporation and Subsidiary

Condensed Consolidated Balance Sheets

(Unaudited)

(in thousands, except share and per share data)

March 31, 

December 31, 

    

2023

    

2022

    

ASSETS

Current Assets:

 

  

 

  

 

Cash and cash equivalents

$

5,328

$

6,451

Short-term held-to-maturity investments

 

3,161

 

2,606

Accounts receivable, net

50

79

Contract assets

 

4

 

20

Prepaid expenses and other assets

 

317

 

577

Total current assets

 

8,860

 

9,733

Fixed assets, net

 

515

 

384

Patents and other intangible assets, net

 

782

 

798

Other assets

 

10

 

10

Total Assets

$

10,167

$

10,925

LIABILITIES AND EQUITY

 

  

 

  

Current Liabilities:

 

 

  

Accounts payable and accrued liabilities

$

398

$

296

Current portion of lease liabilities

 

77

 

133

Accrued compensation and related taxes

 

253

 

471

Contract liabilities

639

247

Total current liabilities

 

1,367

 

1,147

Long Term Liabilities:

 

 

Long term lease liabilities

 

213

226

Total liabilities

 

1,580

 

1,373

Commitments and contingencies (Note 7)

 

 

Stockholders’ Equity:

 

  

 

  

Preferred stock, $0.0001 par value, zero shares issued and outstanding

 

 

Common stock, $0.0001 par value, 38,545,556 and 38,023,701 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively

 

4

4

Additional paid-in capital

 

98,543

98,079

Accumulated other comprehensive loss

(8)

(8)

Accumulated deficit

 

(89,952)

(88,523)

Total equity

 

8,587

 

9,552

Total Liabilities and Equity

$

10,167

$

10,925

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

1

ClearSign Technologies Corporation and Subsidiary

Condensed Consolidated Statements of Operations

(Unaudited)

(in thousands, except share and per share data)

For the Three Months Ended

March 31, 

    

2023

    

2022

    

Revenues

$

894

$

Cost of goods sold

 

788

 

Gross profit

 

106

 

Operating expenses:

Research and development

 

160

 

108

General and administrative

 

1,650

 

1,409

Total operating expenses

 

1,810

 

1,517

Loss from operations

 

(1,704)

 

(1,517)

Other income

Interest, net

58

Government assistance

93

Gain from sale of assets

5

23

Other income, net

119

4

Total other income

 

275

 

27

Net loss

(1,429)

(1,490)

Net loss per share - basic and fully diluted

$

(0.04)

$

(0.05)

Weighted average number of shares outstanding - basic and fully diluted

 

38,262,710

 

31,826,221

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

ClearSign Technologies Corporation and Subsidiary

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

For the Three Months Ended March 31, 2023 and 2022

Total ClearSign

Accumulated Other

Technologies Corp.

(in thousands, except per share data)

Common Stock

Additional

Comprehensive

Accumulated

Stockholders’

Shares

  

Amount

  

Paid-In Capital

  

Income (Loss)

  

Deficit

  

Equity

Balances at December 31, 2022

 

38,023

$

4

$

98,079

$

(8)

$

(88,523)

$

9,552

Share based compensation

223

227

227

Fair value of stock issued in payment of accrued compensation

296

234

234

Shares issued for services ($0.66 per share)

4

3

3

Net loss

(1,429)

(1,429)

Balances at March 31, 2023

 

38,546

$

4

$

98,543

$

(8)

$

(89,952)

$

8,587

Total ClearSign

    

    

    

    

Accumulated Other

    

Technologies Corp.

Common Stock

Additional

Comprehensive

Accumulated

Stockholders'

Shares

Amount

Paid-In Capital

Income (Loss)

Deficit

Equity

Balances at December 31, 2021

31,582

$

3

$

91,035

$

9

$

(82,765)

$

8,282

Shares issued upon exercise of options ($0.89 per share)

1

Shares issued upon exercise of options ($2.93 per share)

 

3

 

 

 

 

Fair value of stock issued in payment of accrued compensation

 

66

 

 

95

 

 

95

Fair value of stock options granted in payment of accrued compensation

12

12

Share based compensation

 

3

 

 

80

 

 

80

Shares issued through the use of At-The Market issuance ($1.24 average per share)

 

496

 

 

578

 

 

578

Shares issued for services ($1.93 per share)

4

7

7

Net loss

(1,490)

(1,490)

Balances at March 31, 2022

32,155

$

3

$

91,807

$

9

$

(84,255)

$

7,564

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

ClearSign Technologies Corporation and Subsidiary

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(in thousands)

For the Three Months Ended March 31, 

    

2023

    

2022

    

Cash flows from operating activities:

Net loss

$

(1,429)

$

(1,490)

Adjustments to reconcile net loss to net cash used in operating activities:

 

Common stock issued for services

 

3

7

Share-based compensation

 

242

80

Depreciation and amortization

 

80

36

Gain from sale of fixed assets

(5)

(23)

Right of use asset amortization

 

43

35

Realized gain from marketable securities

(20)

Lease Amendments

(14)

Change in operating assets and liabilities:

 

Contract assets

 

16

(205)

Accounts receivable

 

29

6

Prepaid expenses and other assets

 

51

(56)

Accounts payable and accrued liabilities

 

57

22

Accrued compensation and related taxes

 

1

85

Contract liabilities

392

Net cash used in operating activities

 

(554)

 

(1,503)

Cash flows from investing activities:

 

  

 

  

Acquisition of fixed assets

 

(5)

Disbursements for patents and other intangible assets

 

(24)

(33)

Proceeds from sale of fixed assets

5

23

Purchases of held-to-maturity short-term US treasuries

(2,162)

Redemption of held-to-maturity US treasuries

1,627

Net cash used in investing activities

 

(554)

 

(15)

Cash flows from financing activities:

 

  

 

  

Proceeds from issuance of common stock, net of offering costs

 

 

578

Taxes paid related to vesting of restricted stock units

(15)

Net cash (used in) provided by financing activities

 

(15)

 

578

Cash and cash equivalents:

Net change in cash and cash equivalents

 

(1,123)

(940)

Cash and cash equivalents, beginning of period

 

6,451

7,607

Cash and cash equivalents, end of period

$

5,328

$

6,667

Supplemental disclosure of cash flow information:

Officer and employee equity awards for prior year accrued compensation

$

234

$

107

Prior year prepaid expenses repurposed to fixed assets as demonstration equipment

$

209

$

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

ClearSign Technologies Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Note 1 – Organization and Description of Business

ClearSign Technologies Corporation (“ClearSign” or the “Company”) designs and develops products and technologies that have been shown to significantly improve key performance characteristics of industrial and commercial systems, including operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness. The Company’s patented technologies are designed to be embedded in established OEM products as ClearSign Core™ and ClearSign Eye™ and other sensing configurations in order to enhance the performance of combustion systems and fuel safety systems in a broad range of markets. These markets include energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. The Company’s primary technology is its ClearSign Core technology, which achieves very low emissions without the need of selective catalytic reduction.

The Company was incorporated in the State of Washington in 2008. During January 2022, the Company relocated its headquarters from Seattle, Washington to Tulsa, Oklahoma. On July 28, 2017, the Company incorporated a subsidiary, ClearSign Asia Limited, in Hong Kong to represent the Company’s business and technological interests throughout Asia. Through ClearSign Asia Limited, the Company has established a Wholly Foreign Owned Enterprise (WFOE) in China – ClearSign Combustion (Beijing) Environmental Technologies Co., LTD.

Unless otherwise stated or the context otherwise requires, the terms ClearSign and the Company refer to ClearSign Technologies Corporation and its subsidiary, ClearSign Asia Limited.

Liquidity

The Company's condensed consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As of March 31, 2023, the Company’s cash and cash equivalents totaled $5,328 thousand, and short-term held-to-maturity investments totaled $3,161 thousand, which is sufficient to fund current operating expenses beyond twelve months from the date hereof. The Company’s technologies are currently in field development, but with nominal fully operational commercial installations, and have generated nominal revenues from operations to date to meet operating expenses. In order to generate meaningful revenues, the technologies must be fully developed, gain market recognition and acceptance, and develop a critical level of successful sales and product installations.

Historically, the Company has financed operations primarily through issuances of equity securities. Since inception, the Company has raised approximately $91.0 million in gross proceeds through the sale of its equity securities. During the three months ended March 31, 2023, the Company did not raise proceeds through the issuance of common stock.

The Company has incurred losses since its inception totaling $90.0 million and expects to experience operating losses and negative cash flows for the foreseeable future. Management believes that the successful growth and operation of the Company’s business is dependent upon its ability to obtain adequate sources of funding through co-development agreements, strategic partnering agreements, or equity or debt financing to adequately support product commercialization efforts, protect intellectual property, form relationships with strategic partners, and provide for working capital and general corporate purposes. There can be no assurance that the Company will be successful in achieving its long-term plans as set forth above, or that such plans, if consummated, will result in profitable operations or enable the Company to continue in the long-term as a going concern.

5

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2022 has been derived from the Company’s audited financial statements as of that date.

In the opinion of management, these condensed consolidated financial statements reflect all normal recurring and other adjustments necessary for a fair presentation. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year or any other future periods.

The accompanying unaudited condensed consolidated financial statements include the accounts of ClearSign and its subsidiary. Intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition and Cost of Sales

The Company recognizes revenue and related cost of goods sold in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 606 Revenue from Contracts with Customers (“ASC 606”). When applying ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the promises and performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the performance obligations are satisfied. Revenues and cost of goods sold are recognized once the goods or services are delivered to the customer’s control or non-refundable performance obligations are satisfied. The Company’s contracts with customers generally have performance obligations and a schedule of non-refundable cancellation obligations. The contracts generally will be fully performed upon delivery of certain drawings or equipment. Revenue related to the contracts is recognized following the completion of non-refundable performance obligations as defined in the contract.

The Company’s contracts generally include progress payments from the customer upon completion of defined milestones. As these payments are received, they are offset against accumulated project costs and recorded as either contract assets or contract liabilities. Upon completion of the performance obligations and collectability is determined, revenue is recorded. For any contract that is expected to incur costs in excess of the contract price, the Company accrues the estimated loss in full in the period such determination is made.

Contract Costs

The Company capitalizes project costs until performance obligations related to the contract are completed. The Company expenses selling and marketing expenses when incurred within the statements of operations in general and administrative expenses.

6

Product Warranties

The Company warrants all installed products against defects in materials and workmanship for a period specified in each contract by replacing failed parts. Accruals for product warranties are based on historical or expected warranty experience and current product performance trends and are recorded as a component of cost of sales at the time revenue is recognized. The warranty liabilities are reduced by material and labor costs used to replace parts over the warranty period in the periods in which the costs are incurred. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary, and such adjustments could be material in the future if estimates differ significantly from actual warranty expense. Product warranties are included in accounts payable and accrued liabilities in the consolidated balance sheets.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on deposit in a checking and savings account, and short-term money market instruments with an original maturity of three months or less. Cash equivalents, which consist of short-term U.S. treasury bills, are based on quoted market prices, a Level 1 fair value measure.

Short-Term Investments

Short-term investments consist of U.S. treasuries with original maturities of twelve months or less and greater than three months. These short-term investments are classified as held to maturity and are recorded on an amortized cost basis based on the Company’s positive intent and ability to hold these securities to maturity. As of March 31, 2023, the Company has not experienced any other-than-temporary impairment of its short-term investments. A decline in the market value of any held-to-maturity security below cost that is deemed other than temporary results in a reduction in carrying amount to fair value. The impairment is charged to earnings and a new cost basis for the security is established. The company evaluates whether the decline in fair value of its investments is other-than temporary at each quarter-end.

The cost basis for the Company’s short-term investments totaled approximately $3,161 thousand and $2,606 thousand as of March 31, 2023 and December 31, 2022, respectively. The unrealized holding gains for the Company’s short-term investments totaled approximately $33 thousand and $4 thousand as of March 31, 2023 and December 31, 2022, respectively. The Company has not experienced any continuous unrealized holding losses on these investments. The fair value for the Company’s short-term investments totaled approximately $3,194 thousand and $2,610 thousand as of March 31, 2023 and December 31, 2022, respectively.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivables are recorded at the contractual invoiced amount. An allowance for doubtful accounts is established, as necessary, based on past experience and management’s judgment. The determination of the collectability of amounts due from customers require the Company to make judgments regarding future events and trends. Allowances for doubtful accounts are determined based on assessing the Company’s portfolio on an individual customer and on an overall basis. This process consists of a review of historical collection experience, current aging status of the customer accounts, and the financial condition of the Company’s customers. Based on a review of these factors, the Company may establish or adjust the allowance for specific customers and the accounts receivable portfolio as a whole.

Fixed Assets and Leases

Fixed assets are recorded at cost. Leases are recorded in accordance with FASB ASC 842, Leases. For those leases with a term greater than one year, the Company recognizes a right-of-use asset, which is included in fixed assets, net on the consolidated balance sheets, and a lease liability measured at the present value of the lease payments at the time of the lease inception or modification. Lease costs are recognized in the consolidated statement of operations over the lease term on a straight-line basis. Leases with a term of 1 year or less are considered short term leases with rent expense recognized over the lease term. Depreciation is computed using the straight-line method over the estimated useful lives of the respective lease assets. Leasehold improvements are depreciated over the life of the lease or their useful life,

7

whichever is shorter. All other fixed assets are depreciated over three to four years. Maintenance and repairs are expensed as incurred.

Patents and Trademarks

Third-party expenses related to patents and trademarks are recorded at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are awarded. Patent application costs are deferred pending the outcome of patent and trademark applications. Costs associated with unsuccessful patent applications and abandoned intellectual property are expensed when determined to have no continuing value in current business activity. The Company evaluates the recoverability of the carrying values of intangible assets each reporting period.

Impairment of Long-Lived Assets

The Company tests long-lived assets, consisting of fixed assets, patents, trademarks, and other intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected from the use and eventual disposition of the assets. In the event an asset is not fully recoverable, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Fair value is determined based on the present value of estimated expected cash flows using a discount rate commensurate with the risks involved, quoted market prices, or appraised values depending upon the nature of the assets. Losses on long-lived assets to be disposed are determined in a similar manner, except those fair values are reduced for the cost of disposal.

Fair Value of Financial Instruments

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs used to establish fair value are the following:

Level 1 – Quoted prices in active markets for identical assets or liabilities;
Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s financial instruments primarily consist of cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributable to the short-term nature of these instruments.

The Company did not identify any other recurring or non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.

Research and Development

The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consumables, and consulting fees, including costs to develop and test prototype equipment and parts. Research and Development costs have been offset by funds received, if any, from strategic partners

8

in cost sharing, collaborative projects. During the three months ended March 31, 2023 and 2022, the Company did not receive funds from these arrangements.

Government Assistance

The Company has adopted Accounting Standards Update (“ASU”) 2021-10, Government Assistance (Topic 832) Disclosures by Business Entities about Government Assistance, which requires footnote disclosure of assistance received from government entities. The Company records gross monies received from government entities in other income, and associated expenses such as salaries and supplies are recorded in Research and Development or General and Administration, depending on the nature of expenditure. The Company accrues for reimbursement requests submitted to government entities in accounts receivable.

Income Taxes

The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not the Company would not be able to realize their benefits, or that future deductibility is uncertain. Tax benefits are recognized only if it is more likely than not that the tax benefits will be utilized in the foreseeable future.

Share-Based Compensation

The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the unaudited condensed consolidated financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, or in the case of performance options, expense is recognized upon completion of milestones as defined in the grant agreement. Share-based compensation for stock grants to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.

Foreign Operations

The accompanying unaudited condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022 include assets amounting to approximately $277 thousand and $172 thousand, respectively, relating to operations of ClearSign Asia Limited. The Beijing registered capital requirement is $350 thousand, which is required to be paid by 2027, and of which $111 thousand has been paid as of March 31, 2023. It is always possible that unanticipated events in foreign countries could disrupt the Company’s operations, and since the first quarter of 2020 this has been and currently continues to be the case with the effects of the COVID-19 pandemic.

Foreign Currency

Assets and liabilities of ClearSign Asia Limited with non-U.S. Dollar functional currency are translated to U.S. Dollars using exchange rates in effect at the end of the period. Revenue and expenses are translated to U.S. Dollars using rates that approximate those in effect during the period. The resulting translation adjustments are included in the Company’s condensed consolidated balance sheets in the stockholders’ equity section as a component of accumulated other comprehensive income (loss).

Net Loss per Common Share

Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their

9

effect would be anti-dilutive. At March 31, 2023 and March 31, 2022, potentially dilutive shares outstanding amounted to 3.7 million and 3.3 million, respectively.

Recently Issued Accounting Pronouncements Adopted

In June 2017, the FASB issued an Accounting Standards Update (“ASU”) ASU 2016-13, Financial Instruments (Topic 326) Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. The standard replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. ASU 2016-13, and related amendments, are effective for fiscal years beginning after December 15, 2022. The Company adopted this standard on January 1, 2023. This standard did not have a material impact on the Company’s condensed consolidated financial statements.

Note 3 – Fixed Assets

Fixed Assets

Fixed assets are summarized as follows:

March 31, 

December 31, 

(in thousands)

    

2023

    

2022

    

Machinery and equipment

$

209

$

390

Office furniture and equipment

 

60

 

177

Leasehold improvements

 

43

 

192

312

759

Accumulated depreciation and amortization

 

(81)

 

(697)

231

62

Operating lease ROU assets, net

284

322

Total

$

515

$

384

Depreciation and amortization expense for the three months ended March 31, 2023 and 2022 totaled $40 thousand and $7 thousand, respectively.

Leases

The Company leases office space in Seattle, Washington, Tulsa, Oklahoma and Beijing, China. During June 2022, the Company entered into a new lease agreement for its Beijing office space for a period of one year with monthly rent at approximately $2 thousand. The Company classified this lease as an operating lease since it is more likely than not the lease will be renewed at the end of its term.

During March 2023, the Company amended its Seattle lease to extend the lease term to September 2023. The amended lease reduced the square footage and lowered the monthly payment to approximately $4 thousand. The Company increased the right of use asset by $5 thousand and decreased the lease liability by $9 thousand. The Seattle, Tulsa, and Beijing leases are classified as operating leases, with remaining terms ranging from six months to six years; contractual language requires renewal negotiations to occur at or near termination. These leases are normal and customary for office space, in that, contractual guarantees exist requiring the lessee to return the premises to its original functional state. The Company accrued a liability of $2 thousand and $87 thousand as of March 31, 2023 and December 31, 2022, respectively, for the estimated cost of the restoration of the Seattle office. The Company plans to exit the Seattle lease on or before contract termination as part of the Company’s headquarters move from Seattle to Tulsa.

The Tulsa lease contains fixed annual lease payments that increase annually by 2%. The Seattle, Tulsa, and Beijing total monthly minimum rent is approximately $11 thousand. Operating lease costs for the three months ended March 31, 2023 and 2022 were $48 thousand and $57 thousand, respectively.

10

Supplemental balance sheet information related to operating leases is as follows:

March 31, 

December 31, 

(in thousands)

2023

2022

Operating lease ROU assets, net

$

284

$

322

Lease Liabilities:

Current lease liabilities

$

77

$

133

Long term lease liabilities

213

226

Total lease liabilities

$

290

$

359

Weighted average remaining lease term (in years):

 

2.7

Weighted average discount rate:

 

5.2

%

For the Three Months Ended

March 31, 

2023

2022

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows used in operating leases

$

66

$

57

Non-cash impact of new leases and lease modifications

Change in operating lease liabilities

$

(9)

$

Change in operating lease ROU assets

$

5

$

Minimum future payments under the Company’s lease liabilities as of March 31, 2023 are as follows:

    

Discounted

    

Payments

lease

due under

(in thousands)

liability

lease

payments

agreements

2023

 

$

64

 

$

73

2024

 

54

 

65

2025

59

66

2026

63

67

2027

50

51

Total

$

290

$

322

At March 31, 2023, $32 thousand of the Company’s future minimum lease payments represents interest.

11

Note 4 – Patents and Other Intangible Assets

Patents and other intangible assets are summarized as follows:

March 31, 

December 31, 

(in thousands)

    

2023

    

2022

    

Patents

Patents pending

$

330

$

307

Issued patents

 

815

 

815

 

1,145

 

1,122

Trademarks

 

 

Trademarks pending

 

7

 

6

Registered trademarks

 

95

 

95

 

102

 

101

Other

 

8

 

8

 

1,255

 

1,231

Accumulated amortization

 

(473)

 

(433)

$

782

$

798

Future amortization expense associated with issued patents and registered trademarks as of March 31, 2023 is as follows:

(in thousands)

2023

    

$

108

2024

 

126

2025

 

96

2026

 

61

2027

 

39

Thereafter

 

7

$

437

The amortization life for patents ranges between three to five years, with trademark lives set at ten years. The Company does not amortize patents or trademarks classified as pending.

During the three months ended March 31, 2023 and 2022, the Company assessed its patent and trademark assets. The Company also evaluated its strategic approach to the pursuit and protection of its intellectual property. It is the intent of the Company to continue to pursue intellectual property protection.

If the Company identifies certain assets where the intellectual property does not directly align with its core technology, the Company will impair the intangible asset and write-off the asset as an expense.

Note 5 – Revenue, Contract Assets and Contract Liabilities

The Company recognized $894 thousand of revenues and $788 thousand of cost of goods sold during the three months ended March 31, 2023. The revenue and cost of goods sold relate predominately to the Company’s process burner product line, where the Company successfully completed a burner performance customer witness test, which represented a contractual performance obligation per ASC 606.

The Company did not recognize revenue or cost of goods sold for the three months ended March 31, 2022.

The Company had contract assets of $4 thousand and $20 thousand at March 31, 2023 and December 31, 2022, respectively. The Company had contract liabilities of $639 thousand and $247 thousand at March 31, 2023 and December 31, 2022, respectively.

12

Note 6 – Equity

Common Stock and Preferred Stock

The Company is authorized to issue 62.5 million shares of common stock and 2.0 million shares of preferred stock. Preferences, limitations, voting powers and relative rights of any preferred stock to be issued may be determined by the Company’s Board of Directors. The Company has not issued any shares of preferred stock.

In July 2018, the Company completed a private equity offering and executed a Stock Purchase Agreement with clirSPV LLC (“clirSPV”) which permits participation in future capital raising transactions (the “Participation Right”) on the same terms as other investors participating in such transactions. In no event may the Participation Right be exercised to the extent it would cause clirSPV or any of its affiliates to beneficially own 20% or more of the Company’s then outstanding common stock. In May 2022, the Company signed an agreement with clirSPV, that provides for an election right to extend the Participation Right beyond the original expiration date of December 31, 2023, but to no later than June 30, 2027. This election is pursuant to specific terms and conditions and expires on December 31, 2023.

The Company has an At-The-Market (“ATM”) Offering Sales Agreement with Virtu Americas LLC, as sales agent pursuant to which it may currently sell shares of common stock with an aggregate offering price of up to $8.7 million. During the three months ended March 31, 2023, the Company issued zero shares of its common stock from the ATM program. As of March 31, 2023, the Company has cumulatively issued approximately 1.6 million shares of common stock under the ATM program, at an average price of $3.84 per share. Gross proceeds totaled approximately $6.1 million and net cash proceeds was approximately $5.9 million.

The Company is currently subject to the SEC’s “baby shelf rules,” which prohibits companies with a public float of less

than $75 million from issuing securities under a shelf registration statement in excess of one-third of such company’s

public float in a 12-month period. These rules may limit future issuances of shares by the Company under its shelf

registration statement on Form S-3, the ATM Offering Sales Agreement or other securities offerings.

Equity Incentive Plan

On June 17, 2021, the Company's shareholders approved and the Company adopted the ClearSign Technologies Corporation 2021 Equity Incentive Plan (the “2021 Plan”) which permits the Company to grant Incentive Stock Options, Non-statutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, and Performance Shares, to eligible participants, which includes employees, directors and consultants. The Compensation Committee of the Board of Directors is authorized to administer the 2021 Plan.

The 2021 Plan provides for an annual increase in available shares equal to the lesser of (i) 10% of the aggregate number of shares of Common Stock issued by the Company in the prior fiscal year; or (ii) such number provided by the Compensation Committee; provided, however, that the total cumulative increase in the number of shares available for issuance pursuant to this automatic share increase shall not exceed 400 thousand shares of common stock. In 2023, the board of directors approved an increase of 400,000 shares available for issuance pursuant to future awards in accordance with the terms of the 2021 Plan.

Ending balances for the 2021 Plan is as follows:

March 31, 

December 31, 

(in thousands)

    

2023

    

2022

Outstanding options and restricted stock units

 

3,332

 

3,202

Reserved but unissued shares under the Plans

2,530

2,777

Total authorized shares under the Plans

 

5,862

 

5,979

13

Stock Options

Under the terms of the 2021 Plan, incentive stock options and nonstatutory stock options must have an exercise price at or above the fair market value on the date of the grant. At the time of grant, the Company will determine the period within which the option may be exercised and will specify any conditions that must be satisfied before the option vests and may be exercised. The Company estimates the fair value of stock options on the date of grant using the Black-Scholes option-pricing model.

As permitted by SEC Staff Accounting Bulletin (SAB) 107, management utilized the simplified approach to estimate the expected term of the options, which represents the period of time that options granted are expected to be outstanding. Expected volatility has been determined through the Company’s historical stock price volatility. The Company has not made an estimate of forfeitures at the time of the grant, but rather accounts for forfeitures at the time they occur. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future.

During the three months ended March 31, 2023, no new options were awarded by the company.

Compensation expense associated with stock option awards for the three months ended March 31, 2023 and 2022 totaled $44 thousand and $42 thousand, respectively.

A summary of the Company’s stock option activity and changes is as follows:

March 31, 

2023

(in thousands)

Options to Purchase Common Stock

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life (in years)

Outstanding at beginning of year

 

2,779

$

2.05

 

6.43

Granted

 

$

 

Exercised

 

$

 

Forfeited/Expired

 

$

 

Outstanding at end of period

 

2,779

$

2.05

 

6.18

Exercisable at end of period

 

2,011

$

1.70

 

5.68

The estimated aggregate pretax intrinsic value of the Company’s outstanding vested stock options at March 31, 2023 is $27 thousand. The intrinsic value is the difference between the Company’s common stock price and the option exercise prices multiplied by the number of in-the-money options. This amount changes based on the fair value of the Company’s common stock.

At March 31, 2023, there was $1.0 million of total unrecognized compensation cost related to non-vested stock option-based compensation arrangements. Vesting criteria ranges from time-based to performance-based. The Company records costs for time-based arrangements ratably across the timeframe, whereas performance-based arrangements require management to continually evaluate predetermined goals against actual circumstances.

Restricted Stock Units

The Company awards employees and directors restricted stock units (“RSUs”) in lieu of cash payment for compensation. These awards are granted pursuant to the 2021 Plan. Employee vesting criteria is time based, and compensation expense is recognized ratably across the timeframe.

14

Director vesting criteria is contingent upon the occurrence of one of four future events, which the Company cannot predict or control. Therefore, compensation expense for director RSUs is not recognized until one of these four future events occur, which is in accordance with FASB Accounting Standards Codification, Topic 718, Compensation-Stock Compensation, (ASC 718). Unrecognized compensation expense for director services amounted to $68 thousand and $85 thousand for the three months ended March 31, 2023 and 2022, respectively. Director compensation is earned on a quarterly basis with the target value of compensation set at approximately $85 thousand per quarter.

A summary of the Company’s RSUs activity and changes is as follows:

March 31, 

2023

(in thousands)

Number of Shares

Weighted Average Grant Date Fair Value

Nonvested at beginning of year

 

423

$

1.49

Granted

 

374

$

0.69

Vested

 

(245)

$

1.34

Nonvested at end of period

 

552

$

1.01

A summary of the Company’s RSU compensation expense is as follows:

For the Three Months Ended

March 31, 

(in thousands)

2023

    

2022

Compensation Expense

$

199

$

35

Weighted Average Value Per Share

$

1.25

$

1.44

Stock Awards

The Company awards employees stock in lieu of cash payment for compensation, typically to satisfy accrued bonus compensation. The awards are granted from the Company’s 2021 Plan.

For the Three Months Ended

March 31, 

    

2023

    

2022

Fair value

$

234

$

98

Weighted Average Value Per Share

$

0.79

$

1.43

15

Consultant Stock Plan

The 2013 Consultant Stock Plan (the “Consultant Plan”) provides for the granting of shares of common stock to consultants who provide services related to capital raising, investor relations, and making a market in or promoting the Company’s securities. The Company’s officers, employees, and board members are not entitled to receive grants from the Consultant Plan. The Compensation Committee of the Board of Directors is authorized to administer the Consultant Plan and establish the grant terms. The Consultant Plan provides for periodic increases in the number of authorized shares available for issuance under the Consultant Plan on the first day of each of the Company’s fiscal quarters. The quarterly increases are equal to 1% of any new shares subsequently issued by the Company or such lesser amount as the Board of Directors shall determine.

The Consultant Plan activity and change is as follows:

March 31, 

(in thousands)

    

2023

Reserved but unissued shares at beginning of year

196

Increases in the number of authorized shares

5

Grants

(4)

Reserved but unissued shares at end of year

 

197

The Consultant Plan compensation expense is summarized as follows:

For the Three Months Ended

March 31, 

    

2023

    

2022

Compensation Expense

$

3

$

7

Weighted Average Value Per Share

$

0.66

$

1.93

Note 7 – Commitments and Contingencies

Litigation

From time to time the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties and an adverse result in any such matter may harm the Company’s business. As of the date of this report, the Company is not a party to any material pending legal proceedings or claims that the Company believes will have a material adverse effect on the business, financial condition or operating results.

Indemnification Agreements

The Company maintains indemnification agreements with its directors and officers that may require the Company to indemnify these individuals against liabilities that arise by reason of their status or service as directors or officers, except as prohibited by law.

16

Note 8 – Government Assistance

During 2022, the Company was awarded a research grant from the Department of Energy (“DOE”) for approximately $250 thousand with the completion occurring in March 2023. The purpose of the grant was to produce a research paper for a flexible fuel ultra-low NOx process burner capable of burning 100% hydrogen fuel. The award allowed the Company to request reimbursements for expenditures such as labor, material, and administrative costs. During the three months ended March 31, 2023, the Company recognized $69 thousand in reimbursements from DOE. The Company did not recognize reimbursements from the DOE for the three months ended March 31, 2022.

Beginning in 2021, the Company received funds relating to the Oklahoma 21st Century Quality Jobs Act. The estimated duration of the program is up to 10 years and is designed to attract growth industries to Oklahoma. By reporting quarterly salary statistics and meeting agreed upon employment thresholds, the state remits benefit monies to the Company. For the three months ended March 31, 2023, the Company recognized $24 thousand in government assistance. During the three months ended March 31, 2022, the Company had no government assistance from this program.

Note 9 – Subsequent Events

The Company has evaluated subsequent events as of the date of this report, and has none to report.

17

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION CONTAINED IN THIS REPORT

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. You can find many (but not all) of these statements by looking for words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “would,” “should,” “could,” “may,” “will” or other similar expressions in this report. In particular, these include statements relating to future actions; prospective products, applications, customers, and technologies; future performance or results of any products; anticipated expenses; and future financial results. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. Factors that could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to:

our limited cash, history of losses, and our expectation that we will continue to experience operating losses and negative cash flows in the near future;
our ability to successfully develop and implement our technologies and achieve profitability;
our limited operating history;
changes in government regulations that could substantially reduce, or even eliminate, the need for our technology;
emerging competition and rapidly advancing technology in our industry that may outpace our technology;
customer demand for the products and services we develop;
the impact of competitive or alternative products, technologies, and pricing;
our ability to manufacture any products we design;
general economic conditions and events and the impact they may have on us and our potential customers;
our doing business in China and related risks with respect to intellectual property protection, currency exchange, contract enforcement, rules on foreign investment and pandemic era regulations;
the impact of a cybersecurity incident or other technology disruption;
our ability to protect our intellectual property;
our ability to obtain adequate financing in the future;
our ability to retain and hire personnel with the experience and talent to develop our products and business;
the financial and operational impacts of the coronavirus pandemic on our business and results of operations, including impacts on our day-to-day operations, collaborative arrangements, revenue and marketing efforts and suppliers;
our success at managing the risks involved in the foregoing items; and
other factors discussed in this report and in the section titled “Risk Factors” in our most recent Annual Report on Form 10-K.

Forward-looking statements may appear throughout this report, including, without limitation, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” The forward-looking statements are based upon management’s beliefs and assumptions and are made as of the date of this report. We undertake no obligation to publicly update or revise any forward-looking statements included in this report. You should not place undue reliance on these forward-looking statements.

Unless otherwise stated or the context otherwise requires, the terms “ClearSign,” “we,” “us,” “our” and the “Company” refer to ClearSign Technologies Corporation and its subsidiary, ClearSign Asia Limited.

18

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited consolidated condensed financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q as well as our audited financial statements and related notes included in our most recent Annual Report on Form 10-K. In addition to historical information, this discussion and analysis here and throughout this Form 10-Q contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements due to a number of factors, including but not limited to, the risks described in the section titled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022.

Overview

We design and develop technologies for the purpose of improving key performance characteristics of combustion systems, including emission and operational performance, energy efficiency and overall cost-effectiveness. Our ClearSign Core™ technology has been proven in full scale industrial test furnaces and boilers and first customer installations are currently operating in normal commercial applications. We have generated nominal revenues from operations to date to meet operating expenses.

We have incurred losses since inception totaling $90.0 million and we expect to experience operating losses and negative cash flow for the foreseeable future. We have historically financed our operations primarily through issuances of equity securities. Since inception, we have raised approximately $91.0 million in gross proceeds through the sale of our equity securities. We may need to raise additional capital in the future, however, the significant volatility in the capital markets may negatively affect our ability to raise this additional capital.

In order to generate meaningful revenues, our technologies must gain market recognition and acceptance to develop sufficient recurring sales. In addition, management believes that the successful growth and operation of our business is dependent upon our ability to obtain adequate sources of funding through co-development agreements, strategic partnering agreements, or equity or debt financing to support commercialization of our research and development efforts, protect intellectual property, form relationships with strategic partners and provide for working capital and general corporate purposes. There can be no assurance that we will be successful in achieving our long-term plans, or that such plans, if consummated, will result in profitable operations or enable us to continue in the long-term as a going concern.

With respect to our China operations, we have a satellite office located in Beijing, China to support our commercialization efforts. At this time, these operations in China are immaterial compared to total company operations. As of March 31, 2023, our China asset balance totaled $277 thousand, or approximately 3%, compared to our total asset balance of $10,167 thousand. During the three months ended March 31, 2023 and 2022, our China operations reported zero revenues.

Our costs include employee salaries and benefits, compensation paid to consultants, materials and supplies for prototype development and manufacture, costs associated with development activities including materials, sub-contractors, travel and administration, legal and accounting expenses, sales and marketing costs, general and administrative expenses, and other costs associated with an early stage, publicly traded technology company. We currently have 16 full-time employees. Because using third party expertise and resources is more efficient than maintaining full time resources, we also expect to incur ongoing consulting expenses related to technology development and some administrative, sales and legal functions commensurate with our current level of activities.

The amount that we spend for any specific purpose may vary significantly, and could depend on a number of factors including, but not limited to, the pace of progress of our commercialization and development efforts, actual needs with respect to product testing, development and research, market conditions, and changes in or revisions to our sales and marketing strategies.

19

Research, development, and commercial acceptance of new technologies are, by their nature, unpredictable.  Although we undertake development and commercialization efforts with reasonable diligence, there can be no assurance that the net proceeds from our securities offerings will be sufficient to enable us to develop our technology to the extent needed to create sufficient future sales to sustain operations.  If the net proceeds from these offerings are insufficient for this purpose, we will consider other options to continue our path to commercialization, including, but not limited to, additional financing through follow-on equity offerings, debt financing, co-development agreements, sale or licensing of developed intellectual or other property, or other alternatives.

We cannot assure that our technologies will be accepted, that we will ever earn revenues sufficient to support our operations, or that we will ever be profitable. Furthermore, we have no committed source of financing, and we cannot assure that we will be able to raise money as and when we need it to continue our operations. If we cannot raise funds as and when we need them, we may be required to scale back our development by reducing expenditures for employees, consultants, business development and marketing efforts or to otherwise severely curtail, or even to cease, our operations.

Critical Accounting Policies

The following discussion and analysis of financial condition and results of operations is based upon our financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting policies and estimates are particularly important to the understanding of our financial position and results of operations. These policies and estimates require the application of significant judgment by management. These estimates can be materially affected by changes from period to period as economic factors and conditions outside of our control change. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, our management uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, our observance of trends in the industry, information provided by our customers and information available from other outside sources, as appropriate. See Note 2 to our unaudited condensed consolidated financial statements included elsewhere in this report for a more complete description of our significant accounting policies.

Revenue Recognition and Cost of Goods Sold.

The Company recognizes revenue and related cost of goods sold in accordance with FASB ASC 606 Revenue from Contracts with Customers (ASC 606). Revenues and cost of goods sold are recognized once the goods or services are delivered to the customer’s control or non-refundable performance obligations are satisfied. The Company’s contracts with customers generally have performance obligations and a schedule of non-refundable cancellation obligations. The contracts generally will be fully performed upon delivery of certain documents or equipment. Revenue related to the contracts is recognized following the completion of non-refundable performance obligations as defined in the contract.

The Company’s contracts generally include progress payments from customers upon completion of defined milestones. As these payments are received, they are offset against accumulated project costs and recorded as either contract assets or contract liabilities. Upon completion of the performance obligations and collectability is determined, revenue can be recorded. For any contract in connection with which the Company is expected to incur costs in excess of the contact price, the Company accrues the estimated loss in full in the period such determination is made.

Impairment of Long-Lived Assets

The Company tests long-lived assets, consisting of fixed assets, patents, and other intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected from the use and eventual disposition of the assets. In the event an asset in not fully recoverable a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Fair value is determined based on the present value of estimated expected cash flows using a discount rate commensurate with the risks involved, quoted market prices, or appraised values

20

depending upon the nature of the assets. Losses on long-lived assets to be disposed of is determined in a similar manner, except those fair values are reduced for the cost of disposal.

Product Warranties

The Company warrants all installed products against defects in materials and workmanship, and shortcomings in performance compared to contractual guarantees for a period specified in each contract. Accruals for product warranties are based on expected warranty experience and current product performance trends which are recorded as a component of cost of sales at the time revenue is recognized. The warranty liabilities are reduced by material and labor costs during the warranty period in the periods in which the costs are incurred. The Company periodically assesses the adequacy of our recorded warranty liabilities and adjusts the amounts as necessary, and such adjustments could be material if estimates differ significantly from actual warranty expense. The warranty liabilities are included in accounts payable and accrued liabilities in the unaudited condensed consolidated balance sheets.

Research and Development

The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consumables, and consulting fees, including costs to develop and test prototype equipment and parts. Research and development costs are offset by any funds received from strategic partners in cost sharing, collaborative projects.

Stock-Based Compensation

The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the unaudited, condensed consolidated financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, or in the case of performance options, expense is recognized upon completion of a milestone as defined in the grant agreement. Stock-based compensation for stock grants to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.

Fair Value of Financial Instruments

The Company's financial instruments primarily consist of cash equivalents, accounts payable, accrued expenses and short-term investments in government securities. As of the balance sheet date, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the consolidated balance sheets. This is primarily attributed to the short maturities of these instruments.

21

RESULTS OF OPERATIONS

Comparison of the Three Months Ended March 31, 2023 and 2022

Highlights of our quarter financial performance are as follows:

For the Three Months Ended

(in thousands, except per share data)

March 31, 

    

2023

    

2022

    

$ Change

    

% Change

Revenues

$

894

$

$

894

NM

Cost of goods sold

788

$

788

NM

Gross profit (loss)

106

$

106

NM

Research and development

160

108

$

52

48.1

%

General and administrative

1,650

1,409

$

241

17.1

%

Operating Expenses

1,810

1,517

$

293

19.3

%

Other income, net

275

27

$

248

918.5

%

Net loss

$

(1,429)

$

(1,490)

$

61

(4.1)

%

Basic and diluted net income per common share

$

(0.04)

$

(0.05)

$

0.01

(20.0)

%

NM = Not meaningful

Sales and Gross Profit

Consolidated revenues for the three months ended March 31, 2023 were $894 thousand compared to zero for the same period in 2022. Revenues for the three months ended March 31, 2023 are mostly related to our process burner product line and an associated burner performance test. The associated burner performance test satisfied a contractual performance obligation, per ASC 606 standards, that required our customer to witness a successful burner performance test that meet their engineering specifications.

Gross profit for the three months ended March 31, 2023, increased by $106 thousand, compared to the three months ended March 31, 2022. During the three months ended March 31, 2023, gross profit was generated predominantly by our successful process burner performance test, which allowed us to recognize revenues and associated profit.

Operating Expenses

Operating expenses consist of research and development (R&D) and general and administrative (G&A) expenses. These are addressed separately below.

Research and Development

Research and development (“R&D”) expenses remained relatively consistent year-over-year.

General and Administrative

General and administrative (“G&A”) expenses increased by $241 thousand, or approximately 17.1%, to $1,650 thousand for the three months ended March 31, 2023, as compared to $1,409 thousand during the three months ended March 31, 2022. During the three months ended March 31, 2023, G&A expenses were unfavorably impacted by $187 thousand, due to vesting of restricted stock units triggered by the departure of a board director.

22

Other Income

Other income for the three months ended March 31, 2023 was $275 thousand as compared to $27 thousand for the three months ended March 31, 2022, or an approximate 918.5% increase. The sale of materials from the decommissioning of our Seattle office favorably impacted other income by $119 thousand for the three months ended March 31, 2023. Further, the receipt of government assistance monies related to our Oklahoma Quality Jobs rebate agreement and Department of Energy grant favorably impacted other income by $93 thousand for the three months ended March 31, 2023. Interest income from short-term investments favorably impacted other income by $58 thousand for the three months ended March 31, 2023.

Net Loss

Net loss for the three months ended March 31, 2023 was $1,429 thousand as compared to $1,490 thousand for the three months ended March 31, 2022, or an approximate 4.1% decrease. The $61 thousand decrease in net loss during the three months ended March 31, 2023, is primarily attributable to the $106 thousand increase in gross profit referenced in the above explanation.

Liquidity and Capital Resources

At March 31, 2023, our cash and cash equivalent balance totaled $5,328 thousand compared to $6,451 thousand at December 31, 2022, a decrease of $1,123 thousand. At March 31, 2023, our short-term held-to-maturity investments totaled $3,161 thousand, which is an increase of $555 thousand compared to $2,606 at December 31, 2022.

At March 31, 2023, our current assets were in excess of current liabilities resulting in working capital of $7,493 thousand as compared to $8,586 thousand at December 31, 2022. We have no contractual debt obligations, and the Company has sufficient working capital to fund current operating expenses for over twelve months. To the extent the Company requires additional funds more than 12 months from the date hereof, and customer cash collections cannot fund our needs, the Company may utilize equity offerings. Historically, the Company has funded operations predominately through equity offerings.

Currently, the Company can sell shares of common stock through its ATM program. As of March 31, 2023, the remaining aggregate offering price for future sales of common stock on the ATM is approximately $8.7 million, subject to the SEC’s “baby shelf rules,” which prohibits companies with a public float of less than $75 million from issuing securities under a shelf registration statement in excess of one-third of such company’s public float in a 12-month period (for more details, see “Note 6 – Equity” in the notes to our condensed consolidated financial statements). Future sales of shares of common stock and the price at which we may be able to sell such shares of common stock under the ATM are dependent on factors beyond our control, including, but not limited to, market conditions, the trading price of our common stock and our capital needs.

We filed a Form S-3 shelf registration statement with the SEC on July 1, 2022 that was declared effective on August 12, 2022.The registration statement on Form S-3 allows us to offer common stock, preferred stock, warrants, subscription rights, debt securities and units from time to time, as market conditions permit to fund, to the extent required beyond the 12 months from the date hereof, the ongoing operations of the Company. Until the growth of revenue increases to a level that covers operating expenses, the Company intends to continue to fund operations in this manner, although, the volatility in the capital markets and potential upcoming recession may negatively affect our ability to do so.

Operating activities for the three months ended March 31, 2023, resulted in cash outflows of $554 thousand, primarily due to the loss for the period of $1,429 thousand, offset with non-cash expenses of $329 thousand, and an increase of $392 thousand of contract liabilities, which represents payments from customers in advance of future project costs.

Operating activities for the three months ended March 31, 2022, resulted in cash outflows of $1,503 thousand, primarily due to the loss for the period of $1,490 thousand, offset with non-cash expenses of $135 thousand.

23

Investing activities for the three months ended March 31, 2023 resulted in cash outflows of $554 thousand, which is primarily attributable to $2,162 thousand of short-term held-to-maturity U.S. treasury purchases offset by $1,627 thousand in redemption of the same investments.

Investing activities for the three months ended March 31, 2022, resulted in cash outflows of $38 thousand in disbursements for fixed and intangible assets, and cash inflows of $23 thousand in proceeds from fixed asset sales.

Financing activities for the three months ended March 31, 2023, included $15 thousand in disbursements for taxes paid related to vesting of employee restricted stock units.

Financing activities for the three months ended March 31, 2022, included $578 thousand in net proceeds from the sale of 496 thousand shares of our common stock through our ATM program at an average price of $1.24 per share.

Off-Balance Sheet Transactions

We do not have any off-balance sheet transactions.

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, we are not required to provide this information.

ITEM 4.CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”), that are designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal accounting and financial officer, as appropriate, to allow timely decisions regarding required disclosure.

We carried out an evaluation under the supervision and with the participation of management, including our Chief Executive Officer (principal executive officer) and our Vice President and Controller (principal accounting and financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2023, the end of the period covered by this Quarterly Report on Form 10-Q. Based upon the evaluation of our disclosure controls and procedures as of March 31, 2023, our Chief Executive Officer (principal executive officer) and our Vice President and Controller (principal accounting and financial officer) concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

Our management, including our Chief Executive Officer (principal executive officer) and our Vice President and Controller (principal accounting and financial officer), does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems,

24

no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART II-OTHER INFORMATION

ITEM 1.LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results.

ITEM 1A.RISK FACTORS

We incorporate herein by reference the risk factors included under “Part I - Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2022, which we filed with the Securities and Exchange Commission on March 31, 2023, and the risk factors included in the reports and other documents we filed with the Securities and Exchange Commission subsequent to that date. There are no material changes from the risk factors set forth in such prior filings, except as set forth below.

If we fail to comply with the continued minimum closing bid requirement of The Nasdaq Capital Market LLC (“Nasdaq”) by October 30, 2023 or other requirements for continued listing, including stockholder equity requirements, our common stock may be delisted and the price of our common stock and our ability to access the capital markets could be negatively impacted. 

Our common stock is listed for trading on Nasdaq, therefore, we must satisfy Nasdaq’s continued listing requirements, including, among other things, a minimum closing bid price requirement of $1.00 per share for 30 consecutive business days. 

 

On November 1, 2022, the Company received notice from Nasdaq that the closing bid price for the Company’s common stock had been below $1.00 per share for the previous 30 consecutive business days, and that the Company was therefore not in compliance with the minimum bid price requirement for continued inclusion on Nasdaq under Nasdaq Listing Rule 5550(a)(2) (the “Rule”). Nasdaq’s notice had no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. The notice indicated that the Company had 180 calendar days, until May 1, 2023, to regain compliance with the Rule. We were not able to regain compliance within this 180-day period. On May 2, 2023, we were granted an additional compliance period of 180 calendar days, or until October 30, 2023, to regain compliance with the minimum closing bid requirement. The Company could regain compliance with the $1.00 minimum bid listing requirement if the closing bid price of its common stock is at least $1.00 per share for a minimum of ten (10) consecutive business days during the 180-day compliance period. To qualify for this additional compliance period of 180 calendar days, the Company was required to meet the continued listing requirement for market value of its publicly held shares and all other Nasdaq initial listing standards, except the bid price requirement, and provide written notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

There can be no assurance that we will be able to regain compliance with Nasdaq’s listing rules. If we are unable to regain compliance with the minimum closing bid price requirement or if we fail to meet any of the other continued listing requirements, including stockholder equity requirements, our securities may be delisted from Nasdaq, which

25

could reduce the liquidity of our common stock materially and result in a corresponding material reduction in the price of our common stock. In addition, delisting could harm our ability to raise capital on terms acceptable to us, or at all, and may result in the potential loss of confidence by investors, employees and business development opportunities.

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On March 27, 2023, we issued 3,750 shares of common stock at a price per share of $0.66, the closing price of our common stock on November 17, 2022, the date of grant, from our 2013 Consultant Stock Plan to our investor relations firm, Firm IR, for services provided during the three months ended March 31, 2023. These shares were issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, for a transaction by an issuer not involving a public offering.

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4.MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.OTHER INFORMATION

None.

26

ITEM 6.EXHIBITS

Exhibit

Number

   

Document

3.1

Articles of Incorporation of ClearSign Technologies Corporation (1)

3.2

Bylaws, as amended effective September 8, 2021 (2)

10.1

Catharine de Lacy’s Offer Letter (3)

10.2

Form of Indemnification Agreement (4)+

31.1*

Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer

31.2*

Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer

32.1**

Section 1350 Certification of Principal Executive Officer and Principal Financial Officer

101.INS

Inline XBRL Instance Document*

101.SCH

Inline XBRL Taxonomy Extension Schema Document*

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document*

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document*

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document*

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document*

104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

*Filed herewith

**Furnished herewith

+ Agreement with management or compensatory plan or arrangement.

(1)Incorporated by reference from the Form 10-Q for the quarter ended September 30, 2019 filed with the Securities and Exchange Commission on November 13, 2019.
(2)Incorporated by reference from the Form 8-K filed with the Securities and Exchange Commission on September 10, 2021.
(3)Incorporated by reference from Exhibit 10.1 of the Form 8-K filed with the Securities and Exchange Commission on February 24, 2023.
(4)Incorporated by reference from Exhibit 10.18 of the Form S-1/A filed with the Securities and Exchange Commission on March 9, 2012.

27

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CLEARSIGN TECHNOLOGIES CORPORATION

Date: May 15, 2023

By:

/s/ Colin James Deller

Colin James Deller

Chief Executive Officer

(Principal Executive Officer)

Date: May 15, 2023

By:

/s/ Brent Hinds

Brent Hinds

Vice President and Controller

(Principal Financial and Accounting Officer)

28

EX-31.1 2 clir-20230331xex31d1.htm EX-31.1

Exhibit 31.1

CERTIFICATION

I, Colin James Deller, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of ClearSign Technologies Corporation;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15-d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2023

/s/ Colin James Deller

Colin James Deller

Chief Executive Officer

(Principal Executive Officer)


EX-31.2 3 clir-20230331xex31d2.htm EX-31.2

Exhibit 31.2

CERTIFICATION

I, Brent Hinds, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of ClearSign Technologies Corporation;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15-d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2023

/s/ Brent Hinds

Brent Hinds

Vice President and Controller

(Principal Financial and Accounting Officer)


EX-32.1 4 clir-20230331xex32d1.htm EX-32.1

Exhibit 32.1

CERTIFICATION

In connection with the periodic report of ClearSign Technologies Corporation (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2023 as filed with the Securities and Exchange Commission (the “Report”), we, Colin James Deller, Chief Executive Officer (Principal Executive Officer) and Brent Hinds, Vice President of Finance & Controller (Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Exchange Act, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Date: May 15, 2023

/s/ Colin James Deller

Colin James Deller

Chief Executive Officer

(Principal Executive Officer)

/s/ Brent Hinds

Brent Hinds

Vice President of Finance & Controller (Principal Financial and Accounting Officer)

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of ClearSign Technologies Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.


EX-101.SCH 5 clir-20230331.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Fixed Assets - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Fixed Assets - ROU and Lease Liability (Details) link:presentationLink link:calculationLink link:definitionLink 40304 - Disclosure - Fixed Assets - Minimum future lease payments (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Patents and Other Intangible Assets - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Patents and Other Intangible Assets - Future amortization expense (Details) link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Organization and Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Summary of Significant Accounting Policies - Fixed Assets and Leases (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Summary of Significant Accounting Policies - Foreign Operations (Details) link:presentationLink link:calculationLink link:definitionLink 40204 - Disclosure - Summary of Significant Accounting Policies - Research and Development (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Fixed Assets - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Patents and Other Intangible Assets - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Revenue, Contract Assets and Contract Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Equity - Common Stock and Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Equity - Equity Incentive Plan (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Equity - Stock Options - Activity (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - Equity - Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 40605 - Disclosure - Equity - Restricted Stock units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 40606 - Disclosure - Equity - Restricted Stock Units - Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 40607 - Disclosure - Equity - Stock Grants (Details) link:presentationLink link:calculationLink link:definitionLink 40608 - Disclosure - Equity - Consultant Stock Plan (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Government Assistance (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Fixed Assets link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Patents and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Revenue, Contract Assets and Contract Liabilities link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Government Assistance link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Fixed Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Patents and Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Significant Accounting Policies - Short-Term Investments (Details) link:presentationLink link:calculationLink link:definitionLink 40205 - Disclosure - Summary of Significant Accounting Policies - Net Loss per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - Fixed Assets - Leases - Supplemental balance sheet and cash flow information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 clir-20230331_cal.xml EX-101.CAL EX-101.DEF 7 clir-20230331_def.xml EX-101.DEF EX-101.LAB 8 clir-20230331_lab.xml EX-101.LAB EX-101.PRE 9 clir-20230331_pre.xml EX-101.PRE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2023
May 10, 2023
Document and Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Transition Report false  
Entity Registrant Name CLEARSIGN TECHNOLOGIES CORPORATION  
Entity File Number 001-35521  
Entity Incorporation, State or Country Code WA  
Entity Tax Identification Number 26-2056298  
Entity Address, Address Line One 8023 E. 63rd Place, Suite 101  
Entity Address, City or Town Tulsa  
Entity Address, State or Province OK  
Entity Address, Postal Zip Code 74133  
City Area Code 918  
Local Phone Number 236-6461  
Title of 12(b) Security Common Stock  
Trading Symbol CLIR  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   38,545,556
Entity Central Index Key 0001434524  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q1  
Amendment Flag false  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 5,328 $ 6,451
Short-term held-to-maturity investments 3,161 2,606
Accounts receivable, net 50 79
Contract assets 4 20
Prepaid expenses and other assets 317 577
Total current assets 8,860 9,733
Fixed assets, net 515 384
Patents and other intangible assets, net 782 798
Other assets 10 10
Total Assets 10,167 10,925
Current Liabilities:    
Accounts payable and accrued liabilities 398 296
Current portion of lease liabilities 77 133
Accrued compensation and related taxes 253 471
Contract liabilities 639 247
Total current liabilities 1,367 1,147
Long Term Liabilities:    
Long term lease liabilities 213 226
Total liabilities 1,580 1,373
Commitments and contingencies (note 11)
Stockholders' Equity:    
Preferred stock, $0.0001 par value, zero shares issued and outstanding
Common stock, $0.0001 par value, 38,545,556 and 38,023,701 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 4 4
Additional paid-in capital 98,543 98,079
Accumulated other comprehensive income (loss) (8) (8)
Accumulated deficit (89,952) (88,523)
Total equity 8,587 9,552
Total Liabilities and Equity $ 10,167 $ 10,925
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Consolidated Balance Sheets    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares issued 38,545,556 38,023,701
Common stock, shares outstanding 38,545,556 38,023,701
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues $ 894,000  
Cost of goods sold 788,000  
Gross profit 106,000  
Operating expenses:    
Research and development 160,000 $ 108,000
General and administrative 1,650,000 1,409,000
Total operating expenses 1,810,000 1,517,000
Loss from operations (1,704,000) (1,517,000)
Other income    
Interest, net 58,000  
Government assistance, reimbursements from Department of Energy 93,000  
Gain from sale of assets 5,000 23,000
Other income, net 119,000 4,000
Total other income 275,000 27,000
Net loss $ (1,429,000) $ (1,490,000)
Net loss per share - basic $ (0.04) $ (0.05)
Net loss per share - fully diluted $ (0.04) $ (0.05)
Weighted average number of shares outstanding - basic 38,262,710 31,826,221
Weighted average number of shares outstanding - fully diluted 38,262,710 31,826,221
Comprehensive loss    
Net loss $ (1,429,000) $ (1,490,000)
Research Grant From The Department Of Energy [Member]    
Other income    
Government assistance, reimbursements from Department of Energy 69,000 0
Oklahoma Quality Jobs Act [Member]    
Other income    
Government assistance, reimbursements from Department of Energy $ 24,000 $ 0
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Total ClearSign Technologies Corp. Stockholders' Equity
Total
Beginning Balance at Dec. 31, 2021 $ 3 $ 91,035 $ 9 $ (82,765) $ 8,282  
Beginning Balances (in shares) at Dec. 31, 2021 31,582,000          
Shares issued upon exercise of options ($0.89 per share) (in shares) 1,000          
Shares issued upon exercise of options ($2.93 per share) (in shares) 3,000          
Fair value of stock issued in payment of accrued compensation   95     95  
Fair value of stock issued in payment of accrued compensation (in shares) 66,000          
Fair value of stock options granted in payment of accrued compensation   12     12  
Share based compensation   80     80  
Share based compensation (in shares) 3,000          
Shares issued through the use of At-The Market issuance   578     578  
Shares issued through the use of At-The Market issuance (in shares) 496,000          
Shares issued for services ($1.93 per share)   7     7  
Shares issued for services ($1.93 per share) (in shares) 4,000          
Net loss       (1,490) (1,490) $ (1,490)
Ending Balance at Mar. 31, 2022 $ 3 91,807 9 (84,255) $ 7,564  
Ending Balances (in shares) at Mar. 31, 2022 32,155,000          
Beginning Balance at Dec. 31, 2022 $ 4 98,079 (8) (88,523)   9,552
Beginning Balances (in shares) at Dec. 31, 2022 38,023,000          
Fair value of stock issued in payment of accrued compensation   234       234
Fair value of stock issued in payment of accrued compensation (in shares) 296,000          
Share based compensation   227       227
Share based compensation (in shares) 223,000          
Shares issued for services ($0.66 per share)   3       3
Shares issued for services ($0.66 per share) (in shares) 4,000          
Net loss       (1,429)   (1,429)
Ending Balance at Mar. 31, 2023 $ 4 $ 98,543 $ (8) $ (89,952)   $ 8,587
Ending Balances (in shares) at Mar. 31, 2023 38,546,000          
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Consolidated Statements of Stockholders' Equity    
Common stock for options exercise, 0.89 per share issue   $ 0.89
Common stock for options exercise, 2.93 per share issue   2.93
Shares issued through at the market issuance 1.24 average per share   1.24
Common stock for services $ 0.66  
Common stock for services   $ 1.93
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (1,429) $ (1,490)
Adjustments to reconcile net loss to net cash used in operating activities:    
Common stock issued for services 3 7
Share-based compensation 242 80
Depreciation and amortization 80 36
Gain from sale of fixed assts (5) (23)
Right of use asset amortization 43 35
Realized gain from market securities (20)  
Lease amendments (14)  
Change in operating assets and liabilities:    
Contract assets 16 (205)
Accounts receivable 29 6
Prepaid expenses and other assets 51 (56)
Accounts payable and accrued liabilities 57 22
Accrued compensation and related taxes 1 85
Contract liabilities 392  
Net cash used in operating activities (554) (1,503)
Cash flows from investing activities:    
Acquisition of fixed assets   (5)
Disbursements for patents and other intangible assets (24) (33)
Proceeds from sale of fixed assets 5 23
Purchases of held-to-maturity short-term US treasuries (2,162)  
Redemption of held-to-maturity US treasuries 1,627  
Net cash used in investing activities (554) (15)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of offering costs   578
Taxes paid related to vesting of restricted stock units (15)  
Net cash (used in) provided by financing activities (15) 578
Net change in cash and cash equivalents (1,123) (940)
Cash and cash equivalents, beginning of period 6,451 7,607
Cash and cash equivalents, end of period 5,328 6,667
Supplemental disclosure of cash flow information:    
Officer and employee equity awards for prior year accrued compensation 234 $ 107
Prior year prepaid expenses repurposed to fixed assets as demonstration equipment $ 209  
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Description of Business
3 Months Ended
Mar. 31, 2023
Organization and Description of Business  
Organization and Description of Business

Note 1 – Organization and Description of Business

ClearSign Technologies Corporation (“ClearSign” or the “Company”) designs and develops products and technologies that have been shown to significantly improve key performance characteristics of industrial and commercial systems, including operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness. The Company’s patented technologies are designed to be embedded in established OEM products as ClearSign Core™ and ClearSign Eye™ and other sensing configurations in order to enhance the performance of combustion systems and fuel safety systems in a broad range of markets. These markets include energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. The Company’s primary technology is its ClearSign Core technology, which achieves very low emissions without the need of selective catalytic reduction.

The Company was incorporated in the State of Washington in 2008. During January 2022, the Company relocated its headquarters from Seattle, Washington to Tulsa, Oklahoma. On July 28, 2017, the Company incorporated a subsidiary, ClearSign Asia Limited, in Hong Kong to represent the Company’s business and technological interests throughout Asia. Through ClearSign Asia Limited, the Company has established a Wholly Foreign Owned Enterprise (WFOE) in China – ClearSign Combustion (Beijing) Environmental Technologies Co., LTD.

Unless otherwise stated or the context otherwise requires, the terms ClearSign and the Company refer to ClearSign Technologies Corporation and its subsidiary, ClearSign Asia Limited.

Liquidity

The Company's condensed consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As of March 31, 2023, the Company’s cash and cash equivalents totaled $5,328 thousand, and short-term held-to-maturity investments totaled $3,161 thousand, which is sufficient to fund current operating expenses beyond twelve months from the date hereof. The Company’s technologies are currently in field development, but with nominal fully operational commercial installations, and have generated nominal revenues from operations to date to meet operating expenses. In order to generate meaningful revenues, the technologies must be fully developed, gain market recognition and acceptance, and develop a critical level of successful sales and product installations.

Historically, the Company has financed operations primarily through issuances of equity securities. Since inception, the Company has raised approximately $91.0 million in gross proceeds through the sale of its equity securities. During the three months ended March 31, 2023, the Company did not raise proceeds through the issuance of common stock.

The Company has incurred losses since its inception totaling $90.0 million and expects to experience operating losses and negative cash flows for the foreseeable future. Management believes that the successful growth and operation of the Company’s business is dependent upon its ability to obtain adequate sources of funding through co-development agreements, strategic partnering agreements, or equity or debt financing to adequately support product commercialization efforts, protect intellectual property, form relationships with strategic partners, and provide for working capital and general corporate purposes. There can be no assurance that the Company will be successful in achieving its long-term plans as set forth above, or that such plans, if consummated, will result in profitable operations or enable the Company to continue in the long-term as a going concern.

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2022 has been derived from the Company’s audited financial statements as of that date.

In the opinion of management, these condensed consolidated financial statements reflect all normal recurring and other adjustments necessary for a fair presentation. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year or any other future periods.

The accompanying unaudited condensed consolidated financial statements include the accounts of ClearSign and its subsidiary. Intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition and Cost of Sales

The Company recognizes revenue and related cost of goods sold in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 606 Revenue from Contracts with Customers (“ASC 606”). When applying ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the promises and performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the performance obligations are satisfied. Revenues and cost of goods sold are recognized once the goods or services are delivered to the customer’s control or non-refundable performance obligations are satisfied. The Company’s contracts with customers generally have performance obligations and a schedule of non-refundable cancellation obligations. The contracts generally will be fully performed upon delivery of certain drawings or equipment. Revenue related to the contracts is recognized following the completion of non-refundable performance obligations as defined in the contract.

The Company’s contracts generally include progress payments from the customer upon completion of defined milestones. As these payments are received, they are offset against accumulated project costs and recorded as either contract assets or contract liabilities. Upon completion of the performance obligations and collectability is determined, revenue is recorded. For any contract that is expected to incur costs in excess of the contract price, the Company accrues the estimated loss in full in the period such determination is made.

Contract Costs

The Company capitalizes project costs until performance obligations related to the contract are completed. The Company expenses selling and marketing expenses when incurred within the statements of operations in general and administrative expenses.

Product Warranties

The Company warrants all installed products against defects in materials and workmanship for a period specified in each contract by replacing failed parts. Accruals for product warranties are based on historical or expected warranty experience and current product performance trends and are recorded as a component of cost of sales at the time revenue is recognized. The warranty liabilities are reduced by material and labor costs used to replace parts over the warranty period in the periods in which the costs are incurred. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary, and such adjustments could be material in the future if estimates differ significantly from actual warranty expense. Product warranties are included in accounts payable and accrued liabilities in the consolidated balance sheets.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on deposit in a checking and savings account, and short-term money market instruments with an original maturity of three months or less. Cash equivalents, which consist of short-term U.S. treasury bills, are based on quoted market prices, a Level 1 fair value measure.

Short-Term Investments

Short-term investments consist of U.S. treasuries with original maturities of twelve months or less and greater than three months. These short-term investments are classified as held to maturity and are recorded on an amortized cost basis based on the Company’s positive intent and ability to hold these securities to maturity. As of March 31, 2023, the Company has not experienced any other-than-temporary impairment of its short-term investments. A decline in the market value of any held-to-maturity security below cost that is deemed other than temporary results in a reduction in carrying amount to fair value. The impairment is charged to earnings and a new cost basis for the security is established. The company evaluates whether the decline in fair value of its investments is other-than temporary at each quarter-end.

The cost basis for the Company’s short-term investments totaled approximately $3,161 thousand and $2,606 thousand as of March 31, 2023 and December 31, 2022, respectively. The unrealized holding gains for the Company’s short-term investments totaled approximately $33 thousand and $4 thousand as of March 31, 2023 and December 31, 2022, respectively. The Company has not experienced any continuous unrealized holding losses on these investments. The fair value for the Company’s short-term investments totaled approximately $3,194 thousand and $2,610 thousand as of March 31, 2023 and December 31, 2022, respectively.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivables are recorded at the contractual invoiced amount. An allowance for doubtful accounts is established, as necessary, based on past experience and management’s judgment. The determination of the collectability of amounts due from customers require the Company to make judgments regarding future events and trends. Allowances for doubtful accounts are determined based on assessing the Company’s portfolio on an individual customer and on an overall basis. This process consists of a review of historical collection experience, current aging status of the customer accounts, and the financial condition of the Company’s customers. Based on a review of these factors, the Company may establish or adjust the allowance for specific customers and the accounts receivable portfolio as a whole.

Fixed Assets and Leases

Fixed assets are recorded at cost. Leases are recorded in accordance with FASB ASC 842, Leases. For those leases with a term greater than one year, the Company recognizes a right-of-use asset, which is included in fixed assets, net on the consolidated balance sheets, and a lease liability measured at the present value of the lease payments at the time of the lease inception or modification. Lease costs are recognized in the consolidated statement of operations over the lease term on a straight-line basis. Leases with a term of 1 year or less are considered short term leases with rent expense recognized over the lease term. Depreciation is computed using the straight-line method over the estimated useful lives of the respective lease assets. Leasehold improvements are depreciated over the life of the lease or their useful life,

whichever is shorter. All other fixed assets are depreciated over three to four years. Maintenance and repairs are expensed as incurred.

Patents and Trademarks

Third-party expenses related to patents and trademarks are recorded at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are awarded. Patent application costs are deferred pending the outcome of patent and trademark applications. Costs associated with unsuccessful patent applications and abandoned intellectual property are expensed when determined to have no continuing value in current business activity. The Company evaluates the recoverability of the carrying values of intangible assets each reporting period.

Impairment of Long-Lived Assets

The Company tests long-lived assets, consisting of fixed assets, patents, trademarks, and other intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected from the use and eventual disposition of the assets. In the event an asset is not fully recoverable, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Fair value is determined based on the present value of estimated expected cash flows using a discount rate commensurate with the risks involved, quoted market prices, or appraised values depending upon the nature of the assets. Losses on long-lived assets to be disposed are determined in a similar manner, except those fair values are reduced for the cost of disposal.

Fair Value of Financial Instruments

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs used to establish fair value are the following:

Level 1 – Quoted prices in active markets for identical assets or liabilities;
Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s financial instruments primarily consist of cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributable to the short-term nature of these instruments.

The Company did not identify any other recurring or non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.

Research and Development

The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consumables, and consulting fees, including costs to develop and test prototype equipment and parts. Research and Development costs have been offset by funds received, if any, from strategic partners

in cost sharing, collaborative projects. During the three months ended March 31, 2023 and 2022, the Company did not receive funds from these arrangements.

Government Assistance

The Company has adopted Accounting Standards Update (“ASU”) 2021-10, Government Assistance (Topic 832) Disclosures by Business Entities about Government Assistance, which requires footnote disclosure of assistance received from government entities. The Company records gross monies received from government entities in other income, and associated expenses such as salaries and supplies are recorded in Research and Development or General and Administration, depending on the nature of expenditure. The Company accrues for reimbursement requests submitted to government entities in accounts receivable.

Income Taxes

The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not the Company would not be able to realize their benefits, or that future deductibility is uncertain. Tax benefits are recognized only if it is more likely than not that the tax benefits will be utilized in the foreseeable future.

Share-Based Compensation

The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the unaudited condensed consolidated financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, or in the case of performance options, expense is recognized upon completion of milestones as defined in the grant agreement. Share-based compensation for stock grants to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.

Foreign Operations

The accompanying unaudited condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022 include assets amounting to approximately $277 thousand and $172 thousand, respectively, relating to operations of ClearSign Asia Limited. The Beijing registered capital requirement is $350 thousand, which is required to be paid by 2027, and of which $111 thousand has been paid as of March 31, 2023. It is always possible that unanticipated events in foreign countries could disrupt the Company’s operations, and since the first quarter of 2020 this has been and currently continues to be the case with the effects of the COVID-19 pandemic.

Foreign Currency

Assets and liabilities of ClearSign Asia Limited with non-U.S. Dollar functional currency are translated to U.S. Dollars using exchange rates in effect at the end of the period. Revenue and expenses are translated to U.S. Dollars using rates that approximate those in effect during the period. The resulting translation adjustments are included in the Company’s condensed consolidated balance sheets in the stockholders’ equity section as a component of accumulated other comprehensive income (loss).

Net Loss per Common Share

Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their

effect would be anti-dilutive. At March 31, 2023 and March 31, 2022, potentially dilutive shares outstanding amounted to 3.7 million and 3.3 million, respectively.

Recently Issued Accounting Pronouncements Adopted

In June 2017, the FASB issued an Accounting Standards Update (“ASU”) ASU 2016-13, Financial Instruments (Topic 326) Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. The standard replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. ASU 2016-13, and related amendments, are effective for fiscal years beginning after December 15, 2022. The Company adopted this standard on January 1, 2023. This standard did not have a material impact on the Company’s condensed consolidated financial statements.

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Fixed Assets
3 Months Ended
Mar. 31, 2023
Fixed Assets  
Fixed Assets

Note 3 – Fixed Assets

Fixed Assets

Fixed assets are summarized as follows:

March 31, 

December 31, 

(in thousands)

    

2023

    

2022

    

Machinery and equipment

$

209

$

390

Office furniture and equipment

 

60

 

177

Leasehold improvements

 

43

 

192

312

759

Accumulated depreciation and amortization

 

(81)

 

(697)

231

62

Operating lease ROU assets, net

284

322

Total

$

515

$

384

Depreciation and amortization expense for the three months ended March 31, 2023 and 2022 totaled $40 thousand and $7 thousand, respectively.

Leases

The Company leases office space in Seattle, Washington, Tulsa, Oklahoma and Beijing, China. During June 2022, the Company entered into a new lease agreement for its Beijing office space for a period of one year with monthly rent at approximately $2 thousand. The Company classified this lease as an operating lease since it is more likely than not the lease will be renewed at the end of its term.

During March 2023, the Company amended its Seattle lease to extend the lease term to September 2023. The amended lease reduced the square footage and lowered the monthly payment to approximately $4 thousand. The Company increased the right of use asset by $5 thousand and decreased the lease liability by $9 thousand. The Seattle, Tulsa, and Beijing leases are classified as operating leases, with remaining terms ranging from six months to six years; contractual language requires renewal negotiations to occur at or near termination. These leases are normal and customary for office space, in that, contractual guarantees exist requiring the lessee to return the premises to its original functional state. The Company accrued a liability of $2 thousand and $87 thousand as of March 31, 2023 and December 31, 2022, respectively, for the estimated cost of the restoration of the Seattle office. The Company plans to exit the Seattle lease on or before contract termination as part of the Company’s headquarters move from Seattle to Tulsa.

The Tulsa lease contains fixed annual lease payments that increase annually by 2%. The Seattle, Tulsa, and Beijing total monthly minimum rent is approximately $11 thousand. Operating lease costs for the three months ended March 31, 2023 and 2022 were $48 thousand and $57 thousand, respectively.

Supplemental balance sheet information related to operating leases is as follows:

March 31, 

December 31, 

(in thousands)

2023

2022

Operating lease ROU assets, net

$

284

$

322

Lease Liabilities:

Current lease liabilities

$

77

$

133

Long term lease liabilities

213

226

Total lease liabilities

$

290

$

359

Weighted average remaining lease term (in years):

 

2.7

Weighted average discount rate:

 

5.2

%

For the Three Months Ended

March 31, 

2023

2022

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows used in operating leases

$

66

$

57

Non-cash impact of new leases and lease modifications

Change in operating lease liabilities

$

(9)

$

Change in operating lease ROU assets

$

5

$

Minimum future payments under the Company’s lease liabilities as of March 31, 2023 are as follows:

    

Discounted

    

Payments

lease

due under

(in thousands)

liability

lease

payments

agreements

2023

 

$

64

 

$

73

2024

 

54

 

65

2025

59

66

2026

63

67

2027

50

51

Total

$

290

$

322

At March 31, 2023, $32 thousand of the Company’s future minimum lease payments represents interest.

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Patents and Other Intangible Assets
3 Months Ended
Mar. 31, 2023
Patents and Other Intangible Assets  
Patents and Other Intangible Assets

Note 4 – Patents and Other Intangible Assets

Patents and other intangible assets are summarized as follows:

March 31, 

December 31, 

(in thousands)

    

2023

    

2022

    

Patents

Patents pending

$

330

$

307

Issued patents

 

815

 

815

 

1,145

 

1,122

Trademarks

 

 

Trademarks pending

 

7

 

6

Registered trademarks

 

95

 

95

 

102

 

101

Other

 

8

 

8

 

1,255

 

1,231

Accumulated amortization

 

(473)

 

(433)

$

782

$

798

Future amortization expense associated with issued patents and registered trademarks as of March 31, 2023 is as follows:

(in thousands)

2023

    

$

108

2024

 

126

2025

 

96

2026

 

61

2027

 

39

Thereafter

 

7

$

437

The amortization life for patents ranges between three to five years, with trademark lives set at ten years. The Company does not amortize patents or trademarks classified as pending.

During the three months ended March 31, 2023 and 2022, the Company assessed its patent and trademark assets. The Company also evaluated its strategic approach to the pursuit and protection of its intellectual property. It is the intent of the Company to continue to pursue intellectual property protection.

If the Company identifies certain assets where the intellectual property does not directly align with its core technology, the Company will impair the intangible asset and write-off the asset as an expense.

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue, Contract Assets and Contract Liabilities
3 Months Ended
Mar. 31, 2023
Revenue, Contract Assets and Contract Liabilities  
Revenue, Contract Assets and Contract Liabilities

Note 5 – Revenue, Contract Assets and Contract Liabilities

The Company recognized $894 thousand of revenues and $788 thousand of cost of goods sold during the three months ended March 31, 2023. The revenue and cost of goods sold relate predominately to the Company’s process burner product line, where the Company successfully completed a burner performance customer witness test, which represented a contractual performance obligation per ASC 606.

The Company did not recognize revenue or cost of goods sold for the three months ended March 31, 2022.

The Company had contract assets of $4 thousand and $20 thousand at March 31, 2023 and December 31, 2022, respectively. The Company had contract liabilities of $639 thousand and $247 thousand at March 31, 2023 and December 31, 2022, respectively.

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Equity
3 Months Ended
Mar. 31, 2023
Equity  
Equity

Note 6 – Equity

Common Stock and Preferred Stock

The Company is authorized to issue 62.5 million shares of common stock and 2.0 million shares of preferred stock. Preferences, limitations, voting powers and relative rights of any preferred stock to be issued may be determined by the Company’s Board of Directors. The Company has not issued any shares of preferred stock.

In July 2018, the Company completed a private equity offering and executed a Stock Purchase Agreement with clirSPV LLC (“clirSPV”) which permits participation in future capital raising transactions (the “Participation Right”) on the same terms as other investors participating in such transactions. In no event may the Participation Right be exercised to the extent it would cause clirSPV or any of its affiliates to beneficially own 20% or more of the Company’s then outstanding common stock. In May 2022, the Company signed an agreement with clirSPV, that provides for an election right to extend the Participation Right beyond the original expiration date of December 31, 2023, but to no later than June 30, 2027. This election is pursuant to specific terms and conditions and expires on December 31, 2023.

The Company has an At-The-Market (“ATM”) Offering Sales Agreement with Virtu Americas LLC, as sales agent pursuant to which it may currently sell shares of common stock with an aggregate offering price of up to $8.7 million. During the three months ended March 31, 2023, the Company issued zero shares of its common stock from the ATM program. As of March 31, 2023, the Company has cumulatively issued approximately 1.6 million shares of common stock under the ATM program, at an average price of $3.84 per share. Gross proceeds totaled approximately $6.1 million and net cash proceeds was approximately $5.9 million.

The Company is currently subject to the SEC’s “baby shelf rules,” which prohibits companies with a public float of less

than $75 million from issuing securities under a shelf registration statement in excess of one-third of such company’s

public float in a 12-month period. These rules may limit future issuances of shares by the Company under its shelf

registration statement on Form S-3, the ATM Offering Sales Agreement or other securities offerings.

Equity Incentive Plan

On June 17, 2021, the Company's shareholders approved and the Company adopted the ClearSign Technologies Corporation 2021 Equity Incentive Plan (the “2021 Plan”) which permits the Company to grant Incentive Stock Options, Non-statutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, and Performance Shares, to eligible participants, which includes employees, directors and consultants. The Compensation Committee of the Board of Directors is authorized to administer the 2021 Plan.

The 2021 Plan provides for an annual increase in available shares equal to the lesser of (i) 10% of the aggregate number of shares of Common Stock issued by the Company in the prior fiscal year; or (ii) such number provided by the Compensation Committee; provided, however, that the total cumulative increase in the number of shares available for issuance pursuant to this automatic share increase shall not exceed 400 thousand shares of common stock. In 2023, the board of directors approved an increase of 400,000 shares available for issuance pursuant to future awards in accordance with the terms of the 2021 Plan.

Ending balances for the 2021 Plan is as follows:

March 31, 

December 31, 

(in thousands)

    

2023

    

2022

Outstanding options and restricted stock units

 

3,332

 

3,202

Reserved but unissued shares under the Plans

2,530

2,777

Total authorized shares under the Plans

 

5,862

 

5,979

Stock Options

Under the terms of the 2021 Plan, incentive stock options and nonstatutory stock options must have an exercise price at or above the fair market value on the date of the grant. At the time of grant, the Company will determine the period within which the option may be exercised and will specify any conditions that must be satisfied before the option vests and may be exercised. The Company estimates the fair value of stock options on the date of grant using the Black-Scholes option-pricing model.

As permitted by SEC Staff Accounting Bulletin (SAB) 107, management utilized the simplified approach to estimate the expected term of the options, which represents the period of time that options granted are expected to be outstanding. Expected volatility has been determined through the Company’s historical stock price volatility. The Company has not made an estimate of forfeitures at the time of the grant, but rather accounts for forfeitures at the time they occur. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future.

During the three months ended March 31, 2023, no new options were awarded by the company.

Compensation expense associated with stock option awards for the three months ended March 31, 2023 and 2022 totaled $44 thousand and $42 thousand, respectively.

A summary of the Company’s stock option activity and changes is as follows:

March 31, 

2023

(in thousands)

Options to Purchase Common Stock

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life (in years)

Outstanding at beginning of year

 

2,779

$

2.05

 

6.43

Granted

 

$

 

Exercised

 

$

 

Forfeited/Expired

 

$

 

Outstanding at end of period

 

2,779

$

2.05

 

6.18

Exercisable at end of period

 

2,011

$

1.70

 

5.68

The estimated aggregate pretax intrinsic value of the Company’s outstanding vested stock options at March 31, 2023 is $27 thousand. The intrinsic value is the difference between the Company’s common stock price and the option exercise prices multiplied by the number of in-the-money options. This amount changes based on the fair value of the Company’s common stock.

At March 31, 2023, there was $1.0 million of total unrecognized compensation cost related to non-vested stock option-based compensation arrangements. Vesting criteria ranges from time-based to performance-based. The Company records costs for time-based arrangements ratably across the timeframe, whereas performance-based arrangements require management to continually evaluate predetermined goals against actual circumstances.

Restricted Stock Units

The Company awards employees and directors restricted stock units (“RSUs”) in lieu of cash payment for compensation. These awards are granted pursuant to the 2021 Plan. Employee vesting criteria is time based, and compensation expense is recognized ratably across the timeframe.

Director vesting criteria is contingent upon the occurrence of one of four future events, which the Company cannot predict or control. Therefore, compensation expense for director RSUs is not recognized until one of these four future events occur, which is in accordance with FASB Accounting Standards Codification, Topic 718, Compensation-Stock Compensation, (ASC 718). Unrecognized compensation expense for director services amounted to $68 thousand and $85 thousand for the three months ended March 31, 2023 and 2022, respectively. Director compensation is earned on a quarterly basis with the target value of compensation set at approximately $85 thousand per quarter.

A summary of the Company’s RSUs activity and changes is as follows:

March 31, 

2023

(in thousands)

Number of Shares

Weighted Average Grant Date Fair Value

Nonvested at beginning of year

 

423

$

1.49

Granted

 

374

$

0.69

Vested

 

(245)

$

1.34

Nonvested at end of period

 

552

$

1.01

A summary of the Company’s RSU compensation expense is as follows:

For the Three Months Ended

March 31, 

(in thousands)

2023

    

2022

Compensation Expense

$

199

$

35

Weighted Average Value Per Share

$

1.25

$

1.44

Stock Awards

The Company awards employees stock in lieu of cash payment for compensation, typically to satisfy accrued bonus compensation. The awards are granted from the Company’s 2021 Plan.

For the Three Months Ended

March 31, 

    

2023

    

2022

Fair value

$

234

$

98

Weighted Average Value Per Share

$

0.79

$

1.43

Consultant Stock Plan

The 2013 Consultant Stock Plan (the “Consultant Plan”) provides for the granting of shares of common stock to consultants who provide services related to capital raising, investor relations, and making a market in or promoting the Company’s securities. The Company’s officers, employees, and board members are not entitled to receive grants from the Consultant Plan. The Compensation Committee of the Board of Directors is authorized to administer the Consultant Plan and establish the grant terms. The Consultant Plan provides for periodic increases in the number of authorized shares available for issuance under the Consultant Plan on the first day of each of the Company’s fiscal quarters. The quarterly increases are equal to 1% of any new shares subsequently issued by the Company or such lesser amount as the Board of Directors shall determine.

The Consultant Plan activity and change is as follows:

March 31, 

(in thousands)

    

2023

Reserved but unissued shares at beginning of year

196

Increases in the number of authorized shares

5

Grants

(4)

Reserved but unissued shares at end of year

 

197

The Consultant Plan compensation expense is summarized as follows:

For the Three Months Ended

March 31, 

    

2023

    

2022

Compensation Expense

$

3

$

7

Weighted Average Value Per Share

$

0.66

$

1.93

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies  
Commitments and Contingencies

Note 7 – Commitments and Contingencies

Litigation

From time to time the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties and an adverse result in any such matter may harm the Company’s business. As of the date of this report, the Company is not a party to any material pending legal proceedings or claims that the Company believes will have a material adverse effect on the business, financial condition or operating results.

Indemnification Agreements

The Company maintains indemnification agreements with its directors and officers that may require the Company to indemnify these individuals against liabilities that arise by reason of their status or service as directors or officers, except as prohibited by law.

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Government Assistance
3 Months Ended
Mar. 31, 2023
Government Assistance [Abstract]  
Government Assistance

Note 8 – Government Assistance

During 2022, the Company was awarded a research grant from the Department of Energy (“DOE”) for approximately $250 thousand with the completion occurring in March 2023. The purpose of the grant was to produce a research paper for a flexible fuel ultra-low NOx process burner capable of burning 100% hydrogen fuel. The award allowed the Company to request reimbursements for expenditures such as labor, material, and administrative costs. During the three months ended March 31, 2023, the Company recognized $69 thousand in reimbursements from DOE. The Company did not recognize reimbursements from the DOE for the three months ended March 31, 2022.

Beginning in 2021, the Company received funds relating to the Oklahoma 21st Century Quality Jobs Act. The estimated duration of the program is up to 10 years and is designed to attract growth industries to Oklahoma. By reporting quarterly salary statistics and meeting agreed upon employment thresholds, the state remits benefit monies to the Company. For the three months ended March 31, 2023, the Company recognized $24 thousand in government assistance. During the three months ended March 31, 2022, the Company had no government assistance from this program.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events  
Subsequent Events

Note 9 – Subsequent Events

The Company has evaluated subsequent events as of the date of this report, and has none to report.

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2023
Summary of Significant Accounting Policies  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2022 has been derived from the Company’s audited financial statements as of that date.

In the opinion of management, these condensed consolidated financial statements reflect all normal recurring and other adjustments necessary for a fair presentation. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year or any other future periods.

The accompanying unaudited condensed consolidated financial statements include the accounts of ClearSign and its subsidiary. Intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition and Cost of Sales

Revenue Recognition and Cost of Sales

The Company recognizes revenue and related cost of goods sold in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 606 Revenue from Contracts with Customers (“ASC 606”). When applying ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the promises and performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the performance obligations are satisfied. Revenues and cost of goods sold are recognized once the goods or services are delivered to the customer’s control or non-refundable performance obligations are satisfied. The Company’s contracts with customers generally have performance obligations and a schedule of non-refundable cancellation obligations. The contracts generally will be fully performed upon delivery of certain drawings or equipment. Revenue related to the contracts is recognized following the completion of non-refundable performance obligations as defined in the contract.

The Company’s contracts generally include progress payments from the customer upon completion of defined milestones. As these payments are received, they are offset against accumulated project costs and recorded as either contract assets or contract liabilities. Upon completion of the performance obligations and collectability is determined, revenue is recorded. For any contract that is expected to incur costs in excess of the contract price, the Company accrues the estimated loss in full in the period such determination is made.

Contract Costs

Contract Costs

The Company capitalizes project costs until performance obligations related to the contract are completed. The Company expenses selling and marketing expenses when incurred within the statements of operations in general and administrative expenses.

Product Warranties

Product Warranties

The Company warrants all installed products against defects in materials and workmanship for a period specified in each contract by replacing failed parts. Accruals for product warranties are based on historical or expected warranty experience and current product performance trends and are recorded as a component of cost of sales at the time revenue is recognized. The warranty liabilities are reduced by material and labor costs used to replace parts over the warranty period in the periods in which the costs are incurred. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary, and such adjustments could be material in the future if estimates differ significantly from actual warranty expense. Product warranties are included in accounts payable and accrued liabilities in the consolidated balance sheets.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on deposit in a checking and savings account, and short-term money market instruments with an original maturity of three months or less. Cash equivalents, which consist of short-term U.S. treasury bills, are based on quoted market prices, a Level 1 fair value measure.

Short-term Investments

Short-Term Investments

Short-term investments consist of U.S. treasuries with original maturities of twelve months or less and greater than three months. These short-term investments are classified as held to maturity and are recorded on an amortized cost basis based on the Company’s positive intent and ability to hold these securities to maturity. As of March 31, 2023, the Company has not experienced any other-than-temporary impairment of its short-term investments. A decline in the market value of any held-to-maturity security below cost that is deemed other than temporary results in a reduction in carrying amount to fair value. The impairment is charged to earnings and a new cost basis for the security is established. The company evaluates whether the decline in fair value of its investments is other-than temporary at each quarter-end.

The cost basis for the Company’s short-term investments totaled approximately $3,161 thousand and $2,606 thousand as of March 31, 2023 and December 31, 2022, respectively. The unrealized holding gains for the Company’s short-term investments totaled approximately $33 thousand and $4 thousand as of March 31, 2023 and December 31, 2022, respectively. The Company has not experienced any continuous unrealized holding losses on these investments. The fair value for the Company’s short-term investments totaled approximately $3,194 thousand and $2,610 thousand as of March 31, 2023 and December 31, 2022, respectively.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivables are recorded at the contractual invoiced amount. An allowance for doubtful accounts is established, as necessary, based on past experience and management’s judgment. The determination of the collectability of amounts due from customers require the Company to make judgments regarding future events and trends. Allowances for doubtful accounts are determined based on assessing the Company’s portfolio on an individual customer and on an overall basis. This process consists of a review of historical collection experience, current aging status of the customer accounts, and the financial condition of the Company’s customers. Based on a review of these factors, the Company may establish or adjust the allowance for specific customers and the accounts receivable portfolio as a whole.

Fixed Assets and Leases

Fixed Assets and Leases

Fixed assets are recorded at cost. Leases are recorded in accordance with FASB ASC 842, Leases. For those leases with a term greater than one year, the Company recognizes a right-of-use asset, which is included in fixed assets, net on the consolidated balance sheets, and a lease liability measured at the present value of the lease payments at the time of the lease inception or modification. Lease costs are recognized in the consolidated statement of operations over the lease term on a straight-line basis. Leases with a term of 1 year or less are considered short term leases with rent expense recognized over the lease term. Depreciation is computed using the straight-line method over the estimated useful lives of the respective lease assets. Leasehold improvements are depreciated over the life of the lease or their useful life,

whichever is shorter. All other fixed assets are depreciated over three to four years. Maintenance and repairs are expensed as incurred.

Patents and Trademarks

Patents and Trademarks

Third-party expenses related to patents and trademarks are recorded at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are awarded. Patent application costs are deferred pending the outcome of patent and trademark applications. Costs associated with unsuccessful patent applications and abandoned intellectual property are expensed when determined to have no continuing value in current business activity. The Company evaluates the recoverability of the carrying values of intangible assets each reporting period.

Impairment of Long-lived Assets

Impairment of Long-Lived Assets

The Company tests long-lived assets, consisting of fixed assets, patents, trademarks, and other intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected from the use and eventual disposition of the assets. In the event an asset is not fully recoverable, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Fair value is determined based on the present value of estimated expected cash flows using a discount rate commensurate with the risks involved, quoted market prices, or appraised values depending upon the nature of the assets. Losses on long-lived assets to be disposed are determined in a similar manner, except those fair values are reduced for the cost of disposal.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs used to establish fair value are the following:

Level 1 – Quoted prices in active markets for identical assets or liabilities;
Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s financial instruments primarily consist of cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributable to the short-term nature of these instruments.

The Company did not identify any other recurring or non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.

Research and Development

Research and Development

The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consumables, and consulting fees, including costs to develop and test prototype equipment and parts. Research and Development costs have been offset by funds received, if any, from strategic partners

in cost sharing, collaborative projects. During the three months ended March 31, 2023 and 2022, the Company did not receive funds from these arrangements.

Government Assistance

Government Assistance

The Company has adopted Accounting Standards Update (“ASU”) 2021-10, Government Assistance (Topic 832) Disclosures by Business Entities about Government Assistance, which requires footnote disclosure of assistance received from government entities. The Company records gross monies received from government entities in other income, and associated expenses such as salaries and supplies are recorded in Research and Development or General and Administration, depending on the nature of expenditure. The Company accrues for reimbursement requests submitted to government entities in accounts receivable.

Income Taxes

Income Taxes

The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not the Company would not be able to realize their benefits, or that future deductibility is uncertain. Tax benefits are recognized only if it is more likely than not that the tax benefits will be utilized in the foreseeable future.

Share-Based Compensation

Share-Based Compensation

The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the unaudited condensed consolidated financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, or in the case of performance options, expense is recognized upon completion of milestones as defined in the grant agreement. Share-based compensation for stock grants to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.

Foreign Operations

Foreign Operations

The accompanying unaudited condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022 include assets amounting to approximately $277 thousand and $172 thousand, respectively, relating to operations of ClearSign Asia Limited. The Beijing registered capital requirement is $350 thousand, which is required to be paid by 2027, and of which $111 thousand has been paid as of March 31, 2023. It is always possible that unanticipated events in foreign countries could disrupt the Company’s operations, and since the first quarter of 2020 this has been and currently continues to be the case with the effects of the COVID-19 pandemic.

Foreign Currency

Foreign Currency

Assets and liabilities of ClearSign Asia Limited with non-U.S. Dollar functional currency are translated to U.S. Dollars using exchange rates in effect at the end of the period. Revenue and expenses are translated to U.S. Dollars using rates that approximate those in effect during the period. The resulting translation adjustments are included in the Company’s condensed consolidated balance sheets in the stockholders’ equity section as a component of accumulated other comprehensive income (loss).

Net Loss per Common Share

Net Loss per Common Share

Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their

effect would be anti-dilutive. At March 31, 2023 and March 31, 2022, potentially dilutive shares outstanding amounted to 3.7 million and 3.3 million, respectively.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements Adopted

In June 2017, the FASB issued an Accounting Standards Update (“ASU”) ASU 2016-13, Financial Instruments (Topic 326) Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. The standard replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. ASU 2016-13, and related amendments, are effective for fiscal years beginning after December 15, 2022. The Company adopted this standard on January 1, 2023. This standard did not have a material impact on the Company’s condensed consolidated financial statements.

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Fixed Assets (Tables)
3 Months Ended
Mar. 31, 2023
Fixed Assets  
Summary of Fixed Assets

March 31, 

December 31, 

(in thousands)

    

2023

    

2022

    

Machinery and equipment

$

209

$

390

Office furniture and equipment

 

60

 

177

Leasehold improvements

 

43

 

192

312

759

Accumulated depreciation and amortization

 

(81)

 

(697)

231

62

Operating lease ROU assets, net

284

322

Total

$

515

$

384

Schedule Of Supplemental Information

March 31, 

December 31, 

(in thousands)

2023

2022

Operating lease ROU assets, net

$

284

$

322

Lease Liabilities:

Current lease liabilities

$

77

$

133

Long term lease liabilities

213

226

Total lease liabilities

$

290

$

359

Weighted average remaining lease term (in years):

 

2.7

Weighted average discount rate:

 

5.2

%

Supplemental cash flow information related to leases

For the Three Months Ended

March 31, 

2023

2022

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows used in operating leases

$

66

$

57

Non-cash impact of new leases and lease modifications

Change in operating lease liabilities

$

(9)

$

Change in operating lease ROU assets

$

5

$

Schedule of minimum future payments

Minimum future payments under the Company’s lease liabilities as of March 31, 2023 are as follows:

    

Discounted

    

Payments

lease

due under

(in thousands)

liability

lease

payments

agreements

2023

 

$

64

 

$

73

2024

 

54

 

65

2025

59

66

2026

63

67

2027

50

51

Total

$

290

$

322

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Patents and Other Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2023
Patents and Other Intangible Assets  
Schedule of Patents and Other Intangible Assets

Patents and other intangible assets are summarized as follows:

March 31, 

December 31, 

(in thousands)

    

2023

    

2022

    

Patents

Patents pending

$

330

$

307

Issued patents

 

815

 

815

 

1,145

 

1,122

Trademarks

 

 

Trademarks pending

 

7

 

6

Registered trademarks

 

95

 

95

 

102

 

101

Other

 

8

 

8

 

1,255

 

1,231

Accumulated amortization

 

(473)

 

(433)

$

782

$

798

Schedule of future amortization expense

Future amortization expense associated with issued patents and registered trademarks as of March 31, 2023 is as follows:

(in thousands)

2023

    

$

108

2024

 

126

2025

 

96

2026

 

61

2027

 

39

Thereafter

 

7

$

437

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Tables)
3 Months Ended
Mar. 31, 2023
Schedule of Outstanding, Reserved and Authorized Shares under Share-based Compensation Plans

March 31, 

December 31, 

(in thousands)

    

2023

    

2022

Outstanding options and restricted stock units

 

3,332

 

3,202

Reserved but unissued shares under the Plans

2,530

2,777

Total authorized shares under the Plans

 

5,862

 

5,979

Schedule of stock option activity

A summary of the Company’s stock option activity and changes is as follows:

March 31, 

2023

(in thousands)

Options to Purchase Common Stock

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life (in years)

Outstanding at beginning of year

 

2,779

$

2.05

 

6.43

Granted

 

$

 

Exercised

 

$

 

Forfeited/Expired

 

$

 

Outstanding at end of period

 

2,779

$

2.05

 

6.18

Exercisable at end of period

 

2,011

$

1.70

 

5.68

Schedule of share-based compensation activity

March 31, 

(in thousands)

    

2023

Reserved but unissued shares at beginning of year

196

Increases in the number of authorized shares

5

Grants

(4)

Reserved but unissued shares at end of year

 

197

Schedule of restricted stock unit activity

March 31, 

2023

(in thousands)

Number of Shares

Weighted Average Grant Date Fair Value

Nonvested at beginning of year

 

423

$

1.49

Granted

 

374

$

0.69

Vested

 

(245)

$

1.34

Nonvested at end of period

 

552

$

1.01

Restricted Stock Units  
Schedule of Compensation Expense

For the Three Months Ended

March 31, 

(in thousands)

2023

    

2022

Compensation Expense

$

199

$

35

Weighted Average Value Per Share

$

1.25

$

1.44

Warrant [Member]  
Schedule of Compensation Expense

For the Three Months Ended

March 31, 

    

2023

    

2022

Fair value

$

234

$

98

Weighted Average Value Per Share

$

0.79

$

1.43

Consultant Stock Plan  
Schedule of Compensation Expense

For the Three Months Ended

March 31, 

    

2023

    

2022

Compensation Expense

$

3

$

7

Weighted Average Value Per Share

$

0.66

$

1.93

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Description of Business (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Organization and Description of Business    
Cash and cash equivalents $ 5,328 $ 6,451
Short-term held-to-maturity investments 3,161 2,606
Gross proceeds to date 91,000  
Accumulated deficit $ (89,952) $ (88,523)
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Short-Term Investments (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies    
Short-term investments at cost $ 3,161 $ 2,606
Unrealized holding gains 33 4
Fair value of short-term investments $ 3,194 $ 2,610
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Fixed Assets and Leases (Details) - Fixed Assets Other Than Leasehold Improvements
3 Months Ended
Mar. 31, 2023
Minimum  
Property, Plant and Equipment [Line Items]  
Fixed assets, depreciated life 3 years
Maximum  
Property, Plant and Equipment [Line Items]  
Fixed assets, depreciated life 4 years
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Foreign Operations (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Assets $ 10,167 $ 10,925
CHINA    
Property, Plant and Equipment [Line Items]    
Assets 277 $ 172
Registered capital requirement 350  
Capital Requirement Satisfied $ 111  
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Research and Development (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Summary of Significant Accounting Policies    
Research and Development costs have been offset by funds received $ 0 $ 0
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Net Loss per Common Share (Details) - shares
shares in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies    
Potentially dilutive shares outstanding (in shares) 3.7 3.3
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Fixed Assets - Summary (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Property, Plant and Equipment [Line Items]      
Fixed assets, gross $ 312   $ 759
Less: Accumulated depreciation and amortization (81)   (697)
Fixed assets, net, after accumulated amortization 231   62
Operating lease ROU assets, net 284   322
Total 515   384
Depreciation expense 40 $ 7  
Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Machinery and equipment 209   390
Office furniture and equipment      
Property, Plant and Equipment [Line Items]      
Office furniture and equipment 60   177
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Leasehold improvements $ 43   $ 192
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Fixed Assets - Leases (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Leases          
Monthly rent expense     $ 11    
Operating lease cost     48 $ 57  
Seattle and Tulsa          
Leases          
Restoration expense     $ 2   $ 87
Monthly rent expense $ 4        
CHINA          
Leases          
Renewal option term   1 year      
Monthly rent expense   $ 2      
Minimum | Seattle and Tulsa          
Leases          
Remaining term (in years) 6 months   6 months    
Annual rent expense, increase (in percent)     2.00%    
Maximum | Seattle and Tulsa          
Leases          
Remaining term (in years) 6 years   6 years    
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Fixed Assets - Leases - Supplemental balance sheet and cash flow information (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Mar. 31, 2023
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Operating Lease        
Operating lease ROU assets, net $ 284 $ 284   $ 322
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Property, Plant and Equipment, Net Property, Plant and Equipment, Net   Property, Plant and Equipment, Net
Lease Liabilities:        
Current lease liabilities $ 77 $ 77   $ 133
Long term lease liabilities 213 213   226
Total lease liabilities $ 290 $ 290   $ 359
Weighted average remaining lease term (in years) 2 years 8 months 12 days 2 years 8 months 12 days    
Weighted average discount rate 5.20% 5.20%    
Cash paid for amounts included in the measurement of lease liabilities:        
Operating cash flows used in operating leases   $ 66 $ 57  
Change in operating lease liabilities $ (9) (9)    
Change in operating lease ROU assets $ 5 $ 5    
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Fixed Assets - Minimum future lease payments (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Fixed Assets    
2023 (remaining) $ 73  
2024 65  
2025 66  
2026 67  
2027 51  
Total 322  
Discounted payments, 2023 (remaining) 64  
Discounted payments, 2024 54  
Discounted payments, 2025 59  
Discounted payments, 2026 63  
Discounted payments, 2027 50  
Operating Lease, Liability 290 $ 359
Total discounted payments 290  
Interest on future minimum payments $ 32  
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Patents and Other Intangible Assets - Summary (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Patents $ 1,145 $ 1,122
Trademarks 102 101
Other 8 8
Patents and other intangible assets 1,255 1,231
Accumulated amortization (473) (433)
Finite-Lived Intangible Assets, Net 782 798
Patents pending    
Patents 330 307
Issued patents    
Patents 815 815
Trademarks pending    
Trademarks 7 6
Registered trademarks    
Trademarks $ 95 $ 95
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Patents and Other Intangible Assets - Future amortization expense (Details)
$ in Thousands
Mar. 31, 2023
USD ($)
Patents and Other Intangible Assets  
2023 $ 108
2024 126
2025 96
2026 61
2027 39
Thereafter 7
Finite-Lived Intangible Assets, Net $ 437
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Patents and Other Intangible Assets - Additional information (Details)
3 Months Ended
Mar. 31, 2023
Minimum  
Intangible assets  
Amortization life (in years) 3 years
Maximum  
Intangible assets  
Amortization life (in years) 5 years
Trademarks  
Intangible assets  
Amortization life (in years) 10 years
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue, Contract Assets and Contract Liabilities (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Revenue, Contract Assets and Contract Liabilities    
Revenues $ 894  
Cost of goods sold 788  
Contract assets 4 $ 20
Contract liabilities $ 639 $ 247
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Equity - Common Stock and Preferred Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jul. 31, 2018
Stockholders' equity      
Common stock, authorized shares 62,500,000    
Preferred stock, authorized shares 2,000,000.0    
Gross proceeds to date $ 91,000    
Proceeds from issuance of common stock, net of offering costs   $ 578  
ATM      
Stockholders' equity      
Number of shares of common stock issued 0    
Number of shares issued to date 1,600,000    
Aggregate offering price $ 8,700    
Participation Right      
Stockholders' equity      
Stock Issued, Investor, Maximum Beneficial Ownership Percentage     20.00%
Common Stock | ATM      
Stockholders' equity      
Gross proceeds to date 6,100    
Net proceeds to date $ 5,900    
Share price of shares issued in offering (in dollars per share) $ 3.84    
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Equity - Equity Incentive Plan (Details) - shares
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Equity Incentive Plan [Member]    
Share-based compensation    
Outstanding options and restricted stock units 3,332,000 3,202,000
Reserved but unissued shares under the Plans 2,530,000 2,777,000
Number of shares authorized 5,862,000 5,979,000
Increases in the number of authorized shares 400,000  
2021 Plan    
Share-based compensation    
Maximum number of shares that may be issued as a proportion of outstanding stock 10.00%  
Maximum increase in number of shares available for issuance 400,000  
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Equity - Stock Options - Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Share-based compensation      
Outstanding shares, beginning balance 2,779,000    
Outstanding shares, ending balance 2,779,000   2,779,000
Exercisable (in shares) 2,011,000    
Outstanding - Weighted Average Exercise Price (in dollars per share) $ 2.05    
Outstanding - Weighted Average Exercise Price (in dollars per share) 2.05   $ 2.05
Exercisable - Weighted Average Exercise Price (in dollars per share) $ 1.70    
Stock options, Contractual life (in years) 6 years 2 months 4 days   6 years 5 months 4 days
Exercisable - Weighted Average Remaining Contractual Life (in years) 5 years 8 months 4 days    
Estimated aggregate pretax intrinsic value $ 27    
Total unrecognized compensation 1,000    
Compensation expense $ 44 $ 42  
Equity Incentive Plan [Member]      
Share-based compensation      
Granted (in shares) 0    
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Equity - Restricted Stock Units (Details) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Compensation expense $ 44 $ 42
Restricted Stock Units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Compensation expense $ 199 35
Number of shares vested 245  
Restricted Stock Units | Director    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Target Value of Compensation per Quarter $ 85  
Unrecognized compensation $ 68 $ 85
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Equity - Restricted Stock units Activity (Details) - Restricted Stock Units
shares in Thousands
3 Months Ended
Mar. 31, 2023
$ / shares
shares
Number of Shares  
Nonvested at beginning of year | shares 423
Granted | shares 374
Vested | shares (245)
Nonvested at end of year | shares 552
Weighted Average Grant Date Fair Value  
Nonvested at beginning of year | $ / shares $ 1.49
Granted | $ / shares 0.69
Vested | $ / shares 1.34
Nonvested at end of year | $ / shares $ 1.01
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Equity - Restricted Stock Units - Compensation Expense (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Compensation expense $ 44 $ 42
Restricted Stock Units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Compensation expense $ 199 $ 35
Weighted Average Value Per Share $ 1.25 $ 1.44
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Equity - Stock Grants (Details) - Employee compensation in lieu of bonus - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-based compensation    
Fair value $ 234 $ 98
Weighted Average Value Per Share $ 0.79 $ 1.43
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Equity - Consultant Stock Plan (Details) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Compensation expense $ 44 $ 42
Consultant Stock Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Reserved but unissued shares at beginning of year 196  
Increases in the number of authorized shares 5  
Stock grants (4)  
Reserved but unissued shares at end of year 197  
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Government Assistance (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Government Assistance [Line Items]        
Government assistance, reimbursements from Department of Energy $ 93,000      
Research Grant From The Department Of Energy [Member]        
Government Assistance [Line Items]        
Total award     $ 250,000  
Government assistance, reimbursements from Department of Energy 69,000 $ 0    
Oklahoma Quality Jobs Act [Member]        
Government Assistance [Line Items]        
Government assistance, reimbursements from Department of Energy $ 24,000 $ 0    
Duration of the program       10 years
XML 53 clir-20230331x10q_htm.xml IDEA: XBRL DOCUMENT 0001434524 us-gaap:RetainedEarningsMember 2023-03-31 0001434524 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001434524 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001434524 us-gaap:RetainedEarningsMember 2022-12-31 0001434524 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001434524 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001434524 us-gaap:RetainedEarningsMember 2022-03-31 0001434524 us-gaap:ParentMember 2022-03-31 0001434524 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001434524 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001434524 us-gaap:RetainedEarningsMember 2021-12-31 0001434524 us-gaap:ParentMember 2021-12-31 0001434524 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001434524 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001434524 us-gaap:CommonStockMember 2023-03-31 0001434524 us-gaap:CommonStockMember 2022-12-31 0001434524 us-gaap:CommonStockMember 2022-03-31 0001434524 us-gaap:CommonStockMember 2021-12-31 0001434524 clir:ConsultantPlanMember 2023-03-31 0001434524 clir:ConsultantPlanMember 2022-12-31 0001434524 clir:EquityIncentivePlanMember 2023-01-01 2023-03-31 0001434524 us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001434524 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001434524 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001434524 clir:ConsultantPlanMember 2023-01-01 2023-03-31 0001434524 srt:MinimumMember clir:PropertyPlantAndEquipmentOtherThanLeaseholdImprovementsMember 2023-01-01 2023-03-31 0001434524 srt:MaximumMember clir:PropertyPlantAndEquipmentOtherThanLeaseholdImprovementsMember 2023-01-01 2023-03-31 0001434524 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001434524 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001434524 us-gaap:MachineryAndEquipmentMember 2023-03-31 0001434524 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001434524 country:CN 2022-06-30 0001434524 srt:MinimumMember clir:SeattleAndTulsaMember 2023-03-31 0001434524 srt:MaximumMember clir:SeattleAndTulsaMember 2023-03-31 0001434524 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2023-03-31 0001434524 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2022-12-31 0001434524 2023-03-01 2023-03-31 0001434524 clir:OklahomaQualityJobsActMember 2021-01-01 2021-12-31 0001434524 clir:ResearchGrantFromDepartmentOfEnergyMember 2023-01-01 2023-03-31 0001434524 clir:OklahomaQualityJobsActMember 2023-01-01 2023-03-31 0001434524 clir:ResearchGrantFromDepartmentOfEnergyMember 2022-01-01 2022-03-31 0001434524 clir:OklahomaQualityJobsActMember 2022-01-01 2022-03-31 0001434524 us-gaap:FurnitureAndFixturesMember 2023-03-31 0001434524 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001434524 clir:TrademarksPendingMember 2023-03-31 0001434524 clir:RegisteredTrademarksMember 2023-03-31 0001434524 clir:TrademarksPendingMember 2022-12-31 0001434524 clir:RegisteredTrademarksMember 2022-12-31 0001434524 clir:PatentsPendingMember 2023-03-31 0001434524 clir:IssuedPatentsMember 2023-03-31 0001434524 clir:PatentsPendingMember 2022-12-31 0001434524 clir:IssuedPatentsMember 2022-12-31 0001434524 us-gaap:TrademarksMember 2023-01-01 2023-03-31 0001434524 srt:MinimumMember 2023-01-01 2023-03-31 0001434524 srt:MaximumMember 2023-01-01 2023-03-31 0001434524 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001434524 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0001434524 2022-03-31 0001434524 2021-12-31 0001434524 country:CN 2022-12-31 0001434524 2022-01-01 2022-12-31 0001434524 2023-05-10 0001434524 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001434524 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001434524 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001434524 clir:ParticipationRightMember 2018-07-31 0001434524 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-01-01 2023-03-31 0001434524 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-03-31 0001434524 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001434524 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001434524 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001434524 us-gaap:ParentMember 2022-01-01 2022-03-31 0001434524 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001434524 clir:TwoThousandAndTwentyOnePlanMember 2023-01-01 2023-03-31 0001434524 clir:SeattleAndTulsaMember 2023-01-01 2023-03-31 0001434524 clir:SeattleAndTulsaMember 2022-01-01 2022-12-31 0001434524 clir:ResearchGrantFromDepartmentOfEnergyMember 2022-01-01 2022-12-31 0001434524 2022-12-31 0001434524 srt:MinimumMember clir:SeattleAndTulsaMember 2023-01-01 2023-03-31 0001434524 clir:EquityIncentivePlanMember 2023-03-31 0001434524 clir:EquityIncentivePlanMember 2022-12-31 0001434524 clir:SeattleAndTulsaMember 2023-03-01 2023-03-31 0001434524 country:CN 2022-06-01 2022-06-30 0001434524 clir:AtMarketOfferingMember 2023-03-31 0001434524 us-gaap:CommonStockMember clir:AtMarketOfferingMember 2023-03-31 0001434524 2023-03-31 0001434524 2022-01-01 2022-03-31 0001434524 2023-01-01 2023-03-31 0001434524 country:CN 2023-03-31 0001434524 clir:AtMarketOfferingMember 2023-01-01 2023-03-31 iso4217:USD iso4217:USD shares shares pure http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet 0001434524 --12-31 2023 Q1 false 0 0 38545556 38023701 P6M P3Y P3Y 10-Q true 2023-03-31 false 001-35521 CLEARSIGN TECHNOLOGIES CORPORATION WA 26-2056298 8023 E. 63rd Place, Suite 101 Tulsa OK 74133 918 236-6461 Common Stock CLIR NASDAQ Yes Yes Non-accelerated Filer true false false 38545556 5328000 6451000 3161000 2606000 50000 79000 4000 20000 317000 577000 8860000 9733000 515000 384000 782000 798000 10000 10000 10167000 10925000 398000 296000 77000 133000 253000 471000 639000 247000 1367000 1147000 213000 226000 1580000 1373000 0.0001 0.0001 0 0 0.0001 0.0001 38545556 38023701 4000 4000 98543000 98079000 -8000 -8000 -89952000 -88523000 8587000 9552000 10167000 10925000 894000 788000 106000 160000 108000 1650000 1409000 1810000 1517000 -1704000 -1517000 58000 93000 5000 23000 119000 4000 275000 27000 -1429000 -1490000 -0.04 -0.04 -0.05 -0.05 38262710 38262710 31826221 31826221 38023000 4000 98079000 -8000 -88523000 9552000 223000 227000 227000 296000 234000 234000 0.66 4000 3000 3000 -1429000 -1429000 38546000 4000 98543000 -8000 -89952000 8587000 31582000 3000 91035000 9000 -82765000 8282000 0.89 1000 2.93 3000 66000 95000 95000 12000 12000 3000 80000 80000 1.24 496000 578000 578000 1.93 4000 7000 7000 -1490000 -1490000 32155000 3000 91807000 9000 -84255000 7564000 -1429000 -1490000 3000 7000 242000 80000 80000 36000 5000 23000 43000 35000 20000 14000 -16000 205000 -29000 -6000 -51000 56000 57000 22000 1000 85000 392000 -554000 -1503000 5000 24000 33000 5000 23000 2162000 1627000 -554000 -15000 578000 15000 -15000 578000 -1123000 -940000 6451000 7607000 5328000 6667000 234000 107000 209000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1 – Organization and Description of Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">ClearSign Technologies Corporation (“ClearSign” or the “Company”) designs and develops products and technologies that have been shown to significantly improve key performance characteristics of industrial and commercial systems, including operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness. The Company’s patented technologies are designed to be embedded in established OEM products as ClearSign Core™ and ClearSign Eye™ and other sensing configurations in order to enhance the performance of combustion systems and fuel safety systems in a broad range of markets. These markets include energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. The Company’s primary technology is its ClearSign Core technology, which achieves very low emissions without the need of selective catalytic reduction. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Company was incorporated in the State of Washington in 2008. During January 2022, the Company relocated its headquarters from Seattle, Washington to Tulsa, Oklahoma. On July 28, 2017, the Company incorporated a subsidiary, ClearSign Asia Limited, in Hong Kong to represent the Company’s business and technological interests throughout Asia. Through ClearSign Asia Limited, the Company has established a Wholly Foreign Owned Enterprise (WFOE) in China – ClearSign Combustion (Beijing) Environmental Technologies Co., LTD.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise stated or the context otherwise requires, the terms ClearSign and the Company refer to ClearSign Technologies Corporation and its subsidiary, ClearSign Asia Limited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Liquidity</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company's condensed consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As of March 31, 2023, the Company’s cash and cash equivalents totaled $5,328 thousand, and short-term held-to-maturity investments totaled $3,161 thousand, which is sufficient to fund current operating expenses beyond twelve months from the date hereof. The Company’s technologies are currently in field development, but with nominal fully operational commercial installations, and have generated nominal revenues from operations to date to meet operating expenses. In order to generate meaningful revenues, the technologies must be fully developed, gain market recognition and acceptance, and develop a critical level of successful sales and product installations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Historically, the Company has financed operations primarily through issuances of equity securities. Since inception, the Company has raised approximately $91.0 million in gross proceeds through the sale of its equity securities. During the three months ended March 31, 2023, the Company did not raise proceeds through the issuance of common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company has incurred losses since its inception totaling $90.0 million and expects to experience operating losses and negative cash flows for the foreseeable future. Management believes that the successful growth and operation of the Company’s business is dependent upon its ability to obtain adequate sources of funding through co-development agreements, strategic partnering agreements, or equity or debt financing to adequately support product commercialization efforts, protect intellectual property, form relationships with strategic partners, and provide for working capital and general corporate purposes. There can be no assurance that the Company will be successful in achieving its long-term plans as set forth above, or that such plans, if consummated, will result in profitable operations or enable the Company to continue in the long-term as a going concern.</p> 5328000 3161000 91000000.0 -90000000.0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 2 – Summary of Significant Accounting Policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Basis of Presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2022 has been derived from the Company’s audited financial statements as of that date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">In the opinion of management, these condensed consolidated financial statements reflect all normal recurring and other adjustments necessary for a fair presentation. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year or any other future periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed consolidated financial statements include the accounts of ClearSign and its subsidiary. Intercompany balances and transactions have been eliminated in consolidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Revenue Recognition and Cost of Sales</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes revenue and related cost of goods sold in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 606 <i style="font-style:italic;">Revenue from Contracts with Customers </i>(“ASC 606”). When applying ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the promises and performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the performance obligations are satisfied. Revenues and cost of goods sold are recognized once the goods or services are delivered to the customer’s control or non-refundable performance obligations are satisfied. The Company’s contracts with customers generally have performance obligations and a schedule of non-refundable cancellation obligations. The contracts generally will be fully performed upon delivery of certain drawings or equipment. Revenue related to the contracts is recognized following the completion of non-refundable performance obligations as defined in the contract. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company’s contracts generally include progress payments from the customer upon completion of defined milestones. As these payments are received, they are offset against accumulated project costs and recorded as either contract assets or contract liabilities. Upon completion of the performance obligations and collectability is determined, revenue is recorded. For any contract that is expected to incur costs in excess of the contract price, the Company accrues the estimated loss in full in the period such determination is made.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Contract Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company capitalizes project costs until performance obligations related to the contract are completed. The Company expenses selling and marketing expenses when incurred within the statements of operations in general and administrative expenses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Product Warranties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The Company warrants all installed products against defects in materials and workmanship for a period specified in each contract by replacing failed parts. Accruals for product warranties are based on historical or expected warranty experience and current product performance trends and are recorded as a component of cost of sales at the time revenue is recognized. The warranty liabilities are reduced by material and labor costs used to replace parts over the warranty period in the periods in which the costs are incurred. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary, and such adjustments could be material in the future if estimates differ significantly from actual warranty expense. Product warranties are included in accounts payable and accrued liabilities in the consolidated balance sheets.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">Cash and cash equivalents consist of cash on deposit in a checking and savings account, and short-term money market instruments with an original maturity of three months or less. Cash equivalents, which consist of short-term U.S. treasury bills, are based on quoted market prices, a Level 1 fair value measure.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Short-Term Investments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term investments consist of U.S. treasuries with original maturities of twelve months or less and greater than three months. These short-term investments are classified as held to maturity and are recorded on an amortized cost basis based on the Company’s positive intent and ability to hold these securities to maturity. As of March 31, 2023, the Company has not experienced any other-than-temporary impairment of its short-term investments. A decline in the market value of any held-to-maturity security below cost that is deemed other than temporary results in a reduction in carrying amount to fair value. The impairment is charged to earnings and a new cost basis for the security is established. The company evaluates whether the decline in fair value of its investments is other-than temporary at each quarter-end. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The cost basis for the Company’s short-term investments totaled approximately $3,161 thousand and $2,606 thousand as of March 31, 2023 and December 31, 2022, respectively. The unrealized holding gains for the Company’s short-term investments totaled approximately $33 thousand and $4 thousand as of March 31, 2023 and December 31, 2022, respectively. The Company has not experienced any continuous unrealized holding losses on these investments. The fair value for the Company’s short-term investments totaled approximately $3,194 thousand and $2,610 thousand as of March 31, 2023 and December 31, 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Accounts Receivable and Allowance for Doubtful Accounts</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">Accounts receivables are recorded at the contractual invoiced amount. An allowance for doubtful accounts is established, as necessary, based on past experience and management’s judgment. The determination of the collectability of amounts due from customers require the Company to make judgments regarding future events and trends. Allowances for doubtful accounts are determined based on assessing the Company’s portfolio on an individual customer and on an overall basis. This process consists of a review of historical collection experience, current aging status of the customer accounts, and the financial condition of the Company’s customers. Based on a review of these factors, the Company may establish or adjust the allowance for specific customers and the accounts receivable portfolio as a whole. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Fixed Assets and Leases</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed assets are recorded at cost. Leases are recorded in accordance with FASB ASC 842, <i style="font-style:italic;">Leases</i>. For those leases with a term greater than one year, the Company recognizes a right-of-use asset, which is included in fixed assets, net on the consolidated balance sheets, and a lease liability measured at the present value of the lease payments at the time of the lease inception or modification. Lease costs are recognized in the consolidated statement of operations over the lease term on a straight-line basis. Leases with a term of 1 year or less are considered short term leases with rent expense recognized over the lease term. Depreciation is computed using the straight-line method over the estimated useful lives of the respective lease assets. Leasehold improvements are depreciated over the life of the lease or their useful life, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">whichever is shorter. All other fixed assets are depreciated over <span style="-sec-ix-hidden:Hidden_MPG0WP9ag0OkPcJh46Q4Dw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span> to four years. Maintenance and repairs are expensed as incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Patents and Trademarks</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">Third-party expenses related to patents and trademarks are recorded at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are awarded. Patent application costs are deferred pending the outcome of patent and trademark applications. Costs associated with unsuccessful patent applications and abandoned intellectual property are expensed when determined to have no continuing value in current business activity. The Company evaluates the recoverability of the carrying values of intangible assets each reporting period.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Impairment of Long-Lived Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The Company tests long-lived assets, consisting of fixed assets, patents, trademarks, and other intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected from the use and eventual disposition of the assets. In the event an asset is not fully recoverable, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Fair value is determined based on the present value of estimated expected cash flows using a discount rate commensurate with the risks involved, quoted market prices, or appraised values depending upon the nature of the assets. Losses on long-lived assets to be disposed are determined in a similar manner, except those fair values are reduced for the cost of disposal.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Fair Value of Financial Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs used to establish fair value are the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 1 – Quoted prices in active markets for identical assets or liabilities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company’s financial instruments primarily consist of cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributable to the short-term nature of these instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company did not identify any other recurring or non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Research and Development</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consumables, and consulting fees, including costs to develop and test prototype equipment and parts. Research and Development costs have been offset by funds received, if any, from strategic partners </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">in cost sharing, collaborative projects. During the three months ended March 31, 2023 and 2022, the Company did not receive funds from these arrangements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Government Assistance</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The Company has adopted Accounting Standards Update (“ASU”) 2021-10, Government Assistance (Topic 832) </span><i style="font-style:italic;text-decoration-line:none;">Disclosures by Business Entities about Government Assistance,</i><span style="text-decoration-line:none;"> which requires footnote disclosure of assistance received from government entities. The Company records gross monies received from government entities in other income, and associated expenses such as salaries and supplies are recorded in Research and Development or General and Administration, depending on the nature of expenditure. The Company accrues for reimbursement requests submitted to government entities in accounts receivable.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not the Company would not be able to realize their benefits, or that future deductibility is uncertain. Tax benefits are recognized only if it is more likely than not that the tax benefits will be utilized in the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Share-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the unaudited condensed consolidated financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, or in the case of performance options, expense is recognized upon completion of milestones as defined in the grant agreement. Share-based compensation for stock grants to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Foreign Operations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022 include assets amounting to approximately $277 thousand and $172 thousand, respectively, relating to operations of ClearSign Asia Limited. The Beijing registered capital requirement is $350 thousand, which is required to be paid by 2027, and of which $111 thousand has been paid as of March 31, 2023. It is always possible that unanticipated events in foreign countries could disrupt the Company’s operations, and since the first quarter of 2020 this has been and currently continues to be the case with the effects of the COVID-19 pandemic.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Foreign Currency</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;">Assets and liabilities of ClearSign Asia Limited with non-U.S. Dollar functional currency are translated to U.S. Dollars using exchange rates in effect at the end of the period. Revenue and expenses are translated to U.S. Dollars using rates that approximate those in effect during the period. The resulting translation adjustments are included in the Company’s condensed consolidated balance sheets in the stockholders’ equity section as a component of accumulated other comprehensive income (loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Net Loss per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">effect would be anti-dilutive. At March 31, 2023 and March 31, 2022, potentially dilutive shares outstanding amounted to 3.7 million and 3.3 million, respectively.<span style="white-space:pre-wrap;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Recently Issued Accounting Pronouncements Adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In June 2017, the FASB issued an Accounting Standards Update (“ASU”) ASU 2016-13, Financial Instruments (Topic 326) <i style="font-style:italic;">Measurement of Credit Losses on Financial Instruments</i>, which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. The standard replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. ASU 2016-13, and related amendments, are effective for fiscal years beginning after December 15, 2022. The Company adopted this standard on January 1, 2023. This standard did not have a material impact on the Company’s condensed consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Basis of Presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2022 has been derived from the Company’s audited financial statements as of that date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">In the opinion of management, these condensed consolidated financial statements reflect all normal recurring and other adjustments necessary for a fair presentation. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year or any other future periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed consolidated financial statements include the accounts of ClearSign and its subsidiary. Intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Revenue Recognition and Cost of Sales</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes revenue and related cost of goods sold in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 606 <i style="font-style:italic;">Revenue from Contracts with Customers </i>(“ASC 606”). When applying ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the promises and performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the performance obligations are satisfied. Revenues and cost of goods sold are recognized once the goods or services are delivered to the customer’s control or non-refundable performance obligations are satisfied. The Company’s contracts with customers generally have performance obligations and a schedule of non-refundable cancellation obligations. The contracts generally will be fully performed upon delivery of certain drawings or equipment. Revenue related to the contracts is recognized following the completion of non-refundable performance obligations as defined in the contract. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company’s contracts generally include progress payments from the customer upon completion of defined milestones. As these payments are received, they are offset against accumulated project costs and recorded as either contract assets or contract liabilities. Upon completion of the performance obligations and collectability is determined, revenue is recorded. For any contract that is expected to incur costs in excess of the contract price, the Company accrues the estimated loss in full in the period such determination is made.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Contract Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company capitalizes project costs until performance obligations related to the contract are completed. The Company expenses selling and marketing expenses when incurred within the statements of operations in general and administrative expenses. </p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Product Warranties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The Company warrants all installed products against defects in materials and workmanship for a period specified in each contract by replacing failed parts. Accruals for product warranties are based on historical or expected warranty experience and current product performance trends and are recorded as a component of cost of sales at the time revenue is recognized. The warranty liabilities are reduced by material and labor costs used to replace parts over the warranty period in the periods in which the costs are incurred. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary, and such adjustments could be material in the future if estimates differ significantly from actual warranty expense. Product warranties are included in accounts payable and accrued liabilities in the consolidated balance sheets.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">Cash and cash equivalents consist of cash on deposit in a checking and savings account, and short-term money market instruments with an original maturity of three months or less. Cash equivalents, which consist of short-term U.S. treasury bills, are based on quoted market prices, a Level 1 fair value measure.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Short-Term Investments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term investments consist of U.S. treasuries with original maturities of twelve months or less and greater than three months. These short-term investments are classified as held to maturity and are recorded on an amortized cost basis based on the Company’s positive intent and ability to hold these securities to maturity. As of March 31, 2023, the Company has not experienced any other-than-temporary impairment of its short-term investments. A decline in the market value of any held-to-maturity security below cost that is deemed other than temporary results in a reduction in carrying amount to fair value. The impairment is charged to earnings and a new cost basis for the security is established. The company evaluates whether the decline in fair value of its investments is other-than temporary at each quarter-end. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The cost basis for the Company’s short-term investments totaled approximately $3,161 thousand and $2,606 thousand as of March 31, 2023 and December 31, 2022, respectively. The unrealized holding gains for the Company’s short-term investments totaled approximately $33 thousand and $4 thousand as of March 31, 2023 and December 31, 2022, respectively. The Company has not experienced any continuous unrealized holding losses on these investments. The fair value for the Company’s short-term investments totaled approximately $3,194 thousand and $2,610 thousand as of March 31, 2023 and December 31, 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">​</span></p> 3161000 2606000 33000 4000 3194000 2610000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Accounts Receivable and Allowance for Doubtful Accounts</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">Accounts receivables are recorded at the contractual invoiced amount. An allowance for doubtful accounts is established, as necessary, based on past experience and management’s judgment. The determination of the collectability of amounts due from customers require the Company to make judgments regarding future events and trends. Allowances for doubtful accounts are determined based on assessing the Company’s portfolio on an individual customer and on an overall basis. This process consists of a review of historical collection experience, current aging status of the customer accounts, and the financial condition of the Company’s customers. Based on a review of these factors, the Company may establish or adjust the allowance for specific customers and the accounts receivable portfolio as a whole. </span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Fixed Assets and Leases</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed assets are recorded at cost. Leases are recorded in accordance with FASB ASC 842, <i style="font-style:italic;">Leases</i>. For those leases with a term greater than one year, the Company recognizes a right-of-use asset, which is included in fixed assets, net on the consolidated balance sheets, and a lease liability measured at the present value of the lease payments at the time of the lease inception or modification. Lease costs are recognized in the consolidated statement of operations over the lease term on a straight-line basis. Leases with a term of 1 year or less are considered short term leases with rent expense recognized over the lease term. Depreciation is computed using the straight-line method over the estimated useful lives of the respective lease assets. Leasehold improvements are depreciated over the life of the lease or their useful life, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">whichever is shorter. All other fixed assets are depreciated over <span style="-sec-ix-hidden:Hidden_MPG0WP9ag0OkPcJh46Q4Dw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span> to four years. Maintenance and repairs are expensed as incurred.</p> P4Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Patents and Trademarks</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">Third-party expenses related to patents and trademarks are recorded at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are awarded. Patent application costs are deferred pending the outcome of patent and trademark applications. Costs associated with unsuccessful patent applications and abandoned intellectual property are expensed when determined to have no continuing value in current business activity. The Company evaluates the recoverability of the carrying values of intangible assets each reporting period.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Impairment of Long-Lived Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The Company tests long-lived assets, consisting of fixed assets, patents, trademarks, and other intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected from the use and eventual disposition of the assets. In the event an asset is not fully recoverable, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Fair value is determined based on the present value of estimated expected cash flows using a discount rate commensurate with the risks involved, quoted market prices, or appraised values depending upon the nature of the assets. Losses on long-lived assets to be disposed are determined in a similar manner, except those fair values are reduced for the cost of disposal.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Fair Value of Financial Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs used to establish fair value are the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 1 – Quoted prices in active markets for identical assets or liabilities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company’s financial instruments primarily consist of cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributable to the short-term nature of these instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company did not identify any other recurring or non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Research and Development</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consumables, and consulting fees, including costs to develop and test prototype equipment and parts. Research and Development costs have been offset by funds received, if any, from strategic partners </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">in cost sharing, collaborative projects. During the three months ended March 31, 2023 and 2022, the Company did not receive funds from these arrangements.</p> 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Government Assistance</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The Company has adopted Accounting Standards Update (“ASU”) 2021-10, Government Assistance (Topic 832) </span><i style="font-style:italic;text-decoration-line:none;">Disclosures by Business Entities about Government Assistance,</i><span style="text-decoration-line:none;"> which requires footnote disclosure of assistance received from government entities. The Company records gross monies received from government entities in other income, and associated expenses such as salaries and supplies are recorded in Research and Development or General and Administration, depending on the nature of expenditure. The Company accrues for reimbursement requests submitted to government entities in accounts receivable.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not the Company would not be able to realize their benefits, or that future deductibility is uncertain. Tax benefits are recognized only if it is more likely than not that the tax benefits will be utilized in the foreseeable future.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Share-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the unaudited condensed consolidated financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award, or in the case of performance options, expense is recognized upon completion of milestones as defined in the grant agreement. Share-based compensation for stock grants to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Foreign Operations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022 include assets amounting to approximately $277 thousand and $172 thousand, respectively, relating to operations of ClearSign Asia Limited. The Beijing registered capital requirement is $350 thousand, which is required to be paid by 2027, and of which $111 thousand has been paid as of March 31, 2023. It is always possible that unanticipated events in foreign countries could disrupt the Company’s operations, and since the first quarter of 2020 this has been and currently continues to be the case with the effects of the COVID-19 pandemic.</p> 277000 172000 350000 111000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Foreign Currency</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;">Assets and liabilities of ClearSign Asia Limited with non-U.S. Dollar functional currency are translated to U.S. Dollars using exchange rates in effect at the end of the period. Revenue and expenses are translated to U.S. Dollars using rates that approximate those in effect during the period. The resulting translation adjustments are included in the Company’s condensed consolidated balance sheets in the stockholders’ equity section as a component of accumulated other comprehensive income (loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Net Loss per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">effect would be anti-dilutive. At March 31, 2023 and March 31, 2022, potentially dilutive shares outstanding amounted to 3.7 million and 3.3 million, respectively.<span style="white-space:pre-wrap;"> </span></p> 3700000 3300000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Recently Issued Accounting Pronouncements Adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In June 2017, the FASB issued an Accounting Standards Update (“ASU”) ASU 2016-13, Financial Instruments (Topic 326) <i style="font-style:italic;">Measurement of Credit Losses on Financial Instruments</i>, which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. The standard replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. ASU 2016-13, and related amendments, are effective for fiscal years beginning after December 15, 2022. The Company adopted this standard on January 1, 2023. This standard did not have a material impact on the Company’s condensed consolidated financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 3 – Fixed Assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Fixed Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fixed assets are summarized as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.91%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">December 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Machinery and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 390</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Office furniture and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 177</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 192</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 312</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 759</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accumulated depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (81)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 62</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Operating lease ROU assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 284</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 515</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 384</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Depreciation and amortization expense for the three months ended March 31, 2023 and 2022 totaled $40 thousand and $7 thousand, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Leases</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;">The Company leases office space in Seattle, Washington, Tulsa, Oklahoma and Beijing, China. During June 2022, the Company entered into a new lease agreement for its Beijing office space for a period of </span><span style="font-size:10pt;">one year</span><span style="font-size:10pt;"> with monthly rent at approximately </span><span style="font-size:10pt;">$2</span><span style="font-size:10pt;"> thousand. The Company classified this lease as an operating lease since it is more likely than not the lease will be renewed at the end of its term. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;white-space:pre-wrap;">During March 2023, the Company amended its Seattle lease to extend the lease term to September 2023. The amended lease reduced the square footage and lowered the monthly payment to approximately </span><span style="font-size:10pt;">$4</span><span style="font-size:10pt;white-space:pre-wrap;"> thousand. The Company increased the right of use asset by </span><span style="font-size:10pt;">$5</span><span style="font-size:10pt;"> thousand and decreased the lease liability by </span><span style="font-size:10pt;">$9</span><span style="font-size:10pt;white-space:pre-wrap;"> thousand. The Seattle, Tulsa, and Beijing leases are classified as operating leases, with remaining terms ranging from </span><span style="-sec-ix-hidden:Hidden_GdPKChcawUWpjDMkumZ2bw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">six months</span></span><span style="font-size:10pt;"> to </span><span style="font-size:10pt;">six years</span><span style="font-size:10pt;">; contractual language requires renewal negotiations to occur at or near termination. These leases are normal and customary for office space, in that, contractual guarantees exist requiring the lessee to return the premises to its original functional state. The Company accrued a liability of </span><span style="font-size:10pt;">$2</span><span style="font-size:10pt;"> thousand and </span><span style="font-size:10pt;">$87</span><span style="font-size:10pt;"> thousand as of March 31, 2023 and December 31, 2022, respectively, for the estimated cost of the restoration of the Seattle office. The Company plans to exit the Seattle lease on or before contract termination as part of the Company’s headquarters move from Seattle to Tulsa. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Tulsa lease contains fixed annual lease payments that increase annually by 2%. The Seattle, Tulsa, and Beijing total monthly minimum rent is approximately $11 thousand. Operating lease costs for the three months ended March 31, 2023 and 2022 were $48 thousand and $57 thousand, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Supplemental balance sheet information related to operating leases is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:84.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">March 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">December 31, </p></td></tr><tr><td style="vertical-align:bottom;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:70.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_wtQTFUzzgES_qesFa3wO4g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Operating lease ROU assets, net</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 284</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 322</p></td></tr><tr><td style="vertical-align:middle;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease Liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:70.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 133</p></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 226</p></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 359</p></td></tr><tr><td style="vertical-align:middle;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average remaining lease term (in years):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average discount rate:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.26%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:26.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">For the Three Months Ended </p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:26.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cash paid for amounts included in the measurement of lease liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating cash flows used in operating leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 57</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-cash impact of new leases and lease modifications</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Change in operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Change in operating lease ROU assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Minimum future payments under the Company’s lease liabilities as of March 31, 2023 are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.92%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Discounted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Payments</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">lease</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">due under</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">lease</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">agreements</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 73</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 65</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 66</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 51</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 322</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">At March 31, 2023, $32 thousand of the Company’s future minimum lease payments represents interest.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.91%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">December 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Machinery and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 390</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Office furniture and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 177</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 192</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 312</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 759</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accumulated depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (81)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 62</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Operating lease ROU assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 284</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:69.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 515</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 384</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 209000 390000 60000 177000 43000 192000 312000 759000 81000 697000 231000 62000 284000 322000 515000 384000 40000 7000 P1Y 2000 4000 5000 -9000 P6Y 2000 87000 0.02 11000 48000 57000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:84.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">March 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">December 31, </p></td></tr><tr><td style="vertical-align:bottom;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:70.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="-sec-ix-hidden:Hidden_wtQTFUzzgES_qesFa3wO4g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Operating lease ROU assets, net</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 284</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 322</p></td></tr><tr><td style="vertical-align:middle;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Lease Liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:70.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Current lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 133</p></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Long term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 226</p></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 359</p></td></tr><tr><td style="vertical-align:middle;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average remaining lease term (in years):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average discount rate:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> 284000 322000 77000 133000 213000 226000 290000 359000 P2Y8M12D 0.052 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:98.26%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:26.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">For the Three Months Ended </p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:26.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cash paid for amounts included in the measurement of lease liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Operating cash flows used in operating leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 57</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-cash impact of new leases and lease modifications</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Change in operating lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:70.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Change in operating lease ROU assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 66000 57000 -9000 5000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Minimum future payments under the Company’s lease liabilities as of March 31, 2023 are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.92%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Discounted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Payments</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">lease</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">due under</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">lease</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">agreements</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 73</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 65</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 66</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 51</p></td></tr><tr><td style="vertical-align:bottom;width:62.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.66%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 322</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 64000 73000 54000 65000 59000 66000 63000 67000 50000 51000 290000 322000 32000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 4 – Patents and Other Intangible Assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patents and other intangible assets are summarized as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.91%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">December 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Patents pending</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 330</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 307</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issued patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 815</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 815</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,145</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,122</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Trademarks pending</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Registered trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 101</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,255</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accumulated amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (473)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (433)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 782</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 798</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Future amortization expense associated with issued patents and registered trademarks as of March 31, 2023 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.96%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 108</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 126</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 96</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 61</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 39</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 7</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 437</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;">The amortization life for patents ranges between </span><span style="-sec-ix-hidden:Hidden_lsg6qUJSlEayDqF6sNd2qw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span><span style="font-size:10pt;"> to </span><span style="font-size:10pt;">five years</span><span style="font-size:10pt;">, with trademark lives set at </span><span style="font-size:10pt;">ten years</span><span style="font-size:10pt;">. The Company does not amortize patents or trademarks classified as pending. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">During the three months ended March 31, 2023 and 2022, the Company assessed its patent and trademark assets. The Company also evaluated its strategic approach to the pursuit and protection of its intellectual property. It is the intent of the Company to continue to pursue intellectual property protection. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If the Company identifies certain assets where the intellectual property does not directly align with its core technology, the Company will impair the intangible asset and write-off the asset as an expense.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patents and other intangible assets are summarized as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.91%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">December 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Patents pending</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 330</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 307</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Issued patents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 815</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 815</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,145</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,122</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Trademarks pending</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Registered trademarks</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 101</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,255</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accumulated amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (473)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (433)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 782</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 798</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 330000 307000 815000 815000 1145000 1122000 7000 6000 95000 95000 102000 101000 8000 8000 1255000 1231000 473000 433000 782000 798000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Future amortization expense associated with issued patents and registered trademarks as of March 31, 2023 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.96%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;"><i style="font-style:italic;">(in thousands)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 108</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 126</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 96</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 61</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 39</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 7</p></td></tr><tr><td style="vertical-align:bottom;width:80.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 437</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 108000 126000 96000 61000 39000 7000 437000 P5Y P10Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 5 – Revenue, Contract Assets and Contract Liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company recognized $894 thousand of revenues and $788 thousand of cost of goods sold during the three months ended March 31, 2023. The revenue and cost of goods sold relate predominately to the Company’s process burner product line, where the Company successfully completed a burner performance customer witness test, which represented a contractual performance obligation per ASC 606. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="background:#ffffff;">The Company did not recognize revenue or cost of goods sold for the three months ended March 31, 2022. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;background:#ffffff;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company had contract assets of $4 thousand and $20 thousand at March 31, 2023 and December 31, 2022, respectively. The Company had contract liabilities of $639 thousand and $247 thousand at March 31, 2023 and December 31, 2022, respectively.</p> 894000 788000 4000 20000 639000 247000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 6 – Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Common Stock and Preferred Stock</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company is authorized to issue 62.5 million shares of common stock and 2.0 million shares of preferred stock. Preferences, limitations, voting powers and relative rights of any preferred stock to be issued may be determined by the Company’s Board of Directors. The Company has not issued any shares of preferred stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In July 2018, the Company completed a private equity offering and executed a Stock Purchase Agreement with clirSPV LLC (“clirSPV”) which permits participation in future capital raising transactions (the “Participation Right”) on the same terms as other investors participating in such transactions. In no event may the Participation Right be exercised to the extent it would cause clirSPV or any of its affiliates to beneficially own 20% or more of the Company’s then outstanding common stock. In May 2022, the Company signed an agreement with clirSPV, that provides for an election right to extend the Participation Right beyond the original expiration date of December 31, 2023, but to no later than June 30, 2027. This election is pursuant to specific terms and conditions and expires on December 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company has an At-The-Market (“ATM”) Offering Sales Agreement with Virtu Americas LLC, as sales agent pursuant to which it may currently sell shares of common stock with an aggregate offering price of up to $8.7 million. During the three months ended March 31, 2023, the Company issued zero shares of its common stock from the ATM program. As of March 31, 2023, the Company has cumulatively issued approximately 1.6 million shares of common stock under the ATM program, at an average price of $3.84 per share. Gross proceeds totaled approximately $6.1 million and net cash proceeds was approximately $5.9 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company is currently subject to the SEC’s “baby shelf rules,” which prohibits companies with a public float of less</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">than $75 million from issuing securities under a shelf registration statement in excess of one-third of such company’s</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">public float in a 12-month period. These rules may limit future issuances of shares by the Company under its shelf</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">registration statement on Form S-3, the ATM Offering Sales Agreement or other securities offerings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Equity Incentive Plan</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">On June 17, 2021, the Company's shareholders approved and the Company adopted the ClearSign Technologies Corporation 2021 Equity Incentive Plan (the “2021 Plan”) which permits the Company to grant Incentive Stock Options, Non-statutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, and Performance Shares, to eligible participants, which includes employees, directors and consultants. The Compensation Committee of the Board of Directors is authorized to administer the 2021 Plan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The 2021 Plan provides for an annual increase in available shares equal to the lesser of (i) 10% of the aggregate number of shares of Common Stock issued by the Company in the prior fiscal year; or (ii) such number provided by the Compensation Committee; provided, however, that the total cumulative increase in the number of shares available for issuance pursuant to this automatic share increase shall not exceed 400 thousand shares of common stock. In 2023, the board of directors approved an increase of 400,000 shares available for issuance pursuant to future awards in accordance with the terms of the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending balances for the 2021 Plan is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">December 31, </p></td></tr><tr><td style="vertical-align:bottom;width:71.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:71.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding options and restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,332</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,202</p></td></tr><tr><td style="vertical-align:bottom;width:71.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reserved but unissued shares under the Plans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,530</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,777</p></td></tr><tr><td style="vertical-align:bottom;width:71.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total authorized shares under the Plans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,862</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,979</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Options </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Under the terms of the 2021 Plan, incentive stock options and nonstatutory stock options must have an exercise price at or above the fair market value on the date of the grant. At the time of grant, the Company will determine the period within which the option may be exercised and will specify any conditions that must be satisfied before the option vests and may be exercised. The Company estimates the fair value of stock options on the date of grant using the Black-Scholes option-pricing model. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As permitted by SEC Staff Accounting Bulletin (SAB) 107, management utilized the simplified approach to estimate the expected term of the options, which represents the period of time that options granted are expected to be outstanding. Expected volatility has been determined through the Company’s historical stock price volatility. The Company has not made an estimate of forfeitures at the time of the grant, but rather accounts for forfeitures at the time they occur. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">During the three months ended March 31, 2023, no new options were awarded by the company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="background:#ffffff;">Compensation expense associated with stock option awards for the three months ended March 31, 2023 and 2022 totaled $</span><span style="background:#ffffff;">44</span><span style="background:#ffffff;"> thousand and $</span><span style="background:#ffffff;">42</span><span style="background:#ffffff;"> thousand, respectively.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">A summary of the Company’s stock option activity and changes is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.92%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="6" style="vertical-align:bottom;white-space:nowrap;width:45.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="6" style="vertical-align:bottom;white-space:nowrap;width:45.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2023</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:12.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Options to Purchase Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Weighted Average Exercise Price</p></td><td style="vertical-align:bottom;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:16.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Weighted Average Remaining Contractual Life (in years)</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,779</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2.05</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6.43</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Forfeited/Expired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,779</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2.05</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6.18</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable at end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,011</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.70</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5.68</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The estimated aggregate pretax intrinsic value of the Company’s outstanding vested stock options at March 31, 2023 is $27 thousand. The intrinsic value is the difference between the Company’s common stock price and the option exercise prices multiplied by the number of in-the-money options. This amount changes based on the fair value of the Company’s common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">At March 31, 2023, there was $1.0 million of total unrecognized compensation cost related to non-vested stock option-based compensation arrangements. Vesting criteria ranges from time-based to performance-based. The Company records costs for time-based arrangements ratably across the timeframe, whereas performance-based arrangements require management to continually evaluate predetermined goals against actual circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Stock Units</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company awards employees and directors restricted stock units (“RSUs”) in lieu of cash payment for compensation. These awards are granted pursuant to the 2021 Plan. Employee vesting criteria is time based, and compensation expense is recognized ratably across the timeframe. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Director vesting criteria is contingent upon the occurrence of one of four future events, which the Company cannot predict or control. Therefore, compensation expense for director RSUs is not recognized until one of these four future events occur, which is in accordance with FASB Accounting Standards Codification<i style="font-style:italic;">, </i>Topic 718<i style="font-style:italic;">, Compensation-Stock Compensation, </i>(ASC 718). Unrecognized compensation expense for director services amounted to $68 thousand and $85 thousand for the three months ended March 31, 2023 and 2022, respectively. Director compensation is earned on a quarterly basis with the target value of compensation set at approximately $85 thousand per quarter. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">A summary of the Company’s RSUs activity and changes is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.94%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:33.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:33.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Number of Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:15.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Weighted Average Grant Date Fair Value</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Nonvested at beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 423</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.49</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 374</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.69</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (245)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.34</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Nonvested at end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 552</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.01</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">A summary of the Company’s RSU compensation expense is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.94%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:62.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">For the Three Months Ended </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:62.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Compensation Expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 199</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Weighted Average Value Per Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Awards</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company awards employees stock in lieu of cash payment for compensation, typically to satisfy accrued bonus compensation. The awards are granted from the Company’s 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.93%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 234</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 98</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Weighted Average Value Per Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.79</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.43</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Consultant Stock Plan</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">The 2013 Consultant Stock Plan (the “Consultant Plan”) provides for the granting of shares of common stock to consultants who provide services related to capital raising, investor relations, and making a market in or promoting the Company’s securities. The Company’s officers, employees, and board members are not entitled to receive grants from the Consultant Plan. The Compensation Committee of the Board of Directors is authorized to administer the Consultant Plan and establish the grant terms. The Consultant Plan provides for periodic increases in the number of authorized shares available for issuance under the Consultant Plan on the first day of each of the Company’s fiscal quarters. The quarterly increases are equal to 1% of any new shares subsequently issued by the Company or such lesser amount as the Board of Directors shall determine. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Consultant Plan activity and change is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:64.95%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:32.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:63.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:32.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2023</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reserved but unissued shares at beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 196</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Increases in the number of authorized shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reserved but unissued shares at end of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 197</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Consultant Plan compensation expense is summarized as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.93%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Compensation Expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Weighted Average Value Per Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0.66</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.93</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">​</span></p> 62500000 2000000.0 0.20 8700000 0 1600000 3.84 3.84 6100000 5900000 0.10 400000 400000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">December 31, </p></td></tr><tr><td style="vertical-align:bottom;width:71.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:71.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding options and restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,332</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,202</p></td></tr><tr><td style="vertical-align:bottom;width:71.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Reserved but unissued shares under the Plans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,530</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,777</p></td></tr><tr><td style="vertical-align:bottom;width:71.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total authorized shares under the Plans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,862</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,979</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 3332000 3202000 2530000 2777000 5862000 5979000 0 44000 42000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">A summary of the Company’s stock option activity and changes is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.92%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="6" style="vertical-align:bottom;white-space:nowrap;width:45.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="6" style="vertical-align:bottom;white-space:nowrap;width:45.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2023</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:12.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Options to Purchase Common Stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:12.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Weighted Average Exercise Price</p></td><td style="vertical-align:bottom;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:16.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Weighted Average Remaining Contractual Life (in years)</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,779</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2.05</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6.43</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Forfeited/Expired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,779</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2.05</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6.18</p></td></tr><tr><td style="vertical-align:bottom;width:51.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable at end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,011</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.70</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5.68</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 2779000 2.05 P6Y5M4D 2779000 2.05 P6Y2M4D 2011000 1.70 P5Y8M4D 27000 1000000.0 68000 85000 85000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.94%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:33.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:33.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:14.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Number of Shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:15.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">Weighted Average Grant Date Fair Value</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Nonvested at beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 423</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.49</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 374</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.69</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (245)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.34</p></td></tr><tr><td style="vertical-align:bottom;width:63.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Nonvested at end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 552</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.01</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p> 423000 1.49 374000 0.69 245000 1.34 552000 1.01 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.94%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:62.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">For the Three Months Ended </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:62.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Compensation Expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 199</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Weighted Average Value Per Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p> 199000 35000 1.25 1.44 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.93%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 234</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 98</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Weighted Average Value Per Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.79</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.43</p></td></tr></table> 234000 98000 0.79 1.43 <p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:64.95%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:32.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">March 31, </p></td></tr><tr><td style="vertical-align:bottom;width:63.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">(<i style="font-style:italic;">in thousands</i>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:32.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">2023</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reserved but unissued shares at beginning of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 196</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Increases in the number of authorized shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Reserved but unissued shares at end of year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:29.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 197</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p> 196000 5000 4000 197000 <p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:74.93%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:37.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Compensation Expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">Weighted Average Value Per Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0.66</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.93</span></p></td></tr></table> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 7 – Commitments and Contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Litigation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">From time to time the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties and an adverse result in any such matter may harm the Company’s business. As of the date of this report, the Company is not a party to any material pending legal proceedings or claims that the Company believes will have a material adverse effect on the business, financial condition or operating results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnification Agreements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Company maintains indemnification agreements with its directors and officers that may require the Company to indemnify these individuals against liabilities that arise by reason of their status or service as directors or officers, except as prohibited by law.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Note 8 – Government Assistance</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">During 2022, the Company was awarded a research grant from the Department of Energy (“DOE”) for approximately $250 thousand with the completion occurring in March 2023. The purpose of the grant was to produce a research paper for a flexible fuel ultra-low NOx process burner capable of burning 100% hydrogen fuel. The award allowed the Company to request reimbursements for expenditures such as labor, material, and administrative costs. During the three months ended March 31, 2023, the Company recognized $69<span style="white-space:pre-wrap;"> thousand in reimbursements from DOE. The Company did </span>not recognize reimbursements from the DOE for the three months ended March 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beginning in 2021, the Company received funds relating to the Oklahoma 21<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">st</sup> Century Quality Jobs Act. The estimated duration of the program is up to 10 years and is designed to attract growth industries to Oklahoma. By reporting quarterly salary statistics and meeting agreed upon employment thresholds, the state remits benefit monies to the Company. For the three months ended March 31, 2023, the Company recognized $24 thousand in government assistance. During the three months ended March 31, 2022, the Company had no government assistance from this program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 250000 69000 0 P10Y 24000 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Note 9 – Subsequent Events</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company has evaluated subsequent events as of the date of this report, and has none to report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> EXCEL 54 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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¸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end XML 55 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 56 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 57 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 90 258 1 false 29 0 false 4 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statements of Operations Sheet http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00305 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) Sheet http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical Consolidated Statements of Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - Consolidated Statements of Cash Flows Sheet http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 10101 - Disclosure - Organization and Description of Business Sheet http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 8 false false R9.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 10301 - Disclosure - Fixed Assets Sheet http://www.clearsigncombustion.com/role/DisclosureFixedAssets Fixed Assets Notes 10 false false R11.htm 10401 - Disclosure - Patents and Other Intangible Assets Sheet http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssets Patents and Other Intangible Assets Notes 11 false false R12.htm 10501 - Disclosure - Revenue, Contract Assets and Contract Liabilities Sheet http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilities Revenue, Contract Assets and Contract Liabilities Notes 12 false false R13.htm 10601 - Disclosure - Equity Sheet http://www.clearsigncombustion.com/role/DisclosureEquity Equity Notes 13 false false R14.htm 10701 - Disclosure - Commitments and Contingencies Sheet http://www.clearsigncombustion.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 10801 - Disclosure - Government Assistance Sheet http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistance Government Assistance Notes 15 false false R16.htm 10901 - Disclosure - Subsequent Events Sheet http://www.clearsigncombustion.com/role/DisclosureSubsequentEvents Subsequent Events Notes 16 false false R17.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPolicies 17 false false R18.htm 30303 - Disclosure - Fixed Assets (Tables) Sheet http://www.clearsigncombustion.com/role/DisclosureFixedAssetsTables Fixed Assets (Tables) Tables http://www.clearsigncombustion.com/role/DisclosureFixedAssets 18 false false R19.htm 30403 - Disclosure - Patents and Other Intangible Assets (Tables) Sheet http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsTables Patents and Other Intangible Assets (Tables) Tables http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssets 19 false false R20.htm 30603 - Disclosure - Equity (Tables) Sheet http://www.clearsigncombustion.com/role/DisclosureEquityTables Equity (Tables) Tables http://www.clearsigncombustion.com/role/DisclosureEquity 20 false false R21.htm 40101 - Disclosure - Organization and Description of Business (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails Organization and Description of Business (Details) Details http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusiness 21 false false R22.htm 40201 - Disclosure - Summary of Significant Accounting Policies - Short-Term Investments (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesShortTermInvestmentsDetails Summary of Significant Accounting Policies - Short-Term Investments (Details) Details 22 false false R23.htm 40202 - Disclosure - Summary of Significant Accounting Policies - Fixed Assets and Leases (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails Summary of Significant Accounting Policies - Fixed Assets and Leases (Details) Details 23 false false R24.htm 40203 - Disclosure - Summary of Significant Accounting Policies - Foreign Operations (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails Summary of Significant Accounting Policies - Foreign Operations (Details) Details 24 false false R25.htm 40204 - Disclosure - Summary of Significant Accounting Policies - Research and Development (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesResearchAndDevelopmentDetails Summary of Significant Accounting Policies - Research and Development (Details) Details 25 false false R26.htm 40205 - Disclosure - Summary of Significant Accounting Policies - Net Loss per Common Share (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails Summary of Significant Accounting Policies - Net Loss per Common Share (Details) Details 26 false false R27.htm 40301 - Disclosure - Fixed Assets - Summary (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails Fixed Assets - Summary (Details) Details 27 false false R28.htm 40302 - Disclosure - Fixed Assets - Leases (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails Fixed Assets - Leases (Details) Details 28 false false R29.htm 40303 - Disclosure - Fixed Assets - Leases - Supplemental balance sheet and cash flow information (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails Fixed Assets - Leases - Supplemental balance sheet and cash flow information (Details) Details 29 false false R30.htm 40304 - Disclosure - Fixed Assets - Minimum future lease payments (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails Fixed Assets - Minimum future lease payments (Details) Details 30 false false R31.htm 40401 - Disclosure - Patents and Other Intangible Assets - Summary (Details) Sheet http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails Patents and Other Intangible Assets - Summary (Details) Details 31 false false R32.htm 40402 - Disclosure - Patents and Other Intangible Assets - Future amortization expense (Details) Sheet http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails Patents and Other Intangible Assets - Future amortization expense (Details) Details 32 false false R33.htm 40403 - Disclosure - Patents and Other Intangible Assets - Additional information (Details) Sheet http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails Patents and Other Intangible Assets - Additional information (Details) Details 33 false false R34.htm 40501 - Disclosure - Revenue, Contract Assets and Contract Liabilities (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilitiesDetails Revenue, Contract Assets and Contract Liabilities (Details) Details http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilities 34 false false R35.htm 40601 - Disclosure - Equity - Common Stock and Preferred Stock (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails Equity - Common Stock and Preferred Stock (Details) Details 35 false false R36.htm 40602 - Disclosure - Equity - Equity Incentive Plan (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails Equity - Equity Incentive Plan (Details) Details 36 false false R37.htm 40603 - Disclosure - Equity - Stock Options - Activity (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails Equity - Stock Options - Activity (Details) Details 37 false false R38.htm 40604 - Disclosure - Equity - Restricted Stock Units (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails Equity - Restricted Stock Units (Details) Details 38 false false R39.htm 40605 - Disclosure - Equity - Restricted Stock units Activity (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails Equity - Restricted Stock units Activity (Details) Details 39 false false R40.htm 40606 - Disclosure - Equity - Restricted Stock Units - Compensation Expense (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsCompensationExpenseDetails Equity - Restricted Stock Units - Compensation Expense (Details) Details 40 false false R41.htm 40607 - Disclosure - Equity - Stock Grants (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails Equity - Stock Grants (Details) Details 41 false false R42.htm 40608 - Disclosure - Equity - Consultant Stock Plan (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails Equity - Consultant Stock Plan (Details) Details 42 false false R43.htm 40801 - Disclosure - Government Assistance (Details) Sheet http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails Government Assistance (Details) Details http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistance 43 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 7 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockSharesOutstanding, us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1, us-gaap:LesseeOperatingLeaseRemainingLeaseTerm, us-gaap:PreferredStockSharesOutstanding, us-gaap:PropertyPlantAndEquipmentUsefulLife - clir-20230331x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 3 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies, us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList - clir-20230331x10q.htm 9 clir-20230331x10q.htm clir-20230331.xsd clir-20230331_cal.xml clir-20230331_def.xml clir-20230331_lab.xml clir-20230331_pre.xml clir-20230331xex31d1.htm clir-20230331xex31d2.htm clir-20230331xex32d1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 60 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "clir-20230331x10q.htm": { "axisCustom": 0, "axisStandard": 11, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 354, "http://xbrl.sec.gov/dei/2022": 29 }, "contextCount": 90, "dts": { "calculationLink": { "local": [ "clir-20230331_cal.xml" ] }, "definitionLink": { "local": [ "clir-20230331_def.xml" ] }, "inline": { "local": [ "clir-20230331x10q.htm" ] }, "labelLink": { "local": [ "clir-20230331_lab.xml" ] }, "presentationLink": { "local": [ "clir-20230331_pre.xml" ] }, "schema": { "local": [ "clir-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 358, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 13, "http://xbrl.sec.gov/dei/2022": 5, "total": 18 }, "keyCustom": 44, "keyStandard": 214, "memberCustom": 13, "memberStandard": 16, "nsprefix": "clir", "nsuri": "http://www.clearsigncombustion.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - Fixed Assets", "menuCat": "Notes", "order": "10", "role": "http://www.clearsigncombustion.com/role/DisclosureFixedAssets", "shortName": "Fixed Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - Patents and Other Intangible Assets", "menuCat": "Notes", "order": "11", "role": "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssets", "shortName": "Patents and Other Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - Revenue, Contract Assets and Contract Liabilities", "menuCat": "Notes", "order": "12", "role": "http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilities", "shortName": "Revenue, Contract Assets and Contract Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - Equity", "menuCat": "Notes", "order": "13", "role": "http://www.clearsigncombustion.com/role/DisclosureEquity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "14", "role": "http://www.clearsigncombustion.com/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GovernmentAssistanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - Government Assistance", "menuCat": "Notes", "order": "15", "role": "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistance", "shortName": "Government Assistance", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GovernmentAssistanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "16", "role": "http://www.clearsigncombustion.com/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "17", "role": "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - Fixed Assets (Tables)", "menuCat": "Tables", "order": "18", "role": "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsTables", "shortName": "Fixed Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - Patents and Other Intangible Assets (Tables)", "menuCat": "Tables", "order": "19", "role": "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsTables", "shortName": "Patents and Other Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - Equity (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.clearsigncombustion.com/role/DisclosureEquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - Organization and Description of Business (Details)", "menuCat": "Details", "order": "21", "role": "http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "shortName": "Organization and Description of Business (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R22": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - Summary of Significant Accounting Policies - Short-Term Investments (Details)", "menuCat": "Details", "order": "22", "role": "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesShortTermInvestmentsDetails", "shortName": "Summary of Significant Accounting Policies - Short-Term Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:MarketableSecuritiesPolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "lang": null, "name": "clir:UnrealizedHoldingGainLossOnShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_clir_PropertyPlantAndEquipmentOtherThanLeaseholdImprovementsMember_x5QcDBoxvEuiI7xIjZ9vmA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - Summary of Significant Accounting Policies - Fixed Assets and Leases (Details)", "menuCat": "Details", "order": "23", "role": "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails", "shortName": "Summary of Significant Accounting Policies - Fixed Assets and Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_clir_PropertyPlantAndEquipmentOtherThanLeaseholdImprovementsMember_x5QcDBoxvEuiI7xIjZ9vmA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40203 - Disclosure - Summary of Significant Accounting Policies - Foreign Operations (Details)", "menuCat": "Details", "order": "24", "role": "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails", "shortName": "Summary of Significant Accounting Policies - Foreign Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "clir:ForeignOperationsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_srt_StatementGeographicalAxis_country_CN_A1gx_l21402e3rmWkd6i6Q", "decimals": "-3", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40204 - Disclosure - Summary of Significant Accounting Policies - Research and Development (Details)", "menuCat": "Details", "order": "25", "role": "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesResearchAndDevelopmentDetails", "shortName": "Summary of Significant Accounting Policies - Research and Development (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40205 - Disclosure - Summary of Significant Accounting Policies - Net Loss per Common Share (Details)", "menuCat": "Details", "order": "26", "role": "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "shortName": "Summary of Significant Accounting Policies - Net Loss per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - Fixed Assets - Summary (Details)", "menuCat": "Details", "order": "27", "role": "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails", "shortName": "Fixed Assets - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "first": true, "lang": null, "name": "clir:OperatingLeasesMonthlyRentExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - Fixed Assets - Leases (Details)", "menuCat": "Details", "order": "28", "role": "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails", "shortName": "Fixed Assets - Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "first": true, "lang": null, "name": "clir:OperatingLeasesMonthlyRentExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40303 - Disclosure - Fixed Assets - Leases - Supplemental balance sheet and cash flow information (Details)", "menuCat": "Details", "order": "29", "role": "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails", "shortName": "Fixed Assets - Leases - Supplemental balance sheet and cash flow information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_gnTlF5tcxk2S604DWBgFbQ", "decimals": "-3", "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_T_l1x2QvqU6JPM5ncMH_Vw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_T_l1x2QvqU6JPM5ncMH_Vw", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40304 - Disclosure - Fixed Assets - Minimum future lease payments (Details)", "menuCat": "Details", "order": "30", "role": "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails", "shortName": "Fixed Assets - Minimum future lease payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedPatentsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - Patents and Other Intangible Assets - Summary (Details)", "menuCat": "Details", "order": "31", "role": "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails", "shortName": "Patents and Other Intangible Assets - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedPatentsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40402 - Disclosure - Patents and Other Intangible Assets - Future amortization expense (Details)", "menuCat": "Details", "order": "32", "role": "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails", "shortName": "Patents and Other Intangible Assets - Future amortization expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_RangeAxis_srt_MaximumMember_DEWPrPLaZ0mh9P_EdFugCA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40403 - Disclosure - Patents and Other Intangible Assets - Additional information (Details)", "menuCat": "Details", "order": "33", "role": "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails", "shortName": "Patents and Other Intangible Assets - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_RangeAxis_srt_MaximumMember_DEWPrPLaZ0mh9P_EdFugCA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - Revenue, Contract Assets and Contract Liabilities (Details)", "menuCat": "Details", "order": "34", "role": "http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilitiesDetails", "shortName": "Revenue, Contract Assets and Contract Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - Equity - Common Stock and Preferred Stock (Details)", "menuCat": "Details", "order": "35", "role": "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails", "shortName": "Equity - Common Stock and Preferred Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_us-gaap_PlanNameAxis_clir_EquityIncentivePlanMember_Oz7sK6hFYkiUf0D_M1KdLA", "decimals": "-3", "first": true, "lang": null, "name": "clir:OutstandingOptionsAndRestrictedStockUnits", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40602 - Disclosure - Equity - Equity Incentive Plan (Details)", "menuCat": "Details", "order": "36", "role": "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails", "shortName": "Equity - Equity Incentive Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_us-gaap_PlanNameAxis_clir_EquityIncentivePlanMember_Oz7sK6hFYkiUf0D_M1KdLA", "decimals": "-3", "first": true, "lang": null, "name": "clir:OutstandingOptionsAndRestrictedStockUnits", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_gnTlF5tcxk2S604DWBgFbQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40603 - Disclosure - Equity - Stock Options - Activity (Details)", "menuCat": "Details", "order": "37", "role": "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails", "shortName": "Equity - Stock Options - Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_s2zTz2wg80qTSq5YAUG_QA", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40604 - Disclosure - Equity - Restricted Stock Units (Details)", "menuCat": "Details", "order": "38", "role": "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails", "shortName": "Equity - Restricted Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_TitleOfIndividualAxis_srt_DirectorMember_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_mXdSVr26V025NddYflYadg", "decimals": "-3", "lang": null, "name": "clir:TargetValueOfCompensationPerQuarter", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember__R2JB3YEJEa7Vsc8WCG_zA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40605 - Disclosure - Equity - Restricted Stock units Activity (Details)", "menuCat": "Details", "order": "39", "role": "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails", "shortName": "Equity - Restricted Stock units Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember__R2JB3YEJEa7Vsc8WCG_zA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40606 - Disclosure - Equity - Restricted Stock Units - Compensation Expense (Details)", "menuCat": "Details", "order": "40", "role": "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsCompensationExpenseDetails", "shortName": "Equity - Restricted Stock Units - Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_3FlhuXCZskCwK7mEYdvzfA", "decimals": "2", "lang": null, "name": "clir:WeightedAverageValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_T_l1x2QvqU6JPM5ncMH_Vw", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_bG-ooz6KWUWKzg4__mtdyQ", "decimals": "-3", "first": true, "lang": null, "name": "clir:StockIssuedDuringPeriodValueIssuedForServicesThree", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40607 - Disclosure - Equity - Stock Grants (Details)", "menuCat": "Details", "order": "41", "role": "http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails", "shortName": "Equity - Stock Grants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_us-gaap_GranteeStatusAxis_us-gaap_ShareBasedPaymentArrangementEmployeeMember_bG-ooz6KWUWKzg4__mtdyQ", "decimals": "-3", "first": true, "lang": null, "name": "clir:StockIssuedDuringPeriodValueIssuedForServicesThree", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40608 - Disclosure - Equity - Consultant Stock Plan (Details)", "menuCat": "Details", "order": "42", "role": "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "shortName": "Equity - Consultant Stock Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_us-gaap_PlanNameAxis_clir_ConsultantPlanMember_XR9uFU9U7E6Cnofst-6S0w", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_hrxZYKgFiEyT5xPcqJmrug", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GovernmentAssistanceAmount", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - Government Assistance (Details)", "menuCat": "Details", "order": "43", "role": "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails", "shortName": "Government Assistance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:GovernmentAssistanceTextBlock", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_GovernmentAssistanceTypeAxis_clir_ResearchGrantFromDepartmentOfEnergyMember_fXumoH--FUeDzavQ9dgdvw", "decimals": "-3", "lang": null, "name": "clir:ResearchGrantTotalAwardAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_rQKmtzulz0ql9KRHGf6rvg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Consolidated Statements of Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_rQKmtzulz0ql9KRHGf6rvg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_xVSymKcfk0Gtej1tQxbpFw", "decimals": "2", "first": true, "lang": null, "name": "clir:CommonStockIssuedForExerciseOfOptions0.89PerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_T_l1x2QvqU6JPM5ncMH_Vw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00305 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)", "menuCat": "Statements", "order": "6", "role": "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical", "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_xVSymKcfk0Gtej1tQxbpFw", "decimals": "2", "first": true, "lang": null, "name": "clir:CommonStockIssuedForExerciseOfOptions0.89PerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_T_l1x2QvqU6JPM5ncMH_Vw", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "7", "role": "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": "-3", "lang": null, "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_zrgyz0A1HUKwn1aK_VDk6g", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - Organization and Description of Business", "menuCat": "Notes", "order": "8", "role": "http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusiness", "shortName": "Organization and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "9", "role": "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "clir-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_sl6YIuvi4EeQny5BV_GlEA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 29, "tag": { "clir_AggregateOfferingPriceInAtMarket": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering price of ATM common stock", "label": "Aggregate Offering Price in At The Market", "terseLabel": "Aggregate offering price" } } }, "localname": "AggregateOfferingPriceInAtMarket", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "monetaryItemType" }, "clir_AtMarketOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to At-The-Market Offering.", "label": "ATM" } } }, "localname": "AtMarketOfferingMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "domainItemType" }, "clir_CapitalRequirement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of capital requirement.", "label": "Capital Requirement", "terseLabel": "Registered capital requirement" } } }, "localname": "CapitalRequirement", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails" ], "xbrltype": "monetaryItemType" }, "clir_CapitalRequirementSatisfied": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of capital requirement that has been satisfied/paid as of balance sheet date.", "label": "Capital Requirement Satisfied" } } }, "localname": "CapitalRequirementSatisfied", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails" ], "xbrltype": "monetaryItemType" }, "clir_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]", "verboseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "clir_CommonStockForServicesPerShareIssueOne": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share value of common share granted (first issue) during the period for services.", "label": "Common Stock For Services Per Share Issue One", "verboseLabel": "Common stock for services" } } }, "localname": "CommonStockForServicesPerShareIssueOne", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "perShareItemType" }, "clir_CommonStockForServicesPerShareIssueTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share value of common share granted during the period for services.", "label": "Common Stock For Services Per Share Issue Two", "verboseLabel": "Common stock for services" } } }, "localname": "CommonStockForServicesPerShareIssueTwo", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "perShareItemType" }, "clir_CommonStockIssuedForExerciseOfOptions0.89PerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share value of common shares issued during the period for exercise of options.", "label": "Common Stock Issued For Exercise Of Options, 0.89 Per Share", "terseLabel": "Common stock for options exercise, 0.89 per share issue" } } }, "localname": "CommonStockIssuedForExerciseOfOptions0.89PerShare", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "perShareItemType" }, "clir_CommonStockIssuedForExerciseOfOptions2.93PerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share value of common shares issued during the period for exercise of options.", "label": "Common Stock Issued For Exercise Of Options, 2.93 Per Share", "terseLabel": "Common stock for options exercise, 2.93 per share issue" } } }, "localname": "CommonStockIssuedForExerciseOfOptions2.93PerShare", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "perShareItemType" }, "clir_ConsultantPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Consultant Plan.", "label": "Consultant Stock Plan" } } }, "localname": "ConsultantPlanMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "domainItemType" }, "clir_ContractAcquisitionCostsAndPracticalExpedientsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy of contract acquisition costs and practical expedients.", "label": "Contract Acquisition Costs And Practical Expedients Policy [Policy Text Block]", "terseLabel": "Contract Costs" } } }, "localname": "ContractAcquisitionCostsAndPracticalExpedientsPolicyPolicyTextBlock", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clir_DepreciationAndAmortizationExcludingRightOfUseAssetAmortization": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets, excluding right-of-use assets, to periods that benefit from use of the assets.", "label": "Depreciation And Amortization Excluding Right-of-use Asset Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortizationExcludingRightOfUseAssetAmortization", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "clir_EquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Equity Incentive Plan.", "label": "Equity Incentive Plan [Member]" } } }, "localname": "EquityIncentivePlanMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "domainItemType" }, "clir_FixedAssetsAndOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Fixed Assets" } } }, "localname": "FixedAssetsAndOperatingLeasesAbstract", "nsuri": "http://www.clearsigncombustion.com/20230331", "xbrltype": "stringItemType" }, "clir_ForeignOperationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for foreign operations.", "label": "Foreign Operations [Policy Text Block]", "terseLabel": "Foreign Operations" } } }, "localname": "ForeignOperationsPolicyTextBlock", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clir_GrossProceedsFromIssuanceOfCommonStockUnderProgramToDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross proceeds from issuance of stock under the program from inception to the balance sheet date.", "label": "Gross Proceeds from Issuance of Common Stock under the Program to Date", "terseLabel": "Gross proceeds to date" } } }, "localname": "GrossProceedsFromIssuanceOfCommonStockUnderProgramToDate", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails", "http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "clir_IssuedPatentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents issued patents.", "label": "Issued patents" } } }, "localname": "IssuedPatentsMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "domainItemType" }, "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDue": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Discounted Payments, Due", "totalLabel": "Total discounted payments" } } }, "localname": "LesseeOperatingLeaseLiabilityDiscountedPaymentsDue", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 4.0, "parentTag": "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's discounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Discounted Payments, Due Next Twelve Months", "terseLabel": "Discounted payments, 2024" } } }, "localname": "LesseeOperatingLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearFour": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 1.0, "parentTag": "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's discounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Discounted Payments, Due Year Four", "terseLabel": "Discounted payments, 2027" } } }, "localname": "LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearFour", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearThree": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 2.0, "parentTag": "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's discounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Discounted Payments, Due Year Three", "terseLabel": "Discounted payments, 2026" } } }, "localname": "LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearThree", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearTwo": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 3.0, "parentTag": "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's discounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Discounted Payments, Due Year Two", "terseLabel": "Discounted payments, 2025" } } }, "localname": "LesseeOperatingLeaseLiabilityDiscountedPaymentsDueYearTwo", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 5.0, "parentTag": "clir_LesseeOperatingLeaseLiabilityDiscountedPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's discounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Discounted Payments, Remainder of Fiscal Year", "terseLabel": "Discounted payments, 2023 (remaining)" } } }, "localname": "LesseeOperatingLeaseLiabilityDiscountedPaymentsRemainderOfFiscalYear", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "clir_NumberOfSharesOfCommonStockIssuedToDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of new stock issued under the program from inception to balance sheet date.", "label": "Number of Shares of Common Stock issued To Date", "terseLabel": "Number of shares issued to date" } } }, "localname": "NumberOfSharesOfCommonStockIssuedToDate", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "clir_OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of officer and employee equity awards for prior year accrued compensation.", "label": "Officer And Employee Equity Awards For Prior Year Accrued Compensation", "terseLabel": "Officer and employee equity awards for prior year accrued compensation" } } }, "localname": "OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "clir_OklahomaQualityJobsActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the Oklahoma Quality Jobs Act.", "label": "Oklahoma Quality Jobs Act [Member]" } } }, "localname": "OklahomaQualityJobsActMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "clir_OperatingLeasesMonthlyRentExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents monthly rent expense. Excludes triple net operating costs.", "label": "Operating Leases, Monthly Rent Expense", "terseLabel": "Monthly rent expense" } } }, "localname": "OperatingLeasesMonthlyRentExpense", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails" ], "xbrltype": "monetaryItemType" }, "clir_OutstandingOptionsAndRestrictedStockUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares of stock already awarded under the share-based compensation plan, including options and restricted stock units.", "label": "Outstanding options and restricted stock units" } } }, "localname": "OutstandingOptionsAndRestrictedStockUnits", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "clir_ParticipationRightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Participation Right under Stock Purchase Agreement with ClirSPV, LLC.", "label": "Participation Right" } } }, "localname": "ParticipationRightMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "domainItemType" }, "clir_PatentsPendingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents patents pending.", "label": "Patents pending" } } }, "localname": "PatentsPendingMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "domainItemType" }, "clir_PercentageOperatingLeasesAnnualRentExpenseIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents percentage of Annual rent expense increase. Excludes triple net operating costs.", "label": "Percentage Operating Leases Annual Rent Expense Increase", "terseLabel": "Annual rent expense, increase (in percent)" } } }, "localname": "PercentageOperatingLeasesAnnualRentExpenseIncrease", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails" ], "xbrltype": "percentItemType" }, "clir_PriorYearPrepaidExpensesRepurposedToFixedAssetsAsDemonstrationEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The Prior year prepaid expenses repurposed to fixed assets as demonstration equipment.", "label": "Prior Year Prepaid Expenses Repurposed To Fixed Assets As Demonstration Equipment", "terseLabel": "Prior year prepaid expenses repurposed to fixed assets as demonstration equipment" } } }, "localname": "PriorYearPrepaidExpensesRepurposedToFixedAssetsAsDemonstrationEquipment", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "clir_ProceedsFromIssuanceOfCommonStockNetOfOfferingCostsUnderProgramToDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of stock under the program from inception to the balance sheet date.", "label": "Proceeds from issuance of common stock, net of offering costs, under the program to date", "terseLabel": "Net proceeds to date" } } }, "localname": "ProceedsFromIssuanceOfCommonStockNetOfOfferingCostsUnderProgramToDate", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "monetaryItemType" }, "clir_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation and excluding construction in progress and lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of physical asset used in normal conduct of business to create and distribute product and service.", "label": "Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease And Construction in Progress, after Accumulated Depreciation", "totalLabel": "Fixed assets, net, after accumulated amortization" } } }, "localname": "PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "clir_PropertyPlantAndEquipmentOtherThanLeaseholdImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to all fixed assets (excluding leasehold improvements).", "label": "Fixed Assets Other Than Leasehold Improvements" } } }, "localname": "PropertyPlantAndEquipmentOtherThanLeaseholdImprovementsMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails" ], "xbrltype": "domainItemType" }, "clir_RegisteredTrademarksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents registered trademarks.", "label": "Registered trademarks" } } }, "localname": "RegisteredTrademarksMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "domainItemType" }, "clir_ResearchGrantFromDepartmentOfEnergyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to research grant from the Department of Energy.", "label": "Research Grant From The Department Of Energy [Member]" } } }, "localname": "ResearchGrantFromDepartmentOfEnergyMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "clir_ResearchGrantTotalAwardAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of the research grant award.", "label": "Research Grant, Total Award Amount", "terseLabel": "Total award" } } }, "localname": "ResearchGrantTotalAwardAmount", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails" ], "xbrltype": "monetaryItemType" }, "clir_RestorationCostPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense recognized during the period for restoration cost.", "label": "Restoration Cost Payable", "terseLabel": "Restoration expense" } } }, "localname": "RestorationCostPayable", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails" ], "xbrltype": "monetaryItemType" }, "clir_SeattleAndTulsaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Seattle Washington and Tulsa Oklahoma.", "label": "Seattle and Tulsa" } } }, "localname": "SeattleAndTulsaMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails" ], "xbrltype": "domainItemType" }, "clir_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumIncreaseSharesAvailableForIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum increase in shares available for issuance under share based payment awards.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Increase Shares Available for Issuance", "terseLabel": "Maximum increase in number of shares available for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumIncreaseSharesAvailableForIssuance", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "clir_ShareIssuedForAtMarketIssuance1.24PerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share value of shares issued during the period for At The Market issuance.", "label": "Share Issued For At The Market issuance, 1.24 Per Share", "terseLabel": "Shares issued through at the market issuance 1.24 average per share" } } }, "localname": "ShareIssuedForAtMarketIssuance1.24PerShare", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "perShareItemType" }, "clir_SharesIssuedThroughUseOfAtMarketIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Number of shares issued through the use of At-The Market issuance.", "label": "Shares Issued Through the Use of At-The Market issuance", "terseLabel": "Shares issued through the use of At-The Market issuance" } } }, "localname": "SharesIssuedThroughUseOfAtMarketIssuance", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "clir_SharesIssuedThroughUseOfAtMarketIssuanceShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued through the use of At-The Market issuance shares.", "label": "Shares Issued Through the Use of At-The Market issuance Shares", "terseLabel": "Shares issued through the use of At-The Market issuance (in shares)" } } }, "localname": "SharesIssuedThroughUseOfAtMarketIssuanceShares", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "clir_StockIssuedDuringPeriodSharesInPaymentsOfAccruedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock (or other type of equity) issued during the period as a result of any payment accrued compensation.", "label": "Stock Issued During Period Shares In Payments Of Accrued Compensation", "terseLabel": "Fair value of stock issued in payment of accrued compensation (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesInPaymentsOfAccruedCompensation", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "clir_StockIssuedDuringPeriodSharesIssuedForServicesFour": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock issued during period shares issued for services four.", "label": "Stock Issued During Period Shares Issued for Services Four", "verboseLabel": "Shares issued for services ($0.66 per share) (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServicesFour", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "clir_StockIssuedDuringPeriodSharesStockOptionsExercised0.89PerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock issued as a result of the exercise of stock option, 0.89 per share.", "label": "Stock Issued During Period Shares Stock Options Exercised, 0.89 Per Share", "terseLabel": "Shares issued upon exercise of options ($0.89 per share) (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised0.89PerShare", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "clir_StockIssuedDuringPeriodSharesStockOptionsExercised2.93PerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock issued as a result of the exercise of stock option, 2.93 per share.", "label": "Stock Issued During Period Shares Stock Options Exercised, 2.93 Per Share", "terseLabel": "Shares issued upon exercise of options ($2.93 per share) (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised2.93PerShare", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "clir_StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock (or other type of equity) issued during the period as a result of any payment of accrued compensation.", "label": "Stock Issued During Period Value In Payments Of Accrued Compensation", "terseLabel": "Fair value of stock issued in payment of accrued compensation" } } }, "localname": "StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "clir_StockIssuedDuringPeriodValueIssuedForServicesFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued for services during the period, with specified price per share four.", "label": "Stock Issued During Period, Value, Issued For Services, Four", "terseLabel": "Shares issued for services ($0.66 per share)" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServicesFour", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "clir_StockIssuedDuringPeriodValueIssuedForServicesThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued for services during the period, with specified price per share three.", "label": "Stock Issued During Period, Value, Issued For Services, Three", "terseLabel": "Fair value" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServicesThree", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails" ], "xbrltype": "monetaryItemType" }, "clir_StockIssuedInvestorMaximumBeneficialOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum beneficial ownership percentage allowed for investor or its affiliates under the terms of the agreement.", "label": "Stock Issued, Investor, Maximum Beneficial Ownership Percentage" } } }, "localname": "StockIssuedInvestorMaximumBeneficialOwnershipPercentage", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "percentItemType" }, "clir_StockOptionsGrantedInPaymentOfAccruedCompensationFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "N/A", "label": "Stock Options Granted In Payment Of Accrued Compensation, Fair Value", "terseLabel": "Fair value of stock options granted in payment of accrued compensation" } } }, "localname": "StockOptionsGrantedInPaymentOfAccruedCompensationFairValue", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "clir_SummarySupplementalCashFlowInformationRelatedToLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information related to leases.", "label": "Summary Supplemental Cash Flow Information Related to Leases [Table Text Block]", "terseLabel": "Supplemental cash flow information related to leases" } } }, "localname": "SummarySupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsTables" ], "xbrltype": "textBlockItemType" }, "clir_TargetValueOfCompensationPerQuarter": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of target value of compensation per quarter.", "label": "Target Value of Compensation per Quarter" } } }, "localname": "TargetValueOfCompensationPerQuarter", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails" ], "xbrltype": "monetaryItemType" }, "clir_TrademarksPendingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents trademarks pending.", "label": "Trademarks pending" } } }, "localname": "TrademarksPendingMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "domainItemType" }, "clir_TwoThousandAndTwentyOnePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to two thousand and twenty one plan.", "label": "2021 Plan" } } }, "localname": "TwoThousandAndTwentyOnePlanMember", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails" ], "xbrltype": "domainItemType" }, "clir_UnrealizedHoldingGainLossOnShortTermInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized holding gain (loss) on short-term investments as of balance sheet date.", "label": "Unrealized Holding Gain (Loss) on Short-Term Investments", "terseLabel": "Unrealized holding gains" } } }, "localname": "UnrealizedHoldingGainLossOnShortTermInvestments", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesShortTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "clir_WeightedAverageValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "N/A", "label": "Weighted Average Value Per Share", "terseLabel": "Weighted Average Value Per Share" } } }, "localname": "WeightedAverageValuePerShare", "nsuri": "http://www.clearsigncombustion.com/20230331", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsCompensationExpenseDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails" ], "xbrltype": "perShareItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHINA" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_DirectorMember": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "label": "Director" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r196", "r197", "r198", "r199", "r251", "r342", "r351", "r371", "r372", "r378", "r380", "r387", "r413", "r452", "r453", "r454", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails", "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r196", "r197", "r198", "r199", "r251", "r342", "r351", "r371", "r372", "r378", "r380", "r387", "r413", "r452", "r453", "r454", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails", "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r196", "r197", "r198", "r199", "r250", "r251", "r279", "r280", "r281", "r341", "r342", "r351", "r371", "r372", "r378", "r380", "r387", "r409", "r413", "r453", "r454", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails", "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r196", "r197", "r198", "r199", "r250", "r251", "r279", "r280", "r281", "r341", "r342", "r351", "r371", "r372", "r378", "r380", "r387", "r409", "r413", "r453", "r454", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails", "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r179", "r180", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r379", "r386", "r414" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r179", "r180", "r357", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r379", "r386", "r414" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r407", "r449" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Relationship to Entity [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r7", "r385" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r182", "r183" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r9" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued compensation and related taxes" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "auth_ref": [ "r123", "r124", "r125", "r126", "r309" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r14", "r15", "r87", "r338", "r352", "r353", "r397", "r398", "r399", "r404", "r405", "r406" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r2", "r385" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r285", "r286", "r287", "r404", "r405", "r406", "r442" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r283" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share-based Compensation Expense", "terseLabel": "Compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsCompensationExpenseDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Potentially dilutive shares outstanding (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r94", "r102", "r118", "r139", "r169", "r172", "r176", "r185", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r299", "r303", "r310", "r385", "r411", "r412", "r450" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r113", "r122", "r139", "r185", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r299", "r303", "r310", "r385", "r411", "r412", "r450" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r278", "r279", "r280", "r281", "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsCompensationExpenseDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r33", "r115", "r373" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r27", "r33", "r35" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r27", "r92" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Stockholders' equity" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r11", "r98", "r106" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies.", "terseLabel": "Commitments and contingencies (note 11)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r59", "r194", "r195", "r358", "r410" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "netLabel": "Reserved but unissued shares under the Plans" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r404", "r405", "r442" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized shares" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r1", "r64" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "verboseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r1", "r385" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001 par value, 38,545,556 and 38,023,701 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r226", "r228", "r247" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, Net, Current", "terseLabel": "Contract assets", "verboseLabel": "Contract assets" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilitiesDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r226", "r227", "r247" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilitiesDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r17", "r344" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r18", "r139", "r185", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r310", "r411" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "verboseLabel": "Cost of goods sold" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent": { "auth_ref": [ "r184" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), classified as current.", "label": "Debt Securities, Held-to-Maturity, Fair Value, Current", "terseLabel": "Fair value of short-term investments" } } }, "localname": "DebtSecuritiesHeldToMaturityFairValueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesShortTermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r31", "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r73", "r82" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "terseLabel": "Schedule of Outstanding, Reserved and Authorized Shares under Share-based Compensation Plans" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r133", "r145", "r146", "r147", "r148", "r149", "r153", "r155", "r156", "r157", "r158", "r160", "r307", "r308", "r347", "r350", "r375" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net loss per share - basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r133", "r145", "r146", "r147", "r148", "r149", "r155", "r156", "r157", "r158", "r160", "r307", "r308", "r347", "r350", "r375" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss per share - fully diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r38", "r39" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r441" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options", "terseLabel": "Total unrecognized compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r64", "r110", "r130", "r131", "r132", "r140", "r141", "r142", "r144", "r150", "r152", "r161", "r186", "r225", "r285", "r286", "r287", "r296", "r297", "r306", "r311", "r312", "r313", "r314", "r315", "r316", "r338", "r352", "r353", "r354" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityTables", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r90", "r91" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r116", "r189" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r54" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months", "verboseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r54" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r54" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r54" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r54" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r187", "r188", "r189", "r190", "r345", "r346" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r53", "r346" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "totalLabel": "Patents and other intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r49", "r52" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r53", "r345" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Finite-Lived Intangible Assets, Net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Amortization life (in years)" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedPatentsGross": { "auth_ref": [ "r53" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.", "label": "Finite-Lived Patents, Gross", "verboseLabel": "Patents" } } }, "localname": "FiniteLivedPatentsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedTrademarksGross": { "auth_ref": [ "r53" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.", "label": "Finite-Lived Trademarks, Gross", "verboseLabel": "Trademarks" } } }, "localname": "FiniteLivedTrademarksGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesGross": { "auth_ref": [ "r56" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures, Gross", "verboseLabel": "Office furniture and equipment" } } }, "localname": "FurnitureAndFixturesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Office furniture and equipment" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r401" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "verboseLabel": "Gain from sale of assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r31" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Gain from sale of fixed assts" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnTerminationOfLease": { "auth_ref": [ "r327" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.", "label": "Gain (Loss) on Termination of Lease", "negatedLabel": "Lease amendments" } } }, "localname": "GainLossOnTerminationOfLease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r19" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "verboseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Patents and Other Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "verboseLabel": "Patents and Trademarks" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GovernmentAssistanceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Government Assistance [Abstract]" } } }, "localname": "GovernmentAssistanceAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GovernmentAssistanceAmount": { "auth_ref": [ "r320" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of government assistance recognized.", "label": "Government Assistance, Amount", "terseLabel": "Government assistance, reimbursements from Department of Energy" } } }, "localname": "GovernmentAssistanceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GovernmentAssistanceLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Government Assistance [Line Items]" } } }, "localname": "GovernmentAssistanceLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GovernmentAssistancePolicyTextBlock": { "auth_ref": [ "r319", "r326" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for government assistance.", "label": "Government Assistance [Policy Text Block]", "terseLabel": "Government Assistance" } } }, "localname": "GovernmentAssistancePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GovernmentAssistanceTable": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about government assistance.", "label": "Government Assistance [Table]" } } }, "localname": "GovernmentAssistanceTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GovernmentAssistanceTextBlock": { "auth_ref": [ "r318", "r322", "r323", "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for government assistance.", "label": "Government Assistance [Text Block]", "terseLabel": "Government Assistance" } } }, "localname": "GovernmentAssistanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistance" ], "xbrltype": "textBlockItemType" }, "us-gaap_GovernmentAssistanceTransactionDuration": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Duration of government assistance transaction, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Government Assistance, Transaction Duration", "terseLabel": "Duration of the program" } } }, "localname": "GovernmentAssistanceTransactionDuration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails" ], "xbrltype": "durationItemType" }, "us-gaap_GovernmentAssistanceTypeAxis": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Information by type of government assistance.", "label": "Government Assistance, Type [Axis]" } } }, "localname": "GovernmentAssistanceTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_GovernmentAssistanceTypeDomain": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Type of government assistance.", "label": "Government Assistance, Type [Domain]" } } }, "localname": "GovernmentAssistanceTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureGovernmentAssistanceDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r252", "r253", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r278", "r279", "r280", "r281", "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [ "r252", "r253", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r278", "r279", "r280", "r281", "r282" ], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r16", "r139", "r169", "r171", "r175", "r177", "r185", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r310", "r377", "r411" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r129", "r290", "r291", "r292", "r293", "r294", "r295" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r30" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r30" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "auth_ref": [ "r400" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Increase (Decrease) in Contract with Customer, Asset", "negatedTerseLabel": "Contract assets" } } }, "localname": "IncreaseDecreaseInContractWithCustomerAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r343", "r400" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Contract liabilities" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r30" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Accrued compensation and related taxes" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r400", "r446" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Change in operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r30" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Patents and Other Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r48", "r51" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "totalLabel": "Finite-Lived Intangible Assets, Net", "verboseLabel": "Patents and other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r99" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "terseLabel": "Interest, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r31" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of Stock and Warrants for Services or Claims", "terseLabel": "Common stock issued for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule Of Supplemental Information" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsGross": { "auth_ref": [ "r56" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements, Gross", "verboseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Asset held by lessee under finance lease and addition or improvement to asset held under lease arrangement.", "label": "Leasehold improvements" } } }, "localname": "LeaseholdsAndLeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Operating Lease" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Leases" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of minimum future payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r336" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r336" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r336" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r336" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r336" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r448" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "terseLabel": "2023 (remaining)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r336" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Interest on future minimum payments" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Remaining Lease Term", "terseLabel": "Remaining term (in years)" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Renewal option term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r8", "r139", "r185", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r300", "r303", "r304", "r310", "r376", "r411", "r450", "r451" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r6", "r95", "r104", "r385", "r403", "r408", "r443" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r10", "r114", "r139", "r185", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r300", "r303", "r304", "r310", "r385", "r411", "r450", "r451" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Long Term Liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r56" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment, Gross", "verboseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "terseLabel": "Short-term Investments" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in marketable security, excluding other-than-temporary impairment (OTTI).", "label": "Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss", "negatedLabel": "Realized gain from market securities" } } }, "localname": "MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r136" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r136" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r27", "r29", "r32" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r20" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "verboseLabel": "Other income" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "verboseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r169", "r171", "r175", "r177", "r377" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r332", "r384" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "verboseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r329" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsRouAndLeaseLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails", "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsMinimumFutureLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability [Abstract]", "terseLabel": "Lease Liabilities:" } } }, "localname": "OperatingLeaseLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r329" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsRouAndLeaseLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current lease liabilities", "verboseLabel": "Current portion of lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r329" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsRouAndLeaseLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "netLabel": "Long term lease liabilities", "terseLabel": "Long term lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r328" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "verboseLabel": "Operating lease ROU assets, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r401" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Right of use asset amortization" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r335", "r384" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "verboseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r334", "r384" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Description of Business" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r36", "r37", "r43", "r89" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Organization and Description of Business" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r117" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherFiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r53" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.", "label": "Other Finite-Lived Intangible Assets, Gross", "verboseLabel": "Other" } } }, "localname": "OtherFiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r21" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Total ClearSign Technologies Corp. Stockholders' Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r28" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payments for Rent", "verboseLabel": "Operating cash flows used in operating leases" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r134" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedLabel": "Taxes paid related to vesting of restricted stock units" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": { "auth_ref": [ "r24", "r46" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.", "label": "Payments to Acquire Held-to-maturity Securities", "negatedLabel": "Purchases of held-to-maturity short-term US treasuries" } } }, "localname": "PaymentsToAcquireHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r25" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Disbursements for patents and other intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r25" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Acquisition of fixed assets" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r0", "r209" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized shares" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r0", "r209" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "verboseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r0", "r385" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, $0.0001 par value, zero shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r396" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r26" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock, net of offering costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities": { "auth_ref": [ "r22", "r46" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of securities that had been designated as held-to-maturity. Excludes proceeds from maturities, prepayments and calls by the issuer.", "label": "Proceeds from Sale of Held-to-Maturity Securities", "terseLabel": "Redemption of held-to-maturity US treasuries" } } }, "localname": "ProceedsFromSaleOfHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r23" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds from Sale of Productive Assets", "terseLabel": "Proceeds from sale of fixed assets" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r112", "r127", "r128", "r135", "r139", "r143", "r151", "r152", "r169", "r171", "r175", "r177", "r185", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r298", "r301", "r302", "r308", "r310", "r348", "r377", "r382", "r383", "r399", "r411" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r58", "r359", "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation": { "auth_ref": [ "r193", "r337" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails": { "order": 1.0, "parentTag": "clir_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of accumulated amortization, depreciation, depletion for physical asset used in normal conduct of business to create and distribute product and service.", "label": "Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease, Accumulated Depreciation", "negatedLabel": "Less: Accumulated depreciation and amortization" } } }, "localname": "PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation": { "auth_ref": [ "r192", "r337" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails": { "order": 2.0, "parentTag": "clir_PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated depreciation and excluding lessor's underlying asset for which right to use has been conveyed to lessee under operating lease, of physical asset used in normal conduct of business to create and distribute product and service.", "label": "Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease, before Accumulated Depreciation", "totalLabel": "Fixed assets, gross" } } }, "localname": "PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r57", "r105", "r349", "r385" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Total", "verboseLabel": "Fixed assets, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r57", "r359", "r360" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Fixed Assets and Leases" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Summary of Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Fixed assets, depreciated life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross": { "auth_ref": [ "r108", "r109", "r192", "r337" ], "calculation": { "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.", "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, before Accumulated Depreciation", "verboseLabel": "Operating lease ROU assets, net" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of customer funding recorded as an offset to costs incurred for a fixed-price, best-efforts research and development cost-sharing arrangement with the Federal Government.", "label": "Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred", "terseLabel": "Research and Development costs have been offset by funds received" } } }, "localname": "ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesResearchAndDevelopmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r83", "r107", "r458" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsCompensationExpenseDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r3", "r71", "r103", "r355", "r356", "r385" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r110", "r140", "r141", "r142", "r144", "r150", "r152", "r186", "r285", "r286", "r287", "r296", "r297", "r306", "r352", "r354" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue, Contract Assets and Contract Liabilities" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r167", "r168", "r170", "r173", "r174", "r178", "r179", "r181", "r245", "r246", "r344" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilitiesDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r249", "r374" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition and Cost of Sales" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r248", "r249" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue, Contract Assets and Contract Liabilities" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureRevenueContractAssetsAndContractLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r333", "r384" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "verboseLabel": "Change in operating lease ROU assets" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsLeasesSupplementalBalanceSheetAndCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]", "terseLabel": "Schedule of Compensation Expense" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r49", "r52", "r345" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "terseLabel": "Schedule of Patents and Other Intangible Assets" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureFixedAssetsSummaryDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFixedAssetsAndLeasesDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesForeignOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r76", "r77", "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "Share-based Compensation, Activity [Table Text Block]", "terseLabel": "Schedule of share-based compensation activity" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r252", "r253", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r278", "r279", "r280", "r281", "r282" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsCompensationExpenseDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of restricted stock unit activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r74", "r77", "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]", "terseLabel": "Schedule of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r61", "r62", "r63", "r65", "r66", "r67", "r68", "r69", "r70", "r71", "r119", "r120", "r121", "r162", "r209", "r210", "r211", "r213", "r217", "r222", "r224", "r378", "r394", "r402" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of future amortization expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r30" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Compensation", "verboseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Nonvested at end of year", "periodStartLabel": "Nonvested at beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Nonvested at end of year", "periodStartLabel": "Nonvested at beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested", "terseLabel": "Number of shares vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsCompensationExpenseDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted", "negatedLabel": "Stock grants", "terseLabel": "Stock grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Increases in the number of authorized shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "periodEndLabel": "Reserved but unissued shares at end of year", "periodStartLabel": "Reserved but unissued shares at beginning of year", "terseLabel": "Shares available for grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityConsultantStockPlanDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Exercisable - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r82" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "netLabel": "Estimated aggregate pretax intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r258", "r259" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding shares, ending balance", "periodStartLabel": "Outstanding shares, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r258", "r259" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding - Weighted Average Exercise Price (in dollars per share)", "periodStartLabel": "Outstanding - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum", "terseLabel": "Maximum number of shares that may be issued as a proportion of outstanding stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityEquityIncentivePlanDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r278", "r279", "r280", "r281", "r282" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsActivityDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsCompensationExpenseDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r257", "r276", "r277", "r278", "r279", "r282", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]", "terseLabel": "Share-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "auth_ref": [ "r253", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r278", "r279", "r280", "r281", "r282" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "2021 Employee Awards", "terseLabel": "Employee compensation in lieu of bonus" } } }, "localname": "ShareBasedPaymentArrangementEmployeeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "verboseLabel": "Exercisable - Weighted Average Remaining Contractual Life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Stock options, Contractual life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "verboseLabel": "Share price of shares issued in offering (in dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balances (in shares)", "periodStartLabel": "Beginning Balances (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r96", "r97", "r101", "r395" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term held-to-maturity investments", "terseLabel": "Short-term held-to-maturity investments", "verboseLabel": "Short-term investments at cost" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesShortTermInvestmentsDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r36", "r137" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Product Warranties" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r13", "r64", "r110", "r130", "r131", "r132", "r140", "r141", "r142", "r144", "r150", "r152", "r161", "r186", "r225", "r285", "r286", "r287", "r296", "r297", "r306", "r311", "r312", "r313", "r314", "r315", "r316", "r338", "r352", "r353", "r354" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails", "http://www.clearsigncombustion.com/role/DisclosureEquityTables", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityTables", "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Stockholders' Equity" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r140", "r141", "r142", "r161", "r344" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityTables", "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsSummaryDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Shares issued for services ($1.93 per share) (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityRestrictedStockUnitsDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r0", "r1", "r64", "r71" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of shares of common stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r0", "r1", "r64", "r71" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures", "verboseLabel": "Share based compensation (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "netLabel": "Shares issued for services ($1.93 per share)" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityStockGrantsDetails", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r0", "r1", "r71", "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures", "terseLabel": "Share based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r1", "r4", "r5", "r45", "r385", "r403", "r408", "r443" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total ClearSign Technologies Corporation stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r85", "r86", "r88", "r110", "r111", "r131", "r140", "r141", "r142", "r144", "r150", "r186", "r225", "r285", "r286", "r287", "r296", "r297", "r306", "r311", "r312", "r316", "r338", "r353", "r354", "r403", "r408", "r443" ], "calculation": { "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedBalanceSheets", "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r72", "r138", "r210", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r223", "r225", "r305" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r339", "r340" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityCommonStockAndPreferredStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosurePatentsAndOtherIntangibleAssetsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r40", "r41", "r42", "r163", "r164", "r165", "r166" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/DisclosureEquityTables" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r154", "r158" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Weighted average number of shares outstanding - fully diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r153", "r158" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average number of shares outstanding - basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.clearsigncombustion.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123422147&loc=d3e41457-112716", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342943-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342943-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342943-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342950-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342950-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342950-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342950-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342950-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342957-244231", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "40", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123386189&loc=SL77918607-209975", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919398-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r388": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r389": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r391": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r392": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r393": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 61 0001558370-23-009840-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-23-009840-xbrl.zip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�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end